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ABSTRACT 
Membrane proteins represent the majority of therapeutic targets for the antibody-based 
drugs available today. These are routinely identified via phage display screening, but 
traditional antigen presentation methods require membrane protein targets to be 
detergent-solubilised in order to preserve their native conformations post-purification. 
Unfortunately, detergent solubilisation can not only lead to gradual target denaturation 
over time, but the detergent micelles can also occlude important epitopes on the 
extramembranous loops and thus prevent the discovery of antibody binders. 
The current thesis aimed to demonstrate that, by reconstituting purified membrane 
proteins into spherical-supported bilayer lipid membranes (SSBLMs) deposited on 
nanosized substrates, a versatile platform can be constructed for performing phage display 
screening against membrane protein targets, while not only presenting these within a 
native-like lipid environment, but also eliminating detergents from the screening phase 
altogether. For providing proof-of-concept, 100- and 200 nm silica nanoparticles were 
covered with POPC SSBLMs embedding the bacterial nucleoside transporter NupC. Full 
substrate coverage and the correct formation of the lipid bilayer components were 
established via spectrofluorometry, using fluorescent labelling and small-angle X-ray 
scattering (SAXS) respectively, while Western blotting and high-affinity antibody 
binding confirmed the presence of SSBLM-embedded NupC. 
The platform was then used to screen designed ankyrin repeat proteins (DARPins) against 
a His6-tagged construct of NupC across different screening formats so as to offer a 
comparison to the classic 96-well plate antigen presentation method. Following that, the 
DARPin binders showing the highest potential affinity for NupC were purified and 
subjected to further binding validation assays against two other constructs – detergent-
solubilised double Strep-tagged NupC and SSBLM-embedded untagged/wild-type NupC 
– in order to identify any binders targeting extramembranous epitopes that would be 
accessible in vivo as well. Ultimately, the results presented throughout indicated that 
SSBLMs constitute a promising means of screening antibody binders against membrane 
protein targets embedded in a close-to-native format.  
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Constants 
AT-cut quartz crystal shear modulus (µq) – 2.947×1011 g cm−1 s2 
Quartz crystal density (ρq) – 2.648 g cm−3 
Room temperature – 293.15 K 
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CHAPTER 1 
 
Project Aim and Introduction 
 
1.1. Background and Aim 
Membrane proteins represent a vital category of cellular membrane constituents 
responsible for facilitating a multitude of processes involved in homeostasis, including 
cell-to-cell interactions, nerve excitation and signal transduction, ion and nutrient 
transmembrane transport, cell respiration and photosynthesis, as well as the elimination 
of unwanted cellular by-products and waste (Patching et al., 2005). Members of this 
protein class include – but are not limited to – G-protein coupled receptors (GPCRs), 
ligand- and voltage-gated ion channels (Overington et al., 2006), protein kinases, 
phospholipases and biochemical receptors of all kinds (Johnson and Cornell, 1999). 
Regardless of whether they span the full thickness of the lipid bilayer (i.e. “integral”) or 
are only attached to one side of their native membranes (i.e. “peripheral”) (Cho and 
Stahelin, 2005), membrane proteins are encoded by approximately 30% of the genomes 
of archaea, eubacteria and eukaryotes – a proportion clearly underlining their 
indispensability towards sustaining life in its many different forms (Wallin and von 
Heijne, 1998). 
1.1.1. The present focus of the pharmaceutical industry 
Given that a large number of debilitating diseases such as Bartter syndrome, osteoporosis, 
myotonia congenita, cardiac arrhythmia, hypertension, congenital deafness and epilepsy 
(Hübner and Jentsch, 2002) or cystic fibrosis and polycystic kidney disease (Aperia, 
2007) are caused by the incorrect function of specific classes of membrane-bound 
proteins, it is unsurprising that a majority of the therapeutics that are commercially-
available today target membrane proteins exclusively (Hopkins and Groom, 2002). Of 
these, antibody-based drugs represent major drivers of the pharmaceutical industry, 
capable of binding virtually any biological target with high affinity and specificity, while 
also provoking less side-effects compared to small molecule therapeutics (Imai and 
Takaoka, 2006). In an attempt at discovering new therapeutic antibodies, the industry 
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relies on the use of high-throughput in vitro techniques such as phage display screening 
in order to scan million-strong binder candidate libraries against the membrane protein 
targets of interest. However, the identification of highly-specific antibody binders 
demands a similarly high level of purity from the targets themselves and this is where the 
bottlenecks impeding membrane protein screening start to arise from. 
1.1.2. The issues surrounding the study of membrane proteins 
As opposed to cytoplasmic (i.e. soluble) proteins, only very few membrane proteins ever 
see high levels of expression within biological membranes (e.g. aquaporins (Zeuthen et 
al., 2013), rhodopsins (Schertler, 2015) or ATPases (Andersen et al., 2016)) and these 
have already been studied at length and have had their structures determined as a result. 
Since circular dichroism (CD), kinetic and ligand-binding characterisation, nuclear 
magnetic resonance (NMR) or X-ray crystallography studies cannot be performed 
directly on native membranes, information on classes of membrane proteins showing poor 
native expression is severely limited by not only the difficulties inherent to the production 
of enough recombinant protein, but also by their isolation with the high purity and 
conformational stability required for meeting the rigours of the above-mentioned research 
techniques (Seddon et al., 2004). 
Whether this is due to various differences in the membrane protein biogenesis pathways 
(e.g. cellular chaperones, foldases, signal recognition and translocon components) or the 
xenobiotic toxicity levied onto the host expression system (Mancia and Love, 2010), the 
overproduction of specific classes of membrane proteins will almost always be very low 
(Bill et al., 2011). This is certainly the case with mammalian membrane proteins 
expressed in bacterial (e.g. Escherichia coli) systems (Tate, 2001), whose cellular 
membranes can only express limited amounts of recombinant protein even in the best 
scenarios (Rahman et al., 2007). Furthermore, membrane proteins are notoriously averse 
to standard purification techniques such as hydrophobic interaction chromatography and 
ion exchange (Mancia and Love, 2010), and even when employing high-affinity 
chromatography methods facilitated by the introduction of specialised (e.g. Strep- or 
polyhistidine) tags (Mohanty and Wiener, 2004), their purification to a high-enough 
standard to support rigorous subsequent studies is also met with considerable hurdles, 
including poor overall yields and post-purification denaturation (Yang et al., 2014). One 
important contributing factor to this latter impediment is undoubtedly represented by the 
traditional reliance on detergent solubilisation for counteracting the considerable 
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hydrophobicity of membrane protein targets and their tendency to aggregate in solution 
once they are removed from their native lipid membrane environment (Bill et al., 2011). 
1.1.3. The detergent solubilisation of membrane proteins 
Owing to their particular structure, consisting of a polar (i.e. hydrophilic) head group 
attached to a non-polar (i.e. hydrophobic) alkyl chain or “tail” (Figure 1.1.3.1), detergents 
are amphipathic molecules that can spontaneously self-associate to form largely spherical 
micellar structures when introduced to aqueous solutions above their critical micellar 
concentration, or “CMC” for short (Garavito and Ferguson-Miller, 2001). 
 
Figure 1.1.3.1. Models of D-octylglucoside monomers and micelles, depicting both their carbon 
(grey) and oxygen atoms (red): A) Individual detergent monomers; B) A 20-monomer micelle; 
C) A 50-monomer micelle. Detergent micelles are seldom perfectly spherical and instead assume 
non-uniform cluster-like shapes, as derived from molecular dynamics (MD) simulation data. 
Since in actuality the polar head groups of individual monomers do not effectively cover the entire 
micellar surface in an orderly fashion, some of the alkyl chains also become exposed to the solvent 
at certain times (black arrows) (adapted from Garavito and Ferguson-Miller, 2001). 
The CMC represents the minimal concentration at which individual detergent monomers 
can self-assemble into micelles and fulfil their role as surfactants, lowering the surface 
tension between different interfaces (e.g. liquid-solid). A multitude of factors influence 
the CMC of a detergent, including the ionic strength, pH and temperature of the aqueous 
solution, along with the length of the alkyl chain (i.e. longer chains reduce the CMC) and 
the number of double bonds and branch points present in the monomer structure (i.e. 
higher double bond and branch point numbers increase the CMC) (Seddon et al., 2004). 
When used for the purification of membrane protein targets, detergents are generally 
present in the buffers used to equilibrate the high-affinity chromatography columns at 
concentrations 2-3× greater than their CMC, in order to ensure that free detergent micelles 
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will always be available in sufficient numbers to prevent membrane proteins from 
becoming unstable upon delipidation (Kunji et al., 2008). 
Detergents are regularly classified according to the chemistry of their head groups, either 
as ionic (i.e. anionic or cationic), non-ionic or zwitterionic (i.e. both anionic and cationic) 
(Garavito and Ferguson-Miller, 2001), and it is through their unique structural and 
functional properties that they are able to bind other hydrophobic surfaces (Seddon et al., 
2004). Since lipids are essentially surfactants as well, detergents can also be used as lipid 
bilayer mimics when isolating membrane proteins from their native environment during 
purification. 
Upon their solubilisation and the removal of surrounding membrane lipids, the 
hydrophobic areas of membrane proteins – which are normally shielded from the aqueous 
phase by the lipid bilayer – become enveloped in a protective detergent micelle which 
renders them soluble as protein-detergent complexes (Garavito and Ferguson-Miller, 
2001). In an ideal scenario, detergent-mediated solubilisation would preserve not only the 
structural properties, but also the in vivo function of a membrane protein target. 
Unfortunately, this is by no means a simple process, as using an unsuitable detergent or 
even non-optimal amounts of a suitable detergent can both hinder membrane protein 
solubilisation (le Maire et al., 2000). 
This is the reason why “milder” (i.e. less denaturing) detergents are better for certain 
membrane protein studies than other, “harsher” (i.e. more denaturing) ones. Two 
parameters that greatly influence the mildness or harshness of a detergent are the length 
of its alkyl chain (Kunji et al., 2008) and the chemistry of its head group (Tate, 2010) 
(Figure 1.1.3.2 overleaf). Whereas short-chain detergents (e.g. octylglucoside) can form 
micelles around membrane proteins while leaving a larger portion of their hydrophilic 
areas exposed (Kunji et al., 2008), long-chain detergents (e.g. n-Dodecyl β-D-maltoside 
(DDM)) are better suited for extracting membrane proteins while also preserving their in 
vivo functions as a consequence of their reduced denaturing effect (Tate, 2010). 
Similarly, the “harsh” nature of ionic detergents (e.g. sodium dodecyl sulfate (SDS)) 
explains why they are commonly used in techniques involving denatured proteins, such 
as polyacrylamide gel electrophoresis (PAGE) (le Maire et al., 2000), despite their highly-
efficient membrane solubilisation properties (Seddon et al., 2004). Conversely, “milder” 
non-ionic detergents (e.g. α-[4-(1,1,3,3-Tetramethylbutyl)phenyl]-w-hydroxy-poly(oxy-
1,2-ethanediyl) (Triton X-100)) are preferred for more delicate membrane protein 
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reconstitution work, due to their efficacy in solubilising lipid membranes without also 
denaturing the proteins present in solution (le Maire et al., 2000). 
 
Figure 1.1.3.2. Structures of common detergent monomers, both mild and harsh (from top-to-
bottom): n-Dodecyl β-D-maltoside (DDM), n-Dodecylphosphocholine (Fos-Choline-12), 
lauryldimethylamine N-oxide (LDAO) and sodium dodecyl sulfate (SDS). While all of these 
detergents feature similarly-long alkyl chains, their denaturing effects increase from top-to-
bottom with the decreasing head group size and the emergence of charged moieties (adapted from 
Tate, 2010). 
In an ideal solubilisation scenario (Figure 1.1.3.3 overleaf), the detergent is added to the 
native membrane solution and begins its interaction with the lipid phase in non-micellar 
form (le Maire et al., 2000). The onset of the solubilisation process increases the turbidity 
of the solution until a maximal detergent saturation point is reached (i.e. Rsat), beyond 
which lipid bilayers cannot preserve their shape (Knol et al., 1998). Following Rsat, the 
turbidity of the solution will steadily fall for the remainder of the process as increasing 
numbers of detergent monomers interact with the lipid bilayers and the detergent-
detergent interactions cause the membrane structure to dissolve (Seddon et al., 2004). 
This leads to the formation of mixed detergent-lipid micelles and the exposure of the 
embedded membrane proteins to the detergent micelles that have already formed in 
solution (le Maire et al., 2000). In the final stage of the process (i.e. Rsol), both the lipid 
component of native membranes and the membrane proteins contained therein become 
completely solubilised (Knol et al., 1998) and any excess detergent will only serve to 
further dilute the phospholipids of individual micelles (Seddon et al., 2004). It is 
important to note, however, that in reality all of these transitions normally overlap and 
that the optimal destabilisation point of any native membrane depends not only on its 
constituent lipid species, but also on the solubilising properties of the detergent at hand 
(le Maire et al., 2000). 
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Figure 1.1.3.3. Diagram of native membrane detergent solubilisation (lipid vesicles in black and 
detergent monomers in white). Increasing the concentration of detergent monomers initially 
triggers the swelling of the vesicles as detergent molecules infiltrate the lipid bilayers. This is 
reflected by a linear increase in turbidity when measuring the light scattering of the solution. 
Beyond point 1, the vesicles steadily become saturated with detergent (Rsat), after which the lipid 
bilayers begin to fall apart into mixed detergent-lipid micelles (i.e. point 2) until all of the lipids 
have been completely solubilised by the detergent (Rsol) (adapted from Seddon et al., 2004). 
1.1.4. The drawbacks of membrane protein detergent solubilisation 
While detergents are often used in excess during membrane protein purification in order 
to always keep their concentration above their CMC, their presence in solution post-
purification is seldom favourable to the subsequent experimental work (Yang et al., 
2014). As such, purified membrane protein suspensions are generally dialysed against 
plain buffer in order to dilute the detergent below the CMC and cause the micelles to 
disintegrate into individual monomers, which can then be more easily removed via further 
dialysis, gel or ion-exchange chromatography or hydrophobic absorption (Seddon et al., 
2004). The purified membrane proteins can then either be transferred into a less disruptive 
detergent solution or alternatively reconstituted into model membranes such as liposomes 
and thus be separated from detergents altogether. This latter method is actually preferred 
in most cases since, depending on the type of detergent being used, a significant number 
of membrane proteins – particularly those originating from higher eukaryotes – can 
rapidly denature upon their extraction from native membranes, rendering their high-
quality purification almost impossible (Bill et al., 2011). 
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While detergent solubilisation does permit the study of protomeric and self-associated 
membrane proteins, as well as their interactions with other biomolecules such as ligands 
or inhibitors (le Maire et al., 2000), even the mildest detergents are ultimately rather poor 
mimics of native membranes and can still lead to the complete inactivation of the 
solubilised membrane proteins over long periods of time (Seddon et al., 2004). 
Furthermore, for the purposes of screening antibody binders against membrane protein 
targets, the presence of detergents can also result in the occlusion of potential epitopes 
(Figure 1.1.4.1) and thus ultimately impede the discovery of novel therapeutics (Kunji et 
al., 2008). 
 
Figure 1.1.4.1. The mitochondrial inner membrane ADP/ATP translocator protein AAC1, 
solubilised in detergents with different alkyl chain lengths. As the size of the detergent monomers 
increases, so too can the resulting micelles block potential epitopes on the surface of the protein 
of interest and thus prevent the binding of antibody candidates (adapted from Kunji et al., 2008). 
To this end, alternative methods for presenting membrane proteins towards antibody 
screening needed to be explored. As previously mentioned, membrane protein targets can 
alternatively be reconstituted into artificial model membranes post-purification in an 
attempt at minimising the negative effects of detergent solubilisation. Doing so will not 
only present them for study or screening in a closer-to-native format that shields their 
hydrophobic regions inside a lipid bilayer, but will also expose their extracellular loops 
to the external aqueous environment (and, consequently, to antibody binding) at the same 
time. 
1.1.5. Improving antibody screening against membrane protein targets 
The main objective of the current research project was to present membrane protein 
targets for phage display screening in a novel format that could forgo the presence of 
detergents during antibody binding. Through the use of solid-supported membrane (SSM) 
technology, purified membrane proteins were reconstituted into biomimetic model 
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membranes providing a close-to-native environment that not only mimicked the original 
biological membranes from which the targets originated, but also completely eliminated 
the need for having detergent present during screening. The means through which this 
aim was achieved will be discussed throughout the thesis, starting with an overview of 
the significant progress reported in lipid membrane research throughout the ages. 
1.2. Lipid Membrane Research 
Cellular membranes represent bioarchitectural structures essential to the existence of all 
known forms of life (Gunning, 2012). Almost all homeostatic processes rely on the 
existence of lipid barriers to provide a clear demarcation between the extracellular and 
intracellular environments, as well as to offer cytoskeletal support, facilitate extracellular 
signalling, enable intracellular transport of electrolytes and regulate cytoplasmic pH, 
among many other functions. Due to their overwhelming complexity and the importance 
of their correct function towards supporting life, substantial research has been channelled 
over the last century into understanding the mechanisms behind their function and 
elucidating the means through which malfunctioning cellular membranes lead to 
pathogenesis. It is this scientific insight that has led to the creation of model lipid 
membranes – facile biomimetic constructs allowing the study of the multifaceted 
interactions occurring between different membrane components via their reconstitution 
into an artificial, yet exceptionally versatile research platform. 
1.2.1. An era of lipid membrane research 
Inquiries into the properties of lipid membranes began millennia ago with the simple 
observation of single molecule lipid film formation at the interface between air and a body 
of water. Films of oil floating on water were actually first described in cuneiform on 
Babylonian clay tablets as a form of divination. The practice was still popular by the time 
of the ancient Greeks, who termed it “lecanomancy” from lekami, meaning “bowl” and 
manteia, meaning “divination” (Tabor, 1980). Lecanomancy proved to be so widespread 
that even the Japanese were no strangers to the practice. In fact, the Nippon civilization 
was credited with the earliest technical application of lipid surface films through the old 
art of sumiganashi or “ink-float”, where Japanese ink – sumi, harbouring a significant 
lipid content – was dropped into a bowl of water and then gently blown across its surface 
in order to create fantastical shapes of great mystical importance (Dynarowicz-Łątka et 
al., 2001). 
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Since ancient times, fishermen, sailors, merchants and other seafarers have reported the 
calming effects oil spreads have on stormy seas and these have even been described in 
the works of great philosophers such as Plutarch, Aristotle and Plinius (Fulford, 1968). 
However, the scientific investigation of the mechanisms behind this favourable property 
of lipid films only began approximately two millennia later, when polymath and 
Founding Father of the United States, Benjamin Franklin, performed the Clapham pond 
experiment in 1774 so as to witness this curious phenomenon for himself. In his reports, 
Franklin noted that “the oil, though not more than a teaspoonful… spread amazingly… 
making all that quarter of the pond, perhaps half an acre, as smooth as a looking glass” 
(Gaines Jr., 1983). In the years since, Franklin’s experiment has been credited as the first 
quantitative observation of the effects lipid films have on water surface tension 
(Dynarowicz-Łątka et al., 2001). 
The molecular study of oil film spreads began more than a century later, following the 
kitchen experiments of then 20-year-old Agnes Pockels. Throughout her career as a 
German Chemistry pioneer, she performed systematic studies on the relationship between 
oil layer compression and water surface tension by spreading oil films of varying 
thicknesses in water-filled troughs (Gaines Jr., 1983). Pockels observed that water surface 
tension dropped rapidly when the suspended oil film was compressed by a certain ratio 
(Pockels, 1891) and disseminated her observations in the now-famous correspondence 
with British physicist and Nobel laureate Lord Rayleigh, who proposed that the films 
were monomolecular in nature (Gaines Jr., 1983). Lord Rayleigh was also the first to 
quantitatively investigate water surface tension reduction following olive oil application 
and to provide a thickness estimate for the oil film itself, namely 16 Å (Dynarowicz-Łątka 
et al., 2001). Agnes Pockels’ observations led Lord Rayleigh to believe that, below a 
certain compression ratio, oil molecules were naturally pressed together and his 
hypothesis later on became the premise for the subject of monomolecular lipid film study. 
The scientific evidence supporting Lord Rayleigh’s theory was only provided years later 
by the American chemist and physicist Irving Langmuir, who characterised the 
orientation of lipid molecules at the air-water interface and showed how monomolecular 
layers could be transferred onto solid substrates (Gaines Jr., 1983). Working alongside 
his fellow compatriot and physicist Katharine Burr Blodgett, Langmuir first demonstrated 
multilayer film formation via the sequential transfer of lipid monolayers onto a solid 
surface (Dynarowicz-Łątka et al., 2001). These structures have since been referred to as 
“Langmuir-Blodgett” films and were shortly thereafter used in a key experiment which 
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gave birth to our contemporary structural vision of a biological membrane (Bagatolli et 
al., 2010). 
The bilayer structure of biological membranes was actually established years later in 
1925, when Dutch physicians Gorter and Grendel compared the total surface areas of lipid 
extracts obtained from human, rabbit, dog, guinea pig, sheep and goat erythrocyte cell 
membranes with the average surface areas of whole blood cells. Discovering that the 
former were curiously double the size of the latter, the two researchers concluded that the 
“layer of lipoids” surrounding blood “chromocytes” was in reality “two molecules thick” 
(Gorter and Grendel, 1925). However, even with all of these scientific findings accrued 
by the onset of the 20th century, the existence of proteins expressed in biological 
membranes still remained completely unknown (Bagatolli et al., 2010). 
1.2.2. The Davson-Danielli-Robertson cell membrane model 
It was only in 1935 that James Frederic Danielli and Hugh Davson, from the Department 
of Biochemistry at University College London, drew attention to the protein content of 
cellular membranes through their thermodynamic studies performed on plant, erythrocyte 
and marine egg cells. Judging from their findings, the two suggested a cell membrane 
model where globular proteins were attached to the surface of the membranes (Figure 
1.2.2.1), forming a protein “film” which was capable of selectively allowing the passage 
of “non-lipoid” molecules of different sizes through an otherwise impermeable “lipoid” 
bilayer. 
 
Figure 1.2.2.1. The Danielli-Davson cell membrane model, depicting a lipid bimolecular layer to 
which a film of globular proteins is attached on both the extra- and intracellular side of the cellular 
membrane (adapted from Danielli and Davson, 1935). 
The two proponents of the eponymous cell membrane model also theorised that, unless 
the lipid content of other cell types was of a radically different composition, the presence 
CHAPTER 1 – PROJECT AIM AND INTRODUCTION 
 
11 
and activity of their associated protein film would remain the same (Danielli and Davson, 
1935). Twelve years later, David J. Robertson, from the Department of Anatomy at 
University College London, confirmed Danielli and Davson’s assumptions through his 
research into the ultrastructure of frog peripheral nerve fibres (Robertson, 1957). 
Robertson’s electron micrographs showed two individualised “dense lines” in frog 
Schwann cell and neuronal axon membranes instead of just the one suggested until then, 
each measuring less than 100 Å in thickness and being separated by a “light interzone” 
almost 150 Å wide (Figure 1.2.2.2). 
 
Figure 1.2.2.2. Electron micrograph of two Schwann cells (Sch.) enveloping two frog peripheral 
nerve axons (ax.). The arrows (1, 2) indicate the bilayer nature of the cell membranes (~75 Å in 
thickness), as well as the “interzones” (~145 Å in thickness) present at the axon-Schwann (1) and 
Schwann-Schwann (2) cellular interfaces (adapted from Robertson, 1957). 
According to Robertson (1957), all cellular membranes featured a bimolecular lipid 
“leaflet” containing embedded “associated proteins” – a construct which he coined the 
“unit membrane” (Figure 1.2.2.3). Robertson’s findings ultimately led to the emergence 
of the “Davson-Danielli-Robertson” (DDR) cell membrane model, which became widely-
accepted in membrane research between the 1960s and 1970s (Stoeckenius, 1962). 
 
Figure 1.2.2.3. Diagrammatic representation of J. D. Robertson’s “unit membrane” hypothesis 
(adapted from Green and Perdue, 1966). 
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The early 1960s provided researchers with another equally important discovery. In 1964, 
light was shed upon the nature of lipid bilayer formation through the work of Bangham 
and Horne, from the Agricultural Research Council Institute of Animal Physiology in 
Cambridge, UK, who reported the formation of “spherulites” (i.e. liposomes) comprised 
of “many hundreds” of concentric lecithin lamellae (Figure 1.2.2.4) while studying lipid 
phase structures under the electron microscope (Bangham and Horne, 1964). 
   
Figure 1.2.2.4. Bangham and Horne’s electron micrographs of the discrete structure of the cell 
membrane. Left: a negatively-stained preparation of ovolecithin, treated by ultrasound and mixed 
with 2% (w/w) potassium phosphotungstate, depicting multi-lamellar lipid “spherulites” (i.e. 
liposomes). Right: enlargement of the lamellar section of a “spherulite” with arrows highlighting 
rod-shaped elements lying at right angles to the axis of the lamellae, presumed to be individual 
lipid molecules (adapted from Bangham and Horne, 1964). 
Bangham and Horne used potassium phosphotungstate as a negative stain for their 
electron micrographs due to its low surface reactivity and its capability of preserving lipid 
structures in a rigid, electron-dense setting that allowed for very high resolution images 
of the discrete membrane structures to be taken. 
1.2.3. The Benson-Green cell membrane model 
Two years later, A. A. Benson, from the Department of Marine Biology at the University 
of California, USA, was one of the first to challenge the universal applicability of the 
DDR cell membrane model by studying plant chloroplasts instead of neuronal or glial 
cells (Benson, 1966). Benson employed the “freeze-etch” technique used previously in 
the study of osmium tetroxide (OsO4)-stained chloroplast sections under the electron 
microscope (Bagatolli et al., 2010) and deduced that plant chloroplast membranes 
featured lamellae that could be clearly divided into individual lipoprotein subunits, or 
“quantasomes”, containing four surfactant lipids arranged in a mosaic-like pattern (Figure 
1.2.3.1 overleaf). 
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Figure 1.2.3.1. Benson’s electron micrographs of the discrete structure of plant chloroplasts. Left: 
a bean leaf stained with osmium tetroxide (OsO4), depicting chloroplasts with lamellar structures 
and bilayer cellular membranes. Right: enlarged chloroplast lamellae section, depicting multiple 
repeating lipoprotein subunits (adapted from Benson, 1966). 
Two other researchers, David E. Green and James F. Perdue, contemporaries of Benson’s 
from the Institute of Enzyme Research at the University of Wisconsin, USA, also 
commented on the limitations of the DDR cell membrane model – more specifically, the 
bond between the phospholipid bilayer and the attached protein film, which were until 
then believed to be held together primarily by electrostatic forces occurring between two 
types of molecules of essentially separate phases (Green and Perdue, 1966). Green and 
Perdue reviewed several membrane studies of their time, such as Green and Fleischer 
(1963) – on the mitochondrial energy coupling system and its oxidative phosphorylation 
pathways, Brown (1965) – on the membranes of the halophilic (i.e. “salt-loving”) 
bacterium Halobacterium halobium and even Benson’s earlier work on plant chloroplast 
membranes and their lipid molecule content (Benson, 1964), ultimately concluding that 
the predominant binding between the phospholipid and protein constituents was not 
electrostatic, but rather hydrophobic in nature, implying a strong connection between the 
hydrophobic regions of membrane proteins and the hydrocarbon residues of phospholipid 
molecules (Bagatolli et al., 2010). 
Furthermore, Green and Perdue uncovered through the work of Fleischer et al. (1962) 
that this hydrophobic interaction was so strong that, upon using bile salts to disassociate 
the lipoprotein complexes of the mitochondrial electron transfer chain, the lipid-protein 
stoichiometry in the separated complexes was left undisturbed. Fleischer et al. (1962) also 
observed that the electron transfer complexes of the inner mitochondrial membrane lost 
their capacity for integrated electron transfer following their disassociation from the lipid 
bilayer, only to regain this property when the lipids were reintroduced. This finding 
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helped underline the importance of lipid molecules towards the correct function of 
membrane proteins. Green and Perdue assumed this was due to the nature of the 
hydrophobic interactions occurring between the lipids and proteins, theorising that lipid 
molecules could influence the conformation of protein molecules to such an extent as to 
prevent their function upon their removal (Green and Perdue, 1966). Nevertheless, the 
reviewers agreed with Robertson’s “paucimolecular” unit membrane, concluding that it 
was “highly probable” that all biological membranes consisted of smaller, repeating 
membrane units. Robertson’s theory was ultimately confirmed through studies such as 
Green et al. (1967) – on the individual complexes of the mitochondrial electron transfer 
chain and the membrane structures of rat liver mitochondria, spinach chloroplasts, as well 
as bovine heart, photoreceptor and liver microsomal cells. 
However, at the beginning of the 1970s, the DDR and Benson-Green cell membrane 
models came under new scrutiny when Walther Stoeckenius and Donald M. Engelman, 
from the Cardiovascular Research Institute at the University of California, USA, 
published a comprehensive review of all of the proposed biological membrane models 
available to that date, presenting each of their limitations in great detail and supporting 
their claims with exhaustive scientific evidence (i.e. approximately 300 individual 
literature sources). Stoeckenius and Engelman (1969) concluded that even though the 
lipid bilayer model provided the best approximation of the main structural principles of 
biological membranes, there was still no model in existence that could explain all of the 
experimental data determined from different types of biological membranes. At a time 
when no immediate consensus could be reached upon a more general representation of 
cellular membranes, the emergence of “the fluid mosaic model” (Figure 1.2.3.2) – 
published by S. J. Singer and Garth L. Nicolson in 1972 – was unanimously heralded as 
a “second wind” in biological membrane research (Singer and Nicolson, 1972). 
 
Figure 1.2.3.2. An integral and peripheral membrane protein mosaic embedded within a lipid 
matrix, or “the fluid mosaic model of the structure of cell membranes” (adapted from Singer and 
Nicolson, 1972). 
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1.2.4. The fluid mosaic cell membrane model 
More than 40 years have passed since this model was proposed and it is still considered 
a central paradigm of biological membrane research even today (Bagatolli et al., 2010). 
The fluid mosaic representation was the first model that could be applied to a majority of 
biological membranes, be they “functional” (e.g. intracellular, mitochondrial, 
plasmalemmal or chloroplast membranes) or otherwise (e.g. myelin sheaths, animal virus 
membranes, etc.) (Singer and Nicolson, 1972). Not just that, but the model also respected 
many experimental observations, such as the limited transverse mobility of lipid 
molecules, the possibility of lateral diffusion for all membrane constituents, the 
permeability capacity of the membrane, as well as the differences between the various 
categories of membrane proteins (e.g. integral, α-helical, globular or peripheral) and those 
between discrete membrane phase transitions (Bagatolli et al., 2010). While the fluid 
mosaic model was at times dismissed as a generalised representation of proteins “floating 
as icebergs in a sea of lipids” (Luckey, 2008), lateral mobility in a pseudo-two-
dimensional liquid is but one of the physical properties accounted for by this cell 
membrane model. The thermodynamics underlying the hydrophobic and hydrophilic 
interactions occurring between different molecules, the multiple types of non-covalent 
binding contributing to the macromolecular membrane structure (e.g. hydrogen bonding, 
electrostatic forces, dipole-dipole interactions), the predominance of protein molecules 
over other major classes of membrane constituents, such as oligosaccharides, as well as 
their role in sustaining a complex homeostatic and structural balance, are equally 
represented and respected by the fluid mosaic cell membrane model (Singer and Nicolson, 
1972). 
Throughout later years, multiple improvements to the fluid mosaic model were proposed, 
usually after new studies uncovered specialised features of specific membrane types 
(Bagatolli et al., 2010). Notable examples include the refinements brought by Marčelja 
(1976) and Israelachvili (1977), which took into account additional membrane properties 
such as folding, pore formation and variations in lipid bilayer thickness. These 
refinements contributed shortly thereafter to Mouritsen and Bloom’s “mattress” cell 
membrane model (Mouritsen and Bloom, 1984), based on their deuterium NMR studies. 
The mattress model suggested that the interactions between membrane-bound lipid and 
protein molecules gave way to positive Gibbs energy due to localised variations existing 
in the hydrophobic regions of each molecule. This, in turn, caused interfacial tension and 
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resulted in the capillary-force-mediated aggregation of specific types of lipids around 
protein molecules, forming mattress-like structures (Figure 1.2.4.1). 
 
Figure 1.2.4.1. Examples of cell membranes embedding integral proteins that do not match the 
equilibrium thickness of the surrounding lipid bilayers and thus resemble the appearance of a 
mattress (adapted from Mouritsen and Bloom, 1984). 
The mattress cell membrane model, together with Sackmann’s principle for trigger 
processes (Sackmann, 1995a) – implying that a majority of membrane processes are 
triggered by a local transient influx of Ca2+ ions, such as the one generated by the fusion 
of synaptic vesicles with the neuronal presynaptic membrane – highlighted the emerging 
importance of modelling membrane regions differently around integral membrane 
proteins (Mouritsen, 2011b). Sackmann also notably provided further refinements to the 
fluid mosaic model, which included the incorporation of the glycocalyx and the 
cytoskeleton, both of which attach to cell membranes and play important cytoarchitectural 
and homeostatic roles (Sackmann, 1995a). Together with several other lipid 
biophysicists, Sackmann anticipated the impact lipid-protein interactions occurring in 
separate membrane regions had towards membrane-mediated processes (Shimshick and 
McConnell, 1973), basing his assumption on the lateral segregation of lipids under 
specific temperatures and compositions giving rise to the formation of distinct lipid 
domains with discrete structural properties (Sackmann, 1995b). Even following lengthy 
discussions regarding alternative membrane models derived from novel experimental 
data, Sackmann’s observations were largely ignored by the Life Sciences community 
until Kai Simons and Elina Ikonen (1997) published a seminal paper on the existence of 
so-called “lipid rafts” within biological membranes – a term coined almost a decade 
earlier by Simons and van Meer (1988), referencing the glycolipoprotein microdomains 
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characteristic of native membrane organisation. To this day, lipid rafts represent an 
actively-researched area of cell membrane biology (Mouritsen, 2011a). 
1.3. Model Membranes 
Native membrane modelling has been known take on many different forms, depending 
on the examined membrane constituents and the types of assays involved in their study. 
Some of the most commonly-used models for membrane protein research are outlined 
throughout the following subsections. 
1.3.1. Supported lipid membranes 
The simplest model of a lipid membrane is represented by the monolayer formed at air-
water or oil-water interfaces, useful for probing the interactions between the lipid 
components of biological membranes and the multitude of enzymes, solutes, peptides, 
drugs and other agents that come into contact with their surfaces (Mouritsen, 2011b). 
Lipid monolayers formed at air-water interfaces can be manipulated and studied with ease 
in a Langmuir trough (Figure 1.3.1.1), enabling the measurement and quantification of 
properties such as membrane thermodynamics (Dynarowicz-Łątka et al., 2001). 
 
Figure 1.3.1.1. Lipid monolayer formation at the air-water interface in a Langmuir trough 
(adapted from Mouritsen, 2011b). 
More advanced studies, including fluorescence spectroscopy, Brewster-angle 
microscopy, or X-ray and neutron scattering techniques can also be performed on an 
aqueous support, while equally benefiting from the transfer of the lipid monolayers onto 
a solid surface (Mouritsen, 2011b). On the other hand, alternative techniques such as 
atomic-force microscopy (AFM) require a solid support (e.g. mica or silica) in order to 
work at all. More complex models, including bilayer lipid membranes, can be formed 
directly on solid supports via Langmuir-Blodgett or Langmuir-Schaefer transfer 
(Rubinger et al., 2006), through spin-coated techniques followed by rehydration 
(Simonsen and Bagatolli, 2004) or by means of lipid vesicle dispersion and lysis on an 
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appropriate hydrophilic substrate, such as gold or silica (Cho et al., 2010). There are also 
multiple examples of SSMs formed using proteoliposomes created through the 
reconstitution of purified membrane proteins into liposomes (Granéli et al., 2003), 
resulting in membrane models incorporating the proteins of interest (Figure 1.3.1.2). 
 
Figure 1.3.1.2. Atomic-force micrograph (100×100 nm) of the lateral structure of an SSM 
embedding reconstituted aquaporin channels (adapted from Mouritsen, 2011b). 
However, studies by both Keller et al. (2005) and Jensen et al. (2007) reinforced the idea 
that “proximal” SSMs formed in direct contact with solid supports are under significant 
influence from electrostatic interactions occurring between the membranes and their 
hydrophilic substrates, which can in turn influence the internal thermodynamics, self-
assembly kinetics and lateral organisation of the SSM. Mouritsen (2011b) added that 
these negative influences could be suppressed to a significant degree through the addition 
of a spin-coated distal bilayer on top of the proximal one. Knoll et al. (2000) and Tanaka 
and Sackmann (2005) described another solution, namely the use of ultrathin polymer 
supports as substrates for lipid bilayer formation. These polymers, mimicking the 
function of the extracellular matrix, are used to tether and/or cushion the reconstituted 
membrane proteins so as to not come into direct contact with the solid support and thus 
allow for their correct incorporation and folding within the SSM. This biological 
membrane model not only improved the diffusion capability and intrinsic activity of the 
embedded membrane proteins compared to the “proximal” model, but also preserved their 
lateral distribution as well (Figure 1.3.1.3 overleaf). 
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Figure 1.3.1.3. Different types of SSMs embedding reconstituted membrane proteins: A) 
Proximal SSM, with the proteins coming into direct contact with the substrate; B) Polymer-
supported SSM, with the lipid bilayer resting on top of a hydrated polymer “cushion” that prevents 
the embedded proteins from interacting with the substrate; C) Lipopolymer-tethered SSM, with 
the lipid bilayer resting on functional lipopolymer “springs”; D) Spaced-out SSM, featuring large 
macromolecular spacers (here, the bacterial enzyme lumazine synthase (LuSy)) attaching entire 
protein complexes (here, actin filaments) via His- and Strep-tag coupling groups to the supported 
membrane (adapted from Tanaka and Sackmann, 2005). 
1.3.2. Inserting membrane protein targets into solid-supported 
membranes 
SSMs have proven to be powerful research tools in the hands of cell biologists, yet they 
have also demonstrated significant potential as remarkably versatile and robust analytical 
platforms for probing the function of multiple types of membrane proteins (Roder et al., 
2011). Membrane protein targets that have already been successfully reconstituted into 
SSMs include transporters (Scalise et al., 2012), symporters (Newstead, 2011), GPCRs 
(Serebryany et al., 2012) and voltage-gated ion channels (Li et al., 2012). 
Despite the fact that novel protein extraction techniques such as electrophoretic-
electroosmotic focusing (EEF) (Liu et al., 2011) have emerged throughout recent years, 
membrane proteins are still routinely purified by first subjecting native cell membranes 
to detergent solubilisation, followed by their elution through a high-affinity column (e.g. 
Ni2+-sepharose for His-tagged targets or streptavidin for Strep-tagged ones, respectively) 
(Scalise et al., 2012). However, alongside their stand-alone presentation in detergent 
solutions, purified membrane proteins can be reconstituted into proteoliposomes and then 
affixed onto solid supports, embedded within SSMs. 
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Two of the most successful membrane protein reconstitution methods involve the limited 
use of detergent solubilisation throughout their incipient stages, followed by the partial- 
or complete removal of detergent from solution after re-lipidation. The first method 
involves mixing detergent-solubilised membrane proteins with a liposomal solution and 
then gradually reducing the concentration of detergent below its CMC via repeated 
dilution so that the micelles shielding the membrane proteins fall apart and the latter 
integrate into the liposomes instead (Seddon et al., 2004). Conversely, the second method 
begins with the destabilisation of pre-formed liposomes using a non-ionic detergent (e.g. 
DDM or Triton X-100) titration to Rsat in order to render them more permeable to protein 
integration, followed by an incubation with the purified membrane proteins and the 
subsequent removal of detergent from the final solution via column chromatography, 
repeated dialysis or incubation with detergent-absorbing beads (e.g. Bio-Beads®) (Knol 
et al., 1998). While both of these methods effectively reach the same end-point (i.e. 
creating a proteoliposomal suspension with minimal or no detergent present), it is 
important to note that both processes are also completely reversible should more detergent 
be reintroduced into either solution (Seddon et al., 2004). 
In order to better support the integration of purified membrane proteins, the liposomes 
used for reconstitution work should first be extruded through a porous polycarbonate 
membrane into unilamellar vesicles of the particular size needed for accommodating the 
protein targets of interest (Figure 1.3.2.1). Liposome diameters can therefore range from 
less than 100 nm (i.e. small unilamellar vesicles (SUVs)), to 1 μm (i.e. large unilamellar 
vesicles (LUVs)) and up to 100 μm (i.e. giant unilamellar vesicles (GUVs)), depending 
on the assay and membrane proteins found under examination (Wesołowska et al., 2009). 
   
Figure 1.3.2.1. Fluorescence microscopy images of giant unilamellar vesicles (GUVs). Left: 
GUV formed using a DOPC/DPPC/Chol lipid mixture (2:2:1 (w/w) ratio). Right: GUV formed 
using native pulmonary surfactant mixtures (adapted from Mouritsen, 2011b). 
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Furthermore, since cellular membranes never comprise of singular bilayer-forming lipid 
species, mixtures of synthetic lipids are routinely used in the creation of liposomes so as 
to better mimic the membrane environment native to the protein targets, which normally 
features both bilayer- and non-bilayer-forming lipids. Two of the most widely-used lipids 
for modelling native membranes in a laboratory setting are 1,2-Dioleoyl-sn-
glycerophosphocholine (DOPC) – a fluid lamellar bilayer-forming lipid – and 1,2-
Dioleoyl-sn-glycerophosphoethanolamine (DOPE) – a non-bilayer-forming lipid whose 
presence complements the hydrophobicity of individual monolayer leaflets (Seddon et 
al., 2004). 
Proteoliposomes represent versatile, robust platforms for the study of membrane protein 
kinetics, including their ability to ferry substrates of biological importance across lipid 
membranes (Nordlund et al., 2009). However, in order to maximise the success of such 
functional assays, the proteoliposomes must first be homogenous in size (i.e. should be 
re-extruded following protein reconstitution) and the reconstituted proteins should be 
embedded as evenly and equidirectionally as possible throughout the entire vesicle 
population. At the same time, the permeability of the lipid bilayer component towards the 
examined substrate should preferably be close to zero (Seddon et al., 2004). 
Unfortunately, one of the main detriments of the proteoliposomal membrane model is that 
the orientation of the purified membrane proteins cannot be controlled during the 
reconstitution process, thereby leading to the formation of vesicles embedding both the 
correct and opposite orientations in equal measure (Schadauer et al., 2015). This 
limitation not only renders proteoliposomes as rather poor alternatives to live cells or 
organelles such as mitochondria or chloroplasts, whose membranes naturally feature only 
correctly-oriented proteins (Trépout et al., 2007), but can also skew the results of 
functional bioassays towards not accurately representing the full in vivo activity profiles 
of the reconstituted membrane protein targets (Schadauer et al., 2015). 
Therefore, instead of directly assaying proteins embedded in a proteoliposomal 
suspension, one way through which the above issue can be overcome is by using the 
vesicles to form SSMs embedding the protein targets on a solid support that can be 
functionalised to favour a specific orientation (Richards et al., 2016). This procedure is 
not without its own caveats, however, since the amphiphilicity or even mere presence of 
reconstituted membrane proteins is often detrimental towards SSM formation compared 
to protein-free liposomes (Trépout et al., 2007). Several solutions were trialled in an 
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attempt at reducing the rather strong non-specific interactions occurring between the 
hydrophilic extramembranous loops of the reconstituted membrane proteins and their 
solid supports, including the deposition of proteoliposomes onto polyethylene glycol 
(PEG)-functionalised surfaces (Wagner and Tamm, 2000), thiolated gold supports 
(Sévin-Landais et al., 2000) and hydrophilic spacers (Giess et al., 2004). Calcium ions 
(Ca2+) have also been known to act as good bilayer formation adjuvants (Jass et al., 2000) 
and detergent-solubilised membrane proteins can also be directly incorporated into pre-
formed SSMs by diluting the detergent concentration below its CMC (Salamon et al., 
1996). 
Alternatively, if the membrane protein targets can be genetically modified to express a 
high-affinity purification tag (e.g. His- or Strep-tag), then their orientation can also be 
much more tightly regulated following their deposition onto a suitably-functionalised 
substrate (i.e. nickel-nitrilotriacetic acid (Ni-NTA)-treated or biotinylated surfaces, 
respectively) (Ataka et al., 2004). With some membrane proteins, however, such genetic 
modification can unfortunately be conducive to expression defects and/or purification 
issues, therefore making a strong case for the development of new surface modifications 
or bilayer formation techniques (Figure 1.3.2.2) that do not rely on the availability of 
high-affinity chromatography tags for the oriented immobilisation of membrane protein 
targets (Trépout et al., 2007). 
 
Figure 1.3.2.2. Diagram of the oriented reconstitution of P2X2-Neon membrane proteins into a 
PEGylated SSM: A) Native membrane vesicles (white) expressing P2X2-Neon are adsorbed onto 
a glass solid support, followed by the adsorption of PEGylated liposomes (lipids in black, 
polymers in magenta); B) Once the critical coverage point has been reached, the vesicles begin to 
rupture and form a continuous lipid bilayer on the glass surface; C) Since the system allows for 
the free mobility of the bilayer constituents, the P2X2-Neon membrane proteins distribute evenly 
throughout the newly-formed SSM; D) Magnification of the PEGylated SSM, highlighting the 
oriented embedding of P2X2-Neon membrane proteins (adapted from Richards et al., 2016). 
CHAPTER 1 – PROJECT AIM AND INTRODUCTION 
 
23 
Fortunately, recent successes observed with native cell membrane “blebs” (i.e. natural 
proteoliposomes formed via membrane budding following the chemical treatment of live 
cell cultures) deposited onto glass slides together with PEGylated liposomes (Figure 
1.3.2.2 above) have demonstrated that the conserved protein mobility afforded by this 
system enabled the formation of SSMs embedding evenly-distributed membrane proteins 
that also preserved their natural in vivo orientation intact (Richards et al., 2016). 
1.3.3. Current model membrane applications 
Ever since their emergence, artificial model membranes have become an essential part of 
biological membrane studies, providing researchers with a native-like framework for 
reconstituting membrane proteins into that not only preserves their in vivo functions, but 
also facilitates the use of investigative and characterisation techniques and assays that 
could not be performed on live cells (Richards et al., 2016). These include quartz crystal 
microbalance with dissipation monitoring (QCM-D) (Cho et al., 2010), surface plasmon 
resonance (SPR) (Terrettaz et al., 1993), as well as atomic-force (Morandat et al., 2013), 
confocal (Korlach et al., 1999), fluorescence (Samsonov et al., 2001), scanning excitation 
(Dietrich et al., 2001) and total internal reflection fluorescence (TIRF) microscopy (Watts 
et al., 1986). SSM technology enables all of these high-resolution microscopy imaging 
techniques to monitor lateral membrane structure organisation and reconstituted protein 
arrangement on scales as small as a few micrometres or even nanometres (Figure 1.3.3.1). 
   
Figure 1.3.3.1. High-resolution microscopy images of different lipid raft domains present in 
SSMs formed using a DOPC/DPPC/Chol lipid mixture (2:2:1 (w/w) ratio): A) Fluorescence 
micrograph depicting large condensed domain features as dark spots; B) AFM scan of the region 
indicated in image A – domain features that were not previously visible via optical microscopy 
are now revealed; C) Atomic-force micrograph of a single condensed domain. The depicted height 
difference is 6.5 ± 2 Å, measured in a line scan (adapted from Jensen et al., 2007). 
Over the last decade, SSMs have also provided stable and reliable patch clamps for 
electrophysiological studies (Yu and Groves, 2010) and contributed to the development 
of membrane array technology. Aiming to fully combine the functionality of native cell 
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membranes with the simplicity and controllability of membrane models embedding 
reconstituted membrane proteins, SSM arrays can be used to perform antibody binding 
or competitive ligand displacement assays against membrane protein targets, as well as 
live cell adhesion assays in a high-throughput manner on an industrial scale, all while 
allowing both the cellular processes occurring within the membrane and the 
pharmacodynamics of the test compounds to be examined on a molecular level (Groves, 
2002). In addition, plasmonic sensors developed using SSM technology are now capable 
of detecting and characterising biologically- and pharmacologically-relevant interactions 
occurring on cell membrane surfaces at similarly diminutive scales (Galush et al., 2009). 
1.4. Providing Proof-of-Concept 
The current project theorised that SSMs incorporating reconstituted membrane proteins 
also represented promising test beds for the screening of antibody libraries towards the 
discovery of binding candidates showing high affinity and specificity for their intended 
protein targets. The overarching aim of the project was, therefore, to incorporate SSMs 
embedding a specific membrane protein into the process of phage display screening and 
then raise antibody mimetics against this target presented in a close-to-native format that 
was also free from the undesirable consequences of detergent solubilisation. In order to 
provide proof-of-concept for this newly-proposed phage display screening platform, the 
bacterial nucleoside transporter NupC was chosen as the membrane protein of interest. 
1.4.1. The bacterial nucleoside transporter NupC 
Given sufficient extracellular concentrations, nucleosides can normally diffuse freely 
across E. coli outer membranes into the periplasmic space through associated porins. 
Otherwise, nucleosides can be actively transported inwardly at low concentrations (i.e. 
<1 nM) via the Tsx/T6 transporter (Hantke, 1976). Conversely, transport across bacterial 
inner membranes (IMs) is almost always performed against a concentration gradient and, 
as such, is facilitated by high-affinity nucleoside transport systems such as NupC, NupG 
and XapB (Loewen et al., 2004). NupC is a H+-dependent nucleoside symporter 
commonly expressed in E. coli IMs (Miller et al., 2012) that belongs to the concentrative 
nucleoside transporter (CNT) family and shares a 22-26% amino acid sequence identity 
with its human analogues – hCNT1, hCNT2 and hCNT3 (Patching et al., 2005). While 
eukaryotic nucleoside transporters generally comprise of an intracellular N-terminal and 
an extracellular C-terminal capping 13 transmembrane helices that span the entire width 
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of their native cellular membranes, NupC is believed to encompass only 10 such 
transmembrane helices arranged in a trimeric format around the central pore (Smith et al., 
2005). Owing to its remarkable homology with its eukaryotic counterparts, as well as its 
biological significance towards correct cellular function (Craig et al., 1994), NupC 
represents a promising model for studying the transmembrane ferrying of nucleoside 
analogues bearing therapeutic payloads such as azidothymidine or gemcitabine (Loewen 
et al., 2004), respectively used in the treatment of life-threatening viral and neoplastic 
diseases (Thorn and Jarvis, 1996). 
Micro-array experiments have demonstrated that NupC and NupG form the two 
predominant CNT species detected in E. coli expression systems under both aerobic and 
anaerobic conditions (Loewen et al., 2004). While NupC is mainly permeable to 
pyrimidine nucleosides, it also efficiently concentrates adenosine into the bacterial 
cytoplasm as a consequence of its evolutionary relation to hCNT1-3, to which the 
heterocyclic ring of adenosine is an easily-recognisable structural motif promoting the 
initiation of transmembrane delivery (Patching et al., 2005). Conversely, NupG is only 
distantly-related to its human counterparts (Patching et al., 2005) and instead shows high 
affinity for guanosine and inosine, both of which are only very poorly transported by 
NupC (Craig et al., 1994). Since the above-mentioned human nucleoside transporters 
represent important targets for drug delivery and therapeutic action (Damaraju et al., 
2003), this important distinction ultimately led to NupC becoming the subject of the 
project at hand and the chosen membrane protein model for testing our proposed novel 
phage display screening platform against. 
1.4.2. Spherical-supported bilayer lipid membranes 
Knowing that membrane proteins cannot always be reconstituted into SSMs in their 
desired orientation (Trépout et al., 2007) and that specific detergents can drastically 
influence the success of the reconstitution process (Knol et al., 1998), in the case of phage 
display screening of antibodies or antibody mimetics against membrane protein targets it 
is crucial to use a platform that embeds as much of the target antigen as possible in order 
to ensure a maximal selection output featuring all of the potential binding candidates that 
can be identified from a given binder library. Therefore, in order to improve antigen 
availability – in this case, the amount of SSM-embedded NupC – and mitigate those 
scenarios where not enough membrane proteins are reconstituted in their native 
orientation, spherical-supported bilayer lipid membranes (i.e. SSBLMs) were assembled 
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on commercially-available silica nanoparticles, whose vastly-increased surface areas 
compared to traditional screening supports (i.e. 96-well plates) enabled the presentation 
of much larger concentrations of NupC within the same close-to-native format afforded 
by planar SSMs. Several published studies have already proven the functionality of the 
SSBLM platform and its significant potential towards replacing live cells in bioassays 
involving membrane protein targets, even though the preferred nomenclature surrounding 
these novel particles varies from author to author. 
For instance, Nordlund et al. (2009) created SSBLMs by mixing mesoporous silica 
nanoparticles (550 nm in diameter, 3 nm pore size) together with proteoliposomes formed 
using a DOPC, DOPE, 1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DOPG) 
and 1,1’,2,2’-Tetraoleoyl cardiolipin (CA) lipid mixture, embedding the reconstituted 
redox-driven proton pump cytochrome c oxidase (CytcO) from Rhodobacter sphaeroides. 
After 1 hour of mixing at room temperature, the silica nanoparticles were fully enveloped 
in defect-free SSBLMs embedding 70% of the total CytcO used for the assay in its native 
orientation, as determined through the application of reducing agents operating 
selectively on either the extra- or intracellular side of the native bacterial membrane (i.e. 
hexaminerutheniumchloride and dithionite, respectively). Furthermore, O2 consumption 
measurements performed on the SSBLM particles, along with their subsequent incubation 
with either valinomycin (K+ ionophore) or carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone (FCCP) (H+ ionophore), also revealed that the 
embedded CytcOs preserved their functionality towards O2 reduction catalysis and 
transmembrane charge separation while presented in this novel format. 
Trépout et al. (2007) focused on the membrane protein OprM – a component of the 
multidrug efflux pump OprM-MexA-MexB of Pseudomonas aeruginosa – and 
demonstrated its oriented reconstitution in DOPC, DOPG and 1,2-Dioleoyl-3-
trimethylammonium-propane (DOTAP) SSBLMs formed on 80- and 175 nm silica 
nanoparticles. In order to ensure the correct orientation of the SSBLM-embedded OprM, 
Trépout et al. functionalised the nanoparticles with aminosilane prior to their incubation 
with OprM-containing proteoliposomes, which ultimately resulted in the protein 
adsorbing onto the nanoparticles in a single preferred orientation due to the electrostatic 
interactions occurring between the treated surface and the cylindrical base of the 
embedded protein. This singular protein orientation could not be replicated using regular, 
untreated silica nanoparticles as the SSBLM substrate. As shown via cryo-electron 
microscopy (cryo-EM) (Figure 1.4.2.1 overleaf), the correct orientation of the proteins 
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and the large number of embedded units permitted the further study of OprM in an attempt 
at preventing the assembly of the OprM-MexA-MexB efflux pump and thus nullifying its 
undesirable effect towards antimicrobial drug treatments. 
 
Figure 1.4.2.1. Cryo-EM image of SSBLM-embedded OprM (highlighted by the black arrows). 
The lipid bilayer component surrounding the nanoparticles was also revealed (indicated by the 
white arrow). The scale bar represents 50 nm (adapted from Trépout et al., 2007). 
Finally, Schadauer et al. (2015) bound C-terminal-His-tagged CytcO constructs from 
Paracoccus denitrificans to 25 nm Ni-NTA-functionalised silica nanoparticles. After 
incubating these “composite beads” in the presence of 1,2-Diphytanoyl-sn-glycero-3-
phosphocholine (DiPhyPC) vesicles, a continuous lipid bilayer was formed in-between 
the immobilised proteins, resulting in the creation of “proteo-lipobeads” (Figure 1.4.2.2 
overleaf). These particles not only embedded CytcO in a native-like lipid membrane, but 
also did so strictly in its intended orientation, thus preserving the functionality of the 
protein towards initiating electron transfer in the presence of reduced cytochrome c or via 
light excitation of its ruthenium (Ru) complexes. 
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Figure 1.4.2.2. Diagram of a “proteo-lipobead”: C-terminal-His-tagged membrane proteins (red) 
are first bound to Ni-NTA-functionalised silica nanoparticles (blue), after which phospholipid 
molecules (grey) are inserted in-between the immobilised membrane proteins to form the SSBLM 
lipid component (adapted from Schadauer et al., 2015). 
The examples presented in the current subsection served to demonstrate the significant 
potential of the SSBLM platform towards the development of functional bioassays for the 
study of membrane protein targets. The formation of our proprietary NupC-embedding 
SSBLMs on silica nanoparticles will be described in Chapter 4, following an overview of 
the techniques involved in their characterisation and quality-assessment presented in the 
upcoming Chapter 2. So as to aid readers in following through the rather complex method 
development process, an illustrative summary of the overall project aims, as well as an 
experimental plan for materialising the SSBLM concept can also be found in Figure 
1.4.2.3 overleaf. 
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SSBLM EXPERIMENTAL DEVELOPMENT PLAN 
NupC construct expression and purification 
➢ Choosing double Strep-tagged, His6-tagged and untagged/wild-type NupC constructs 
➢ Expressing and purifying NupC from E. coli according to established working protocols 
↓ 
Purified NupC transport activity measurement 
➢ Performing assays to confirm purified NupC ex vivo nucleoside transport activity 
➢ Establishing whether the NupC constructs retained their conformation post-purification 
↓ 
Planar SSM formation and characterisation 
➢ Investigating model lipid SSM formation on planar silica substrates 
➢ Testing the formation of planar SSMs embedding reconstituted purified NupC 
↓ 
SSBLM formation and characterisation 
➢ Determining the saturation thresholds resulting in full coverage of the tested nanoparticles 
➢ Confirming the correct formation of SSBLMs on 100- and 200 nm silica nanoparticles 
↓ 
Embedding NupC into the SSBLM platform 
➢ Reconstituting purified NupC into proteoliposome LUVs and then forming SSBLMs 
➢ Confirming the presence and epitope accessibility of SSBLM-embedded NupC 
↓ 
Testing the SSBLM platform for phage display screening 
➢ Interrogating antibody-mimetic binder libraries against SSBLM-embedded NupC 
➢ Using different screening formats so as to compare SSBLMs to traditional methodologies 
↓ 
Identifying and purifying the “lead candidate” binders 
➢ Aligning the total selection output and establishing binder structural relationships 
➢ Isolating the plasmids of phage-bound binders and purifying the chosen lead candidates 
↓ 
Determining the success of the SSBLM platform 
➢ Re-screening the purified lead candidates so as to confirm genuine binding to NupC 
➢ Assessing the applicability of the SSBLM platform to other membrane protein targets 
Figure 1.4.2.3. Workflow illustrating the overall project aims and experimental plan for the 
development of our proposed SSBLM phage display screening platform. 
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CHAPTER 2 
 
Experimental Techniques 
 
2.1. Quartz Crystal Microbalance with Dissipation 
Monitoring 
At its core, any quartz crystal microbalance (QCM) comprises of a bulk acoustic wave 
transducer that uses piezoelectric quartz crystal sensors to detect a wide variety of surface 
interactions. By inducing electromechanical resonations throughout the sensor crystal, a 
wealth of information can be derived on the biological and physico-chemical properties 
of the material deposited onto the sensor surface (Tuantranont et al., 2011). In fact, the 
applications of this technology are so diverse that the term “microbalance” is somewhat 
of a misnomer, since QCMs can do much more than simply measure subtle changes in 
adsorbed mass. As will be seen throughout the following subsections, the descriptors 
“bulk acoustic wave sensor” or “thickness shear mode resonator” might be more 
appropriate for describing their expansive detection capabilities (Cheng et al., 2012). 
2.1.1. Introduction to QCM-D technology 
The technical principles underlying modern quartz crystal microbalances with added 
dissipation monitoring (QCM-Ds) were established through research started in 1976 at 
Chalmers University of Technology in Gothenburg, Sweden. After nearly two decades of 
experimentation, the technology was granted a patent in 1995 and Q-Sense AB was 
founded as a company developing QCM-D instruments a year later (Q-Sense, 2006). 
Since the launch of Q-Sense’s first commercial microbalance in 1999 (Biolin Scientific 
AB, 2016a), QCM-Ds have become widely-used research tools in applications as diverse 
as monitoring live lipid bilayer formation kinetics on a solid support (Richter et al., 2006), 
performing nanogram-sensitive measurements of molecules binding to a sensor surface 
(Heller et al., 2015) or investigating the interactions between different nanoparticle 
species and model cell membranes (Chen et al., 2016). All of these powerful measurement 
capabilities are made possible through the physical properties of the piezoelectric 
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crystalline quartz that forms the basis of every sensor chip contained within a QCM-D 
flow cell (Figure 2.1.1.1). 
 
Figure 2.1.1.1. Diagram of a QCM-D flow cell featuring a singular flow module. A freshly-
cleaned piezoelectric quartz crystal sensor is rested on a rubber O-ring fixed to the interior of the 
cell before the experiment is started and the buffers or sample solutions come into contact with 
its surface (adapted from Heller et al., 2015). 
2.1.2. The QCM-D operating principle 
The principle through which signals transduce through a QCM sensor is known as the 
“converse piezoelectric effect”: when a crystalline material is deformed through the 
application of pressure or torsion in a given direction, electrical charges will be generated 
on its opposing surfaces. In a QCM setup (Figure 2.1.2.1), the introduction of an 
alternating current (AC) across the surface electrodes transforms the sensor chip into an 
equivalent electrical circuit and causes the embedded quartz crystal to alternatingly 
expand and contract, generating bulk acoustic waves that produce mechanical oscillations 
at its fundamental resonance frequency (i.e. approximately 5 MHz) (Cheng et al., 2012). 
 
Figure 2.1.2.1. Diagram of the converse piezoelectric effect, illustrating the oscillations and 
electrical charges propagating through a piezoelectric quartz crystal sensor upon the application 
of an AC potential. For a coherent measurement to be registered, the charges at the top and bottom 
of the sensor must oppose one another to create a working electrical circuit (adapted from Chen 
et al., 2016). 
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Should an oscillating sensor then come into contact with foreign materials, the shear 
displacements inside the crystal will cause any adsorbed mass to move lateral of the 
quartz surface and resonate at a frequency other than its fundamental one. This property 
renders QCM sensors particularly suitable for conducting ultrasensitive measurements of 
the mass and viscosity of sensor-bound materials (Chen et al., 2016). 
QCMs register frequency changes over a range of odd overtones (i.e. usually from the 3rd 
to the 13th crystal oscillation harmonic), since the shear displacements required for 
producing measurable responses are only triggered by acoustic waves propagating 
through the quartz crystal at odd overtones (Janshoff et al., 2000). While frequency 
measurements can give an indication of the total mass deposited onto the sensor chip, 
QCM-D instruments are also capable of determining changes in dissipation, thus offering 
information on the rigidity of the structure forming on the sensor surface as well. As 
opposed to frequency measurements, dissipation is measured by interrupting the current 
applied to the sensor chip and registering the damping oscillations of the resonating quartz 
crystal. If the deposited structure is rigid, the oscillations will dissipate more slowly and 
a low dissipation value will be reported. On the other hand, should the deposited structure 
be flexible, then the oscillations will dissipate faster and a high dissipation value will be 
registered. It is only when both frequency and dissipation are jointly monitored that 
changes within the mass adsorbed onto the surface of a sensor can be accurately correlated 
with the frequency measurement output of a QCM-D instrument (Heller et al., 2015). 
2.1.3. QCM-D sensor design and sample loading 
Modern microbalances generally use sensors featuring micrometre-thin, disk-shaped 
quartz crystals that can be cut at different angles depending on the type of induced 
mechanical vibration they are meant to resonate to, such as face shear mode (FSM), 
flexural mode (FM) or thickness shear mode (TSM) (Cheng et al., 2012). Given that 
QCMs generally operate in TSM, the AT-cut (i.e. 35° 10’ from the optical Z-axis of a 
crystal wafer) represents the preferred choice for the manufacturing of quartz sensor 
chips, since it allows them to resonate stably at room temperature with little to no 
frequency fluctuations arising from minor temperature changes (Marx, 2003). 
A high surface quality is a vital characteristic of any QCM sensor and thus the underlying 
quartz crystals are usually optically-polished to produce an extremely smooth contact 
surface. This is especially important when studying the deposition of soluble materials, 
for instance, since the solvent can easily infiltrate any crevice found on the surface of a 
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rough crystal and thus generate false-positive frequency changes that can be mistakenly 
interpreted as adsorbed mass (O’Sullivan and Guilbault, 1999). In order to avoid such 
anomalous results, most QCM sensors feature hydrophobic surfaces that do not wet 
easily, but rather attract pockets of air or vacuum, losing less energy in the process 
compared to sensors with hydrophilic surface chemistries (Janshoff et al., 2000). 
The final components of a working QCM sensor are represented by the conducting metal 
film electrodes sandwiching the top and bottom of the functionalised quartz crystal disk. 
These normally comprise of evaporated nickel, aluminium, gold, silver or even platinum 
threads that interface with the contacts located inside a QCM flow module in order to 
establish a connection with the oscillator circuit of the microbalance (Cheng et al., 2012). 
Regarding the surface chemistry of QCM-D sensors, there are two main processes 
through which investigated samples can interact with the exposed quartz crystal – 
physisorption and chemisorption – and both involve the adsorption of solutes to its contact 
surface (Table 2.1.3.2). 
QCM 
sensor 
surface 
chemistries 
Physisorption 
Hydrophobic bonds 
Ionic bonds 
Hydrogen bonds 
Chemisorption 
Self-assembled monolayers 
Plasma-polymerised films 
Photochemistry 
Sensing ionic liquids 
Table 2.1.3.2. Examples of QCM sensor surface chemistry interactions. Self-assembled 
monolayers can offer thiol, amine, amide, protein A, avidin-biotin, concanavalin A, click 
chemistry and mixed sensor surface functionalisations (adapted from Cheng et al., 2012). 
The first of these two solute adsorption methods refers to the simple physical adsorption 
of materials to the sensor chip via non-specific interactions or non-covalent bonds, its 
direct advantage being a quick and easy experimental setup that also allows for a certain 
degree of reversibility given the poor strength of the interactions involved. By contrast, 
chemisorption relies on the adsorbed mass binding covalently to the sensor surface. 
Compared to the weak forces involved in the previous process, the considerably stronger 
covalent bonds aid in the deposition of larger amounts of material at the expense of 
binding reversibility. Furthermore, while physisorption is essentially disorganised and 
cannot account for the orientation of the adsorbed material, through chemisorption, test 
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samples can be bound to the sensor surface in their intended orientation – a critically-
important feature for experiments involving the creation of tethered supported bilayers or 
the monitoring of protein-protein interactions, where the accessibility of specific binding 
epitopes is key (Cheng et al., 2012). 
Finally, the external loading of sample materials onto QCM-D sensors can also take one 
of two forms: gravimetric or viscoelastic. In the case of the former, the force of the 
crystalline shear gradient will balance out the gravimetric force exerted by the deposited 
mass on the sensor surface, which in turn will generate a measurable resonance frequency 
shift that can be calculated via the Sauerbrey equation (Sauerbrey, 1959). Provided that 
dissipation is either zero or close enough to be negligible, the equation effectively 
correlates any frequency shift with the mass of material adsorbed onto the QCM-D sensor 
surface: 
 
𝜟𝒇𝒈 = −
𝟐𝒇𝟎
𝟐
√𝝆𝒒𝝁𝒒
𝜟𝒎
𝑨
 𝒇𝟎 =
𝒗
𝟐𝒕𝒒
=
√(𝝁𝒒/𝝆𝒒)
𝟐𝒕𝒒
 
 
where Δfg represents the resonance frequency shift, f0 – the fundamental resonance 
frequency, m – the mass of the adsorbed material, ρq – the density of the quartz crystal 
(i.e. 2.648 g cm−3), µq – the shear modulus of AT-cut quartz (i.e. 2.947×1011 g cm−1 s2), 
A – the area of the sensor, v – the velocity of the acoustic wave and tq – the thickness of 
the sensor crystal (Tuantranont et al., 2011). 
The gravimetric approach is regularly used to monitor increases in adsorbed layer 
thickness during physical vapour deposition processes, for instance (Elliot et al., 2014). 
Another example of gravimetric loading is given by the “dip and dry” method, which 
involves taking measurements before and after the test material has adsorbed onto the 
sensor surface and any superficially-bound material has been removed via repeated 
washing (Cheng et al., 2012). While these approaches to sample loading normally result 
in the precise measurement of frequency changes – thus being particularly relevant to 
antibody binding studies – they are not without their drawbacks, represented by their 
laborious implementation, the impossibility of capturing live data and their susceptibility 
to humidity, solvent retention and sensor hydration conditions (Arce et al., 2007). 
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Conversely, during viscoelastic loading, the frequency shifts are triggered by the 
acoustic-fluid damping effects occurring when a quartz crystal oscillates inside a liquid 
medium (Tuantranont et al., 2011). One such example is represented by flow injection 
analysis (FIA), during which small sample volumes are applied to the QCM-D sensor via 
capillary laminar flow in an attempt at keeping turbulence and any other sensor 
disturbances originating as a result of fluid dynamics phenomena to a minimum (Cheng 
et al., 2012). While the real-time monitoring of adsorption kinetics is supported through 
the use of viscoelastic loading methods, major changes in both dissipation and resonance 
resistance can be registered due to the way shear waves travel through a non-rigid 
environment, resulting in potential energy losses. In such cases, where dissipation will 
almost always be greater than zero, the following equations ought to be used instead: 
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where Δfv, ΔD and ΔR represent the viscoelastic resonance frequency shift, dissipation 
factor and resonant resistance changes, respectively, while ηL, ρL and k signify the 
viscosity, density and electrochemical coupling factor of the adsorbate solution 
(Tuantranont et al., 2011). 
2.1.4. The Q-Sense E4 QCM-D setup 
As one of the most widely-used QCM-D instruments, the Q-Sense E4 (Figure 2.1.4.1 
overleaf) features four QFM 401 flow modules that enable the live frequency and 
dissipation monitoring of up to four parallel experiments investigating separate molecular 
kinetics on each of their different sensor surfaces (Biolin Scientific Holding AB, 2016a). 
More specialised modules, such as the QEM 401 electrochemistry module or the QELM 
401 ellipsometry module, can be installed in place of the standard QFM 401 flow modules 
to confer additional functionalities when performing experiments that require 
combination measurements to be taken (Biolin Scientific Holding AB, 2016b). The wide 
variety of different flow modules, combined with a multitude of metal, polymer and 
chemically-modified sensor surfaces allow for the detection of changes in the viscoelastic 
properties of the adsorbed materials with nanogram-sensitivity (Biolin Scientific Holding 
AB, 2016a). 
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Figure 2.1.4.1. The Q-Sense E4 QCM-D setup, consisting of an electronics unit (responsible for 
applying the AC potential and the detection of any sensor surface changes), a measurement 
chamber (containing the four flow modules) and an attached computer (running the measurement 
software). Capillary tubes connected to a pump unit (not shown here) can deliver up to four 
separate test solutions to each of the four different sensor surfaces at adjustable flow rates ranging 
between 50-200 µL per minute (adapted from Biolin Scientific Holding AB, 2016a). 
QCM-D experiments benefit from a high degree of stability and detection specificity 
while offering the possibility of providing real-time data on live and label-free binding 
kinetics at a relatively low operating cost using easy-to-follow experimental protocols 
(Tuantranont et al., 2011). The latter can be generally divided into four main steps: 1) 
sensor cleaning and mounting; 2) buffer and sample solution application; 3) live 
frequency and dissipation data collection and 4) data analysis. In a typical QCM-D 
experiment, ozone-cleaned sensors chips are mounted into either one of the four separate 
flow modules and their respective capillary tubes are connected in turn to the supplied 
pump unit. Buffer is then allowed to pass through the system until a stable baseline is 
achieved, after which the sample solutions are introduced. Any changes in the properties 
of the sensor surface caused by the deposition of soluble material will be reflected by the 
frequency and dissipation kinetics monitored via the measurement software. During the 
data analysis phase, these findings can then be translated into information regarding the 
mass, rigidity and viscoelastic properties of the sensor-bound material (Biolin Scientific 
Holding AB, 2016a). 
2.1.5. Monitoring lipid bilayer formation kinetics via QCM-D 
The QCM-D can also be a powerful tool for monitoring the formation of lipid SSMs on 
quartz crystal sensor chips. Measurements typically follow a two-step mechanism 
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occurring spontaneously once specific conditions such as temperature, vesicle 
concentration, solution osmolarity and flow rate have been met. After a stable baseline 
has been established using plain buffer, the first step in a QCM-D experiment involves 
the introduction of lipid vesicles diluted in the same buffer to the flow module sensor. 
Contact with the sensor surface triggers the absorption of the vesicles, evidenced by a 
sudden drop in frequency and a mirrored increase in dissipation (Figure 2.1.5.1). The 
vesicles continue to accumulate on the sensor until critical vesicle coverage has been 
reached, as illustrated by the minimal frequency/maximal dissipation values, respectively. 
 
Figure 2.1.5.1. The frequency and dissipation changes brought on by the deposition of different 
lipid vesicles onto a silica-coated QCM-D sensor. DOPC, DOPS and DOTAP lipids were used to 
form vesicles at the specified molar mixing ratios and their adsorption onto the QCM-D sensor 
resulted in the following outcomes: A) DOPC/DOPS (1:2 molar ratio) vesicles did not adsorb 
onto the sensor; B) DOPC/DOPS (1:1 molar ratio) vesicles adsorbed onto the silica surface, but 
did not rupture; C) DOPC/DOPS (4:1 molar ratio) vesicles adsorbed and ruptured after reaching 
critical vesicular coverage, forming a lipid bilayer on the sensor surface; D) DOTAP-only vesicles 
ruptured and formed a bilayer almost immediately after coming into contact with the silica 
substrate (adapted from Richter et al., 2006). 
Upon reaching critical coverage, the vesicles begin to rupture and form a planar lipid 
bilayer on the surface of the sensor (Figure 2.1.5.2 overleaf), as evidenced by the 
frequency and dissipation traces adopting new baselines. Following bilayer formation, 
the sensor-bound structure can be rinsed with deionised water in order to osmotically 
burst or remove any vesicles that may have adhered to the sensor, yet remained intact 
throughout the adsorption process. Finally, plain buffer is once again added through the 
system and a new baseline is established. Stable SSMs are typically characterised by a 
frequency change of approximately 25 Hz from the initial baseline, as well as a dissipation 
value of approximately 0.1×10-6 (Cho et al., 2010). 
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Figure 2.1.5.2. The different pathways leading to lipid bilayer formation after vesicles have been 
deposited onto a solid support: A) Isolated vesicles are deformed by the contact with the substrate 
and rupture spontaneously to form a lipid bilayer patch; B) Two adsorbed vesicles found in close 
proximity fuse and rupture, creating a lipid bilayer; C) Adsorbed vesicles coming into contact 
with the active edge of an already-existing lipid bilayer will rupture and add their mass to it; D) 
Upon reaching critical coverage, multiple vesicles come into contact and cause one of them to 
rupture, forming a lipid bilayer patch. The sudden appearance of an active edge sets off a chain 
reaction that ruptures all of the other neighbouring adsorbed vesicles, resulting in the formation 
of an extensive lipid bilayer (adapted from Richter et al., 2006). 
2.1.6. The virtues and limitations of QCM-D technology 
The remarkable sensitivity of QCM technology towards measuring surface changes 
renders it ideal for the creation of biosensors enabling the detection of compounds of 
medical interest. The existing literature on the subject already details a host of successful 
applications, such as the detection of volatile environmental pollutants (Tuantranont et 
al., 2011), of harmful extraneous compounds binding to α-oestrogen receptors attached 
to piezoelectric sensors (Carmon et al., 2005), of monoclonal antibodies binding to 
antigen-displaying biomimetic membrane vesicles tethered to silica-coated QCM-D 
crystals (Patel et al., 2009), as well as of single-base polymorphisms associated with 
hereditary diseases, identified through DNA strand displacement reactions performed on 
gold-coated sensor chips dotted with sample capture probes (Li et al., 2015). Furthermore, 
a QCM-based immunosensor was also successfully developed for the detection of phage-
displayed antibodies binding to biotinylated antigens attached to streptavidin-coated gold 
surfaces. This novel approach for interrogating phage display libraries was shown to yield 
antigen-specific clones that demonstrated similar binding affinities to antibodies isolated 
via traditional plate-based screening protocols, thus highlighting once again the breadth 
of potential applications for QCM technology (Hengerer et al., 1999). 
Unlike its counterpart techniques that rely on optical measurements, namely surface 
plasmon resonance (SPR) and dual polarisation interferometry (DPI), the QCM-D uses 
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mechanical measurements to detect frequency changes. While all three techniques are 
capable of determining substrate binding affinities, only QCM-Ds can detect changes in 
mass caused by solvent trapped within the adsorbent material, which can prove useful in 
establishing the effects of sensor hydration when data sets from all three techniques are 
compared to one another (Heller et al., 2015). In particular, the combined usage of QCM-
D and SPR when examining physical interactions at liquid-solid interfaces has grown in 
popularity over recent years due to its possibility of generating a comprehensive overview 
of the mass, orientation, thickness, lateral distribution and viscoelasticity of the adsorbed 
material (Fang et al., 2015). Similarly, the pairing of QCM-D and AFM techniques has 
led to the development of sensors functionalised with thin mica sheets that show none of 
the surface roughness of regular gold- or silicon dioxide (SiO2)-coated QCM-D chips. 
These particular sensors can thus be readily used for performing highly stable and 
sensitive measurements yielding physicochemical and structural information than could 
only be derived by using both techniques in tandem on an identical support (Richter and 
Brisson, 2004). 
Alternatively, when investigating the porosity of the sampled material – for instance, in 
the study of inward and outward ion fluxes arising within lithium-ion battery electrodes 
during charging and discharging (Shpigel et al., 2015) – the electrochemical quartz crystal 
microbalance (EQCM) suddenly becomes relevant (Buttry, 1992). Instead of relying on 
mechanical measurements, the EQCM uses electrochemical reactions to monitor not just 
mass changes occurring on its sensor surfaces, but also the amount of charge passing 
through their associated electrodes as well, thus being particularly well-suited for the 
study of underlying biological interactions towards biosensor development (Tuantranont 
et al., 2011), as well as for monitoring the physico-chemical interactions involved in 
processes such as metal electro-adsorption (i.e. electroplating) (Buttry, 1992). 
However, one important limitation of QCM technology is given by its susceptibility to 
changes in environmental conditions, which can severely impact measurement accuracy. 
While AT quartz crystals are not as susceptible to temperature fluctuations (Marx, 2003), 
even this particular cut cannot account for all possible disruptive scenarios. An array of 
at least two independent QCMs operating in parallel under the same environmental 
conditions – one for taking reference measurements and the other(s) for running the actual 
experiment(s) – was therefore proposed to compensate for such disruptions, since the 
frequency fluctuations resulting from environmental changes could then be easily 
subtracted from the experimental measurements during the data analysis phase. 
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Unfortunately, this method came with hindrances of its own, one of the most pressing 
being an extremely bulky experimental setup that could also suffer from sensor 
uniformity issues caused by differences in quartz crystal manufacturing, which would 
undoubtedly render post-experimental fluctuation subtraction inaccurate and error-prone 
(Tuantranont et al., 2011). To this end, instruments featuring multiple QCM sensors 
embedded onto a singular monolithic quartz wafer have been developed specifically to 
alleviate both the experimental setup and sensor uniformity concerns (Tatsuma et al., 
1999). Using one such monolithic quartz crystal microbalance (MQCM), at least one 
sensor can be dedicated exclusively to taking reference environmental readings, while the 
other identical electrodes can take the actual experimental measurements (Figure 2.1.6.1). 
 
Figure 2.1.6.1. Diagram of an enhanced MQCM sensor design: A) Cross-section view of the 
three sensing electrodes, sandwiched between acrylic layers and shielded by 
polydimethylsiloxane (PDMS) walls; B) 3D conceptualisation of the same sensors arranged in a 
serial flow cell module (adapted from Jaruwongrungsee et al., 2015). 
This miniaturisation not only significantly decreased the large footprint typical of a 
discrete QCM array, but also concurrently reduced sample consumption, as well as the 
time and effort required to perform each measurement. While concerns were initially 
raised over potential signal interference occurring between the different electrodes as a 
consequence of their close proximity, studies have shown that this phenomenon is 
negligible in real-life experimental settings (Jin et al., 2009) and recent improvements in 
MQCM design also saw the use of polydimethylsiloxane (PDMS) walls interposed 
between adjacent sensors (Figure 2.1.6.1 above) in order to effectively nullify TSM 
oscillation crossover (Jaruwongrungsee et al., 2015). 
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In spite of these minor limitations, its highly-sensitive means of monitoring SSM 
formation kinetics in real-time rendered QCM-D technology invaluable to the project at 
hand, as will be seen throughout the upcoming Chapter 3. 
2.2. SURFE2R N1 Transport Activity Assay 
The activity of proteins functioning as transporters, pumps and channels within living cell 
membranes can be characterised through a variety of electrophysiological methods. 
Historically, membrane proteins have been expressed in oocytes or mammalian cell lines 
and investigated using conventional electrophysiology techniques, such as patch- or 
voltage-clamp, which are laborious, time-consuming and require the help of highly-
trained and experienced personnel (Schulz et al., 2009). Throughout the last decades, 
however, substantial developments in SSM technology have led to the development of 
quicker and less demanding approaches for assaying membrane protein activities. 
Following their expression in a suitable organism, membrane protein targets can now be 
tested for ex vivo substrate transport by forming proteoliposomes using harvested cell 
membranes and then applying modern, SSM-based electrophysiology techniques. 
2.2.1. Introduction to SSM-based electrophysiology 
Based on a technique perfected by previous pre-steady-state experiments studying 
membrane protein transport rates by measuring the electrical charge difference observed 
after a rapid introduction of charged substrate (Pintschovius and Fendler, 1999), the 
Nanion SURFE2R N1 workstation is capable of investigating the activity of membrane 
protein targets – such as anion or cation symporters and antiporters – reconstituted or 
embedded into multiple heterologous formats. The assay requires only microlitre-
volumes of cell membrane preparations or purified membrane proteins reconstituted into 
proteoliposomes and has thus far been proven to work with targets originating from 
bacterial, insect and mammalian cell lines (Nanion Technologies GmbH, 2016b). The 
sensors used with the SURFE2R generally consist of a 3 mm-wide well capable of 
holding volumes of up to 400 µL, at the bottom of which lies a gold measurement 
electrode (Figure 2.2.1.1 overleaf). Prior to adsorbing the proteoliposomes or membrane 
preparations, however, an octadecanethiol monolayer is first covalently bound to the gold 
surface via its sulfhydryl groups, followed by a second phosphatidylcholine monolayer 
deposited directly on top of it. Taken together, the two stacked monolayers form a hybrid 
alkanethiol/phospholipid biomimetic SSM (Plant, 1993). 
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Figure 2.2.1.1. Top (left) and bottom (right) views of a SURFE2R N1 sensor chip, featuring a 3 
mm-wide well. At its bottom lies a thin gold electrode coated with a hybrid biomimetic SSM to 
which the cell membrane preparations adhere (adapted from Nanion Technologies GmbH, 
2016a). 
2.2.2. The SURFE2R operating principle 
In the first phase of a SURFE2R transporter assay, the proteoliposomes containing 
reconstituted purified membrane proteins or the cell membrane vesicles expressing the 
membrane protein targets are adsorbed onto the sensor-bound SSM component, creating 
a capacitively-coupled system (Figure 2.2.2.1) enabling the measurement of any transient 
electrical currents generated by the transport of permeant substrate (Bazzone et al., 2013). 
 
Figure 2.2.2.1. Proteoliposomes or cell membrane vesicles expressing the membrane protein 
targets (only one shown here for clarity, in green) are adsorbed onto the sensor-bound hybrid 
SSM, consisting of a phosphatidylcholine monolayer stacked on top of a gold-supported 
octadecanethiol basal monolayer. The resulting vesicle-SSM complex forms a capacitively-
coupled system capable of measuring transient currents (adapted from Bazzone et al., 2013). 
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The adsorbed vesicles are then filled with a control solution (e.g. plain buffer) and a 
baseline is established, after which the activating solution containing the charged 
substrate is rapidly applied. Should the investigated protein still be capable of ex vivo 
transmembrane transport, the influx of transported substrate into the vesicles will cause a 
charge difference across the lipid membranes, giving rise to either a transient positive or 
negative current (for positively- or negatively-charged substrates, respectively). This 
inward current will be directly proportional to the concentration of substrate transported 
into the vesicles and will be registered by the workstation as a capacitive correction 
current at the surface of the gold measurement electrode (Figure 2.2.2.2). Once the 
adsorbed vesicles become saturated with substrate and the system reaches equilibrium, 
the transient inward current will disappear and the signal trace will return to its baseline 
level. Owing to the nature of measuring rapid transient currents in capacitively-coupled 
systems, the declining half of a positive inward current peak can sometimes be followed 
by a shallow negative overshoot phase that will slowly return to baseline given enough 
time (Bazzone et al., 2013). When the control solution is reintroduced to the sensor well, 
the substrate will be transported back out of the adsorbed vesicles, generating an outward 
transient current in the process. Finally, once all of the substrate has been removed from 
the vesicles, the trace will return to its baseline value measured at the beginning of the 
experiment (Nanion Technologies GmbH, 2016b). 
 
Figure 2.2.2.2. Diagram of the SURFE2R operating principle: after establishing a baseline using 
a control solution (e.g. plain buffer), the addition of an activating solution containing the charged 
transporter substrate will cause any active membrane proteins embedded within the adsorbed 
vesicles to initiate transmembrane transport, generating a transient inward current (in this case, 
positive). The resulting charge difference will be compensated by a capacitive correction current 
at the surface of the measurement electrode, represented by a sharp signal on the SURFE2R trace. 
When the control solution is reintroduced, a transient outward current (in this case, negative) will 
be registered as the substrate is transported back out of the adsorbed vesicles (adapted from 
Nanion Technologies GmbH, 2016b). 
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2.2.3. Successful applications of SURFE2R technology 
One of the many success stories involving the SURFE2R assay revolves around the 
measurement and subsequent modulation of the ion transport capabilities exhibited by 
reconstituted uncoupling protein 1 (UCP1). This inner mitochondrial membrane-bound 
proton transporter, involved in adult human metabolism and non-shivering 
thermogenesis, was purified and subsequently reconstituted into phosphatidylcholine 
(PC), phosphatidylethanolamine (PE) and cardiolipin (CA) vesicles. These were then 
adsorbed onto a sensor-bound SSM and the transport activity of UCP1 was modulated 
through the use of activator (i.e. fatty acid) and inhibitor (i.e. purine nucleotide) 
compounds (Blesneac et al., 2012). Similarly, the nitrite/proton antiporter qualities of the 
NirC transporter from Salmonella typhimurium were also discovered using a custom 
SURFE2R-like assay. After the protein had been purified and reconstituted into E. coli 
polar phospholipid vesicles, the resulting proteoliposomes were adsorbed onto an 
octadecanethiol/diphytanoyl-phosphatidylcholine hybrid bilayer and subjected to the 
same control-activating-control solution exchange used in a traditional SURFE2R 
experiment (Rycovska et al., 2012). 
Target membrane protein purification followed by reconstitution into lipid vesicles is not 
mandatory for an SSM-based electrophysiology assay to function, however, as native 
membrane vesicles or even membrane fragments have also been shown to produce 
measurable signals (Schulz et al., 2008). For instance, SURFE2R-like technology has 
been successfully used to develop an SSM-based electrophysiological assay for 
measuring the K+ and Na+ currents generated through the transport activity of the 
reversible murine neuronal glutamate transporter mEAAC1 expressed in whole plasma 
membrane vesicles. Bearing an impressive 90% amino acid sequence identity with the 
human glutamate transporters involved in neuronal pathology, the assay provided a fast, 
low-cost and highly-automated means of screening for novel anti-Parkinson’s disease 
drugs with therapeutic actions based on modulating the activity of this particular 
transporter (Krause et al., 2009). 
Similarly, the ion transport kinetics of P-type ATPases were also studied in their native 
environment without the need for purification, while being expressed in either pig kidney 
outer medulla planar membranes (Pintschovius and Fendler, 1999) or vesicular fragments 
of animal sarcoplasmic reticulum (Tadini-Buoninsegni et al., 2008). These preparations 
were then adsorbed onto both black lipid membrane (BLM) and SSM platforms, 
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highlighting once again the robustness and versatility of functional model membrane 
electrophysiology. While both BLMs and SSMs share a set of physical properties that 
make them ideal for measuring transient electrical currents, namely a low specific 
conductance (so as to control background noise) and a high specific capacitance (in order 
to produce large, easily-measurable signals), SSMs have been historically preferred over 
BLMs due to their increased mechanical stability against external vibrations, as well as 
their more expansive surface areas (Seifert et al., 1993). 
2.2.4. The virtues and limitations of SURFE2R technology 
The strengths of SSM-based electrophysiological techniques stem from their ability to 
measure the transport activities of membrane proteins embedded into very small 
structures, including sarcoplasmic reticulum and parietal cell vesicles (Schulz et al., 
2008). This capability is further enhanced by their high degree of pliancy to different 
assay formats and asymmetrical experimental conditions, such as performing successive 
measurements under a pH gradient (Mager et al., 2011). However, these techniques also 
suffer from a share of limitations that need to be taken into consideration during the 
planning phase of future experiments. 
When compared to the older patch- and voltage-clamp methodologies, SSM-based 
electrophysiology cannot be used to measure the transport activity of proteins relying on 
the application of a membrane potential or the aid of other intracellular components such 
as binding proteins (Schulz et al., 2009). Further limitations of SSM electrophysiological 
platforms arise from the possibility of encountering large current artefacts caused by the 
binding of lipophilic substrates directly onto the SSM sensor component, although this 
phenomenon can be largely mediated through the use of buffers with high salt 
concentrations. Proper sample preparation yielding homogenous proteoliposomes, 
followed by their thorough sonication and careful application to the measurement sensor 
are equally important, since the introduction of air bubbles to the system should be 
avoided at all times (Bazzone et al., 2013). 
Given its established transport activity measurement capabilities, the SURFE2R assay 
was used to determine which of the NupC constructs employed throughout the project 
still retained their in vivo nucleoside transport activities following their expression and 
purification, as will be seen further on in Chapter 4. 
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2.3. Cryo-Electron Microscopy 
With the advent of electron microscopy (EM) at the beginning of the 20th century (Figure 
2.3.1.1), the high-resolution imaging of molecular structures and interactions all the way 
down to the atomic level quickly turned from mere pipe dream to scientific reality. 
2.3.1. Introduction to electron microscopy 
Similar to how conventional light microscopes make use of the visible spectrum of light 
for imaging samples, electron microscopes operate by focusing a high-powered electron 
beam through a set of electromagnetic and/or electrostatic lenses in order to pass it 
directly through sub-micrometre-thin sample preparations (Milne et al., 2013). As the 
beam travels through the immobilised specimen, regions of varying densities within the 
sample will scatter the incident electrons at different angles (e.g. fewer electrons will pass 
through sections comprised of heavier elements and will instead be redirected towards 
the walls and apertures of the specimen chamber), resulting in dark structures appearing 
on the final image formed on the attached imaging plate (Miranda et al., 2015). Since 
electrons propagate at much smaller wavelengths than visible light, greyscale images at 
magnifications thousands of times higher than those attainable with traditional light 
microscopes can thus be recorded. Depending on the means of interaction between the 
electron beam and the imaged specimen, the different types of electron microscopes 
available today (i.e. transmission or scanning) can provide a wealth of morphological and 
compositional information on virtually any suitably-prepared sample (Jensen, 2012). 
 
Figure 2.3.1.1. Digitally-enhanced photograph of German physicists Max Knoll (left) and Ernst 
Ruska (right) working on the first electron microscope prototype in the 1930s (adapted from 
Williams and Carter, 2009). 
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2.3.2. The different types of electron microscopes 
With EM, the resolution of the recorded images is inversely proportional to the 
wavelength of the electron radiation passing through the imaged specimen, as given by 
the accelerating voltage of the electron gun located at the top of the instrument. This 
critical parameter is normally measured in kilovolts (kV) and the higher it is set to, the 
lower the wavelength of the emitted beam will be, resulting in an enhanced image 
resolution and the ability to capture even smaller structures at magnifications of up to 
2,000,000× (John Innes Centre, 2016). Based on the power and scattering angle of the 
electron beam, electron microscopes can be divided into two main categories – 
transmission and scanning – each with its own distinct virtues, limitations and 
applications (Jensen, 2012). The first of these (and the type used throughout the current 
project), transmission electron microscopes (TEMs) represent the original and, 
consequently, the oldest form of EM. Traditionally, such microscopes comprise of a 
cylindrical high-vacuum chamber featuring a top-mounted, down-facing electron gun. An 
array of solenoid-like electromagnetic condenser lenses and apertures concentrates the 
beam onto the immobilised sample, followed by a set of objective lenses and apertures 
that magnify and focus the resulting image onto a screen such as a photographic plate or, 
more modernly, a charged-coupled device (CCD) camera (Figure 2.3.2.1). 
   
Figure 2.3.2.1. Left: the FEI Tecnai – a modern TEM (adapted from FEI, 2016a). Right: 
simplified diagram of the interior organisation of a typical TEM (adapted from the Department 
of Physics, The Chinese University of Hong Kong, 2016). 
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TEM instruments emit highly-powerful electron beams (i.e. up to 1,000 kV) that are 
focused into passing through sub-micrometre-thin sample preparations in order to 
produce 2D images of structures measuring up to less than 1 Å (i.e. 10-10 m) in size. This 
renders TEMs invaluable for any applications requiring imaging down to the atomic level 
(Erni et al., 2009). Of all of the different electron microscopes available today, TEMs 
offer the most powerful magnification capabilities – up to 50,000,000× (John Innes 
Centre, 2016) – and, consequently, the ability to produce the highest-quality images for 
biological and material science applications following a period of specialist training. 
However, these virtues do come at the cost of having to dedicate considerable time and 
effort towards preparing electron-transparent samples whose thinness also renders them 
particularly vulnerable to electron radiation damage (e.g. whole cell preparations) 
(Jensen, 2012). Nevertheless, TEMs have been instrumental over the years towards 
imaging key biological structures, including the various cellular organelles such as the 
Golgi apparatus (Dalton, 1951), mitochondria (Palade, 1953), nucleus (Bradfield, 1954) 
and the plasma membrane (Figure 2.3.2.2) (Stoeckenius, 1962), among many other 
biological entities and interactions. 
 
Figure 2.3.2.2. TEM image of the phospholipid bilayer component of the plasma membrane, 
magnified 280,000×. The sample was fixed using osmium tetroxide (OsO4) and the contrast was 
enhanced via lead hydroxide (Pb(OH)2) staining (adapted from Stoeckenius, 1962). 
2.3.3. Cryofixation and the emergence of cryo-EM 
Ever since their rise in popularity during the middle 20th century, various concerns were 
raised over using TEMs in the imaging of ultra-thin biological samples, with special 
consideration given to the precarious balance between achieving the lower wavelengths 
at which high resolutions were attainable and the sheer destructive force of even short-
term exposure to high-power electron beams. Thankfully, a revolutionary method of TEM 
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specimen preparation emerged towards the end of the same century, alleviating most, if 
not all of these concerns and ushering in an exciting new realm of potential biological and 
medical applications. Developed in 1981, the process of cryofixation involves flash-
freezing EM samples in cryogens such as liquid propane or ethane in order to preserve 
them as close to their native state as physically possible (Dobro et al., 2010). 
Whereas classic biological specimen fixation methods involved subjecting samples to 
lengthy chemical treatments (e.g. osmium tetroxide for preserving lipids and 
glutaraldehyde for fixing proteins) resulting in their dehydration and the subsequent 
generation of shrinkage artefacts, through cryofixation, micrometre-thin preparations are 
frozen in their entirety almost instantly (John Innes Centre, 2016). This procedure not 
only results in the effective vitrification of EM specimens, since water crystals do not 
have enough time to form in the surrounding solution, but the resulting preparations are 
preserved in their hydrated state while also only generating a minimal number of potential 
artefacts related to the quality of the newly-formed ice (Jensen, 2012). It is through 
cryofixation that cryo-electron microscopy (cryo-EM) came into being at the end of the 
20th century and swiftly became the preferred means of harnessing the high resolving 
power characteristic of TEMs for capturing images of the ultrastructure of delicate 
biological preparations (Fitzpatrick et al., 2013). 
2.3.4. Preparing samples for cryo-EM 
The principle behind the preparation of cryo-EM samples via flash-freezing evolved little 
over the years since its inception, even after the introduction of automated vitrification 
devices such as the FEI Vitrobot (FEI, 2016b). Fundamentally, the process involves 
spreading microlitre-sized solubilised samples onto a specialised EM grid, after which 
any excess solution is removed via gentle blotting with filter paper. Once only a thin 
sample film remains, the grid is rapidly plunged into a cryogenic liquid to form vitreous 
ice, this also being the reason why this particular step is more commonly referred to as 
“plunge-freezing”. Finally, the flash-frozen grids are quickly, but carefully transferred 
into liquid nitrogen storage holders until they are ready to be imaged under a TEM (Dobro 
et al., 2010). 
Although relatively straightforward, the successful creation of cryo-EM grids relies not 
only on the quality of both the applied samples and the EM grids themselves, but also on 
a correct blotting procedure followed by an extremely fast plunge into a suitable cryogen. 
Since the effectiveness of the technique is limited by the heat conductivity of the solvent 
CHAPTER 2 – EXPERIMENTAL TECHNIQUES 
 
50 
solutions, cryo-EM preparations need to be as thin as possible in order to ensure that heat 
is quickly transferred out of the samples after they have been plunged into the cryogen. 
Similarly, the material and quality of both the grids and their support films constitute 
equally relevant attributes. Cryo-EM grids generally consist of a copper, nickel, 
aluminium, molybdenum, titanium or gold mesh upon which thin carbon films are 
deposited in either continuous or “holey” layers (Quantifoil, 2016). While thicker grid 
meshes can offer better support, they will also occupy additional space that could be 
dedicated to fixing more of the sample material instead. Furthermore, whereas continuous 
carbon films might be better at supporting samples in a specific orientation during 
imaging (e.g. protein crystals), holey and “lacey” films featuring either patterned or 
disorganised holes (Figure 2.3.4.2) can reduce background noise by immobilising 
individual specimens within the vitreous ice forming inside the gaps (Dobro et al., 2010). 
   
Figure 2.3.4.2. Different types of cryo-EM grids and their respective support films: A) Lacey 
grid with a carbon support film featuring different hole sizes in a disorganised pattern; B) 
Quantifoil grid with equally-sized holes arranged at regular intervals. Such grids typically feature 
micrometre-sized holes (adapted from Dobro et al., 2010). 
In order to ensure the uniform distribution of liquid samples across the supporting films, 
the hydrophilicity of cryo-EM grids must be reinforced before use. Historically, this was 
achieved by cleaning previously-used grids via plasma glow discharging (Dubochet et 
al., 1971), but submerging them into solvents such as chloroform, acetone or ethanol, or 
simply replacing the carbon support film with a fresh one have also been proven as valid 
alternatives over the years (Quispe et al., 2007). Cell adhesion can also be facilitated by 
functionalising the grids with organic molecules (e.g. polylysine). Nevertheless, it is 
generally accepted that more extreme cleaning methods, such as overnight electron 
irradiation inside a TEM, should ultimately be avoided as they can lead to microfissures 
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developing throughout the carbon support films, which future samples can inadvertently 
infiltrate following their application (Dobro et al., 2010). 
Once the samples have been applied, the cryo-EM grids can be blotted either unilaterally 
– to reduce the chances of damaging delicate specimens – or bilaterally – to remove all 
of the excess fluids (Lepper et al., 2010). Achieving optimal ice thinness is particularly 
important, since insufficient ice coverage might cause the cells or particles contained 
within an applied sample to aggregate towards the edges of the grids upon plunge-
freezing, which would in turn make their imaging rather problematic (Dobro et al., 2010). 
To this end, both the duration and pressure of blotting need to be optimised for the 
specimen at hand, since the integrity as well as the number of constituent entities (e.g. 
cells, sporozoites, nanoparticles, etc.) can be seriously compromised through the 
application of excessive or extensive force (Lepper et al., 2010). 
Finally, the cryogenic liquids themselves must also meet very specific criteria before they 
can be used in the production of high-quality EM grids. These include high thermal 
conductivities and boiling points – to prevent vapour formation at the interface between 
the samples and the cryogen – as well as freezing points that are lower than the sample 
vitrification temperatures (Dobro et al., 2010). Given that aqueous solutions only vitrify 
at cooling rates of 105-106 K/s (Brüggeller and Mayer, 1980), liquid nitrogen has been 
deemed unsuitable for serving as a plunge-freezing cryogen due to its low thermal 
conductivity of only 400 K/s, which is not even nearly quick enough to prevent the 
formation of crystalline ice (Dobro et al., 2010). This prompted the use of liquid ethane 
or propane instead, since both of these feature much higher thermal conductivities. 
However, their different boiling points (i.e. -89 °C for ethane versus -42 °C for propane) 
meant that the latter cryogen suffers from a slower evaporation rate and is thus more prone 
to leave behind ice crusts on freshly-vitrified EM grids, which can in turn be a source of 
eventual imaging artefacts (Dubochet et al., 1988). It is for this additional reason that 
liquid ethane remains the most popular plunge-freezing cryogen for the production of 
high-quality cryo-EM specimens to date, while liquid nitrogen is only used as a coolant 
intended to keep the temperature of the primary cryogen constant throughout the grid 
preparation process. Even so, only pure cryogen should be used during the actual plunge-
freezing step, since any impurities or contaminants can easily transfer onto the grids and 
show up as artefacts during imaging (Dobro et al., 2010). 
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2.3.5. The virtues and limitations of cryo-EM 
While its limitations closely follow those of TEMs in general, cryo-EM benefits from 
significant advantages that have rendered it an essential tool for studying biological 
specimens at ultra-high resolutions (Muench et al., 2009). For one, cryofixation preserves 
biological samples in a hydrated, close-to-native state without the need for any of the old 
chemical staining or stabilising agents. Additionally, vitrified samples are more stable 
when exposed to the harsh conditions encountered inside a cryo-EM and low-powered 
electron beams (<100 kV) can therefore be used over longer periods of time without 
compromising the quality of the final images (Jensen, 2012). This not only effectively 
limits the total radiation absorbed by the preparations throughout an entire imaging run, 
but also enables prolonged measurements to be taken of fragile specimens such as 
adenoviruses and T4 bacteriophages (Adrian et al., 1984). 
The versatility of cryo-EM also enables it to be successfully used in place of older, more 
established techniques. X-ray crystallography has long been a staple of structural biology, 
but it nevertheless requires the use of large, well-ordered and highly-pure protein crystals 
that must also be able to withstand the radiation damage inflicted by prolonged exposure 
to focused X-ray beams. While short X-ray pulses can minimise this to an extent, a 
significant number of crystals is nevertheless required and, unfortunately, not all proteins 
can be purified to a high-enough standard for crystallography work. Furthermore, some 
formats such as membrane proteins reconstituted into proteoliposomes or expressed in 
total membrane extract preparations cannot even be crystallised at all. Electron 
crystallography, on the other hand, operates via the same principle (i.e. an electron beam 
is scattered by the examined protein crystal into a quantifiable diffraction pattern), but 
given that electrons interact much more strongly with the crystal matrix than X-rays, 
higher resolution data sets can be gathered from smaller and even less pure crystals 
(Boekema et al., 2009). Furthermore, while the potential electron radiation damage is 
indeed proportionately higher than that inflicted through X-ray exposure, following a 
reduction in the total electron dose down to 0.1 e-/Å2/s, up to 90 individual diffraction 
patterns could be obtained from singular crystals via cryo-EM crystallography (Shi et al., 
2013). Termed “MicroED”, this particular technique proved capable of determining the 
structure of lysozyme with a resolution of only 2.9 Å, thus reiterating the advantages of 
utilising cryo-EM in structural biology studies. 
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With respect to the current project, cryo-EM was also successfully used towards imaging 
SSBLM formation on silica nanoparticles. Mornet et al. (2005) achieved this by 
sonicating mixed DOPC/DOPS SUVs (4:1 (w/w) ratio) together with 100 nm silica 
nanoparticles for 1 hour and then inspecting the vitrified solution under a FEI Tecnai F20 
TEM operating at 200 kV. Their images, taken at a resolution of 2 nm using a CCD 
camera, captured the newly-formed SSBLMs as 4-5 nm electron-dense rings enveloping 
the silica nanoparticle substrates (Figure 2.3.5.1). 
 
Figure 2.3.5.1. Evidence of SSBLM formation around 100 nm silica nanoparticles as determined 
via cryo-EM: A) 100 nm bare silica nanoparticles (scale bar: 50 nm); B) Following a 1-hour 
sonication with DOPC/DOPS SUVs (4:1 (w/w) ratio), the nanoparticles became enveloped in 
SSBLMs, as evidenced by the surrounding rings of electron-dense material represented 
schematically in (D). Inset: negative-staining comparison revealing the dehydration damage 
typical of this method of EM sample preparation (scale bar: 50 nm); C) Stand-alone DOPC/DOPS 
SUVs; E) Close-up of a DOPC/DOPS SSBLM, highlighting the twin leaflets of the supported 
lipid bilayer, whose polar head groups scatter electrons more strongly than the hydrocarbon chains 
sandwiched in-between (scale bar: 20 nm) (adapted from Mornet et al., 2005). 
As will be seen later on, Chapter 4 will describe yet another successful cryo-EM 
application, namely the imaging of NupC embedded into the lipid bilayer component of 
SSBLMs formed on 200 nm silica nanoparticles. 
2.4. Small-Angle X-Ray Scattering 
Another technique capable of offering structural information on microscopic specimens 
is represented by small-angle X-ray scattering (SAXS). Since any inhomogeneities 
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present within a given sample solution – be they amorphous or crystalline solids, liquids 
of varying densities or even gases – will invariably diffract an incident X-ray radiation 
from its initial course, the analysis of the small angle of scattered radiation can reveal 
substantial information on the examined specimen at hand (Pauw, 2013). 
2.4.1. Introduction to X-ray scattering 
Through SAXS, the shape and distribution of kDa-to-GDa biomolecules can be rapidly 
derived under a multitude of experimental conditions, ranging from close-to-native 
hydrated protein solutions to cryofixed specimens, especially upon harnessing high-
intensity X-rays sources such as those found in synchrotrons. The widespread popularity 
of SAXS in fields as diverse as medical, materials and even food sciences stems from its 
capability of quantitatively characterising the polydispersity of both ordered and 
disordered particles, such as intrinsically-disordered proteins (IDPs). Furthermore, since 
the technique is performed in a time-resolved manner, the dynamics and kinetics of 
various biomolecular interactions can also be studied at the same time (Kikhney and 
Svergun, 2015). With a basic operating principle shared with alternative small-angle 
scattering techniques based on other forms of radiation, such as SAGS (gamma rays), 
SAES (electrons), SANS (neutrons) and LS (visible light) (Pauw, 2013), and in spite of 
having a relatively lower structural resolving power compared to staple techniques such 
as X-ray crystallography (Pérez and Nishino, 2012), SAXS nevertheless offers a powerful 
means of studying close-to-native-state biomolecular morphologies in hydrated, non-
crystalline samples and has thus become an integral part of structural biology research 
laboratories around the world. 
2.4.2. The SAXS experimental setup and operating principle 
Following their inception in the first half of the 20th century, a majority of SAXS setups 
were custom-made and as such varied considerably between individual laboratories. 
Thankfully, a multitude of present-day industrial manufacturers, including Bruker, 
Rigaku and Xenocs, now offer a wide range of commercial X-ray scattering instruments. 
With that being said, the basic SAXS operating principle has not changed fundamentally 
over the years and at their core, all modern setups still consist of an X-ray emitter, a beam 
collimation section, a sample chamber, an evacuated flight tube fitted with a beam stopper 
and, most importantly, a detector for capturing and recording the scattered X-rays (Figure 
2.4.2.1 overleaf). Based on the process through which the initially-disordered X-rays are 
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collimated (i.e. arranged into a parallel, non-dispersible beam), SAXS instruments can be 
categorised into one of several classes: pinhole-collimated, slit-collimated and Bonse-
Hart-collimated (Pauw, 2013). 
 
Figure 2.4.2.1. Diagram of the basic components of a pinhole-collimated SAXS instrument 
(adapted from Pauw, 2013). 
SAXS experiments usually comprise of three successive phases, all of them referring to 
the stage the experimental data is in: data collection, data correction and data analysis 
(Pauw, 2013). The first step in any classic SAXS experiment involves pipetting 
microlitre-sized volumes of the sample solution into a quartz capillary tube, which is then 
secured in place within the sample chamber of the instrument and irradiated with a 
collimated, monochromatic X-ray beam (Figure 2.4.2.2). 
 
Figure 2.4.2.2. Diagrammatic representation of the SAXS operating principle (adapted from 
Kikhney and Svergun, 2015). 
As incident X-rays pass through the sample chamber, a number of them will be elastically 
scattered by the electrons of the solubilised particles present in the sampled solution 
(Pérez and Nishino, 2012). The scattered X-rays will then travel on different vectors 
throughout the evacuated flight tube and will ultimately be captured by the detector 
located beyond, instead of simply being stopped at the end of the tube like the remainder 
of the undeviated incident radiation. After subtracting the signal generated by a sample 
of pure solvent, a scattering profile of just the solubilised particles can be determined, 
holding information on the size and morphology of the examined solute (Kikhney and 
Svergun, 2015). 
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Whereas the data collection step is relatively straightforward, the collected scattering 
profiles must first be corrected by factoring out any potential noise or distortions 
generated by the X-ray detection system, accounting for sample polarisation and self-
absorption, as well as scaling results to absolute units, since only by using corrected data 
sets can the intensity of solute-exclusive scattering profiles be accurately determined 
(Pauw, 2013). Finally, it is during data analysis that the intensity of the scattered X-rays, 
I(s), can be calculated as a function of the momentum transfer s = 4πsinθ/λ, where 2θ 
represents the scattering angle and λ signifies the wavelength of the X-ray beam: 
 
𝑰(𝒔) = [𝑰(𝒔)]𝜴 = [𝑨(𝒔)𝑨
∗(𝒔)]𝜴  
 
Next, by applying a Fourier transformation to the excess electron density, the scattering 
amplitude, A(s), can now be calculated: 
 
𝑨(𝒔) = ∫ 𝜟𝝆(𝒓) 𝐞𝐱𝐩(𝒊𝒔𝒓) 𝒅𝒓 
 
where Δρ(r) = ρ(r) – ρs (i.e. the electron density of the sampled particles minus the 
electron density of the solvent itself) and []Ω represents the spherical average (Kikhney 
and Svergun, 2015). Given that soluble particles can be contained in any number of 
orientations within a sample solution, their scattering patterns can be plotted as isotropic, 
one-dimensional I(s) curves depicting the averaged signatures of all of the sampled 
particles, whose number will be proportional to the detected X-ray scattering intensity 
(Pérez and Nishino, 2012). 
When performing SAXS studies of virtually any sample solution, the three main 
parameters that researchers usually aim to gather information on are the morphology (i.e. 
shape/size), heterogeneity (i.e. polydispersity) and distribution (i.e. packing) of the 
sampled particles. While not all of these parameters might become readily available by 
the end of the data correction phase, if only two of them are known or even just reasonably 
assumed, then they can be used to infer on the quality of the missing third. For instance, 
assuming a monodisperse solution at an infinite dilution (so that any possibility of 
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aggregation can be eliminated altogether), the morphology of its solubilised particles 
could be deduced using shape-resolving computational techniques, at the expense of a 
lower final resolution. Similarly, structure-resolving techniques can be used to determine 
the distribution of solute in a specified volume, should information on its shape and 
polydispersity be made available through other means such as TEM (Pauw, 2013). 
Apart from the above, several other sample parameters can be derived directly during the 
data analysis phase. These include the maximum dimension of the sampled particles, 
Dmax, their molecular weight, as well as the radius of gyration, Rg. It is important to note 
that while these values will pertain to every single particle contained within a 
monodisperse solution (i.e. harbouring identical particles), a scattering profile derived 
from a polydisperse sample (i.e. containing particles of different shapes and sizes) will 
instead give averages of the above values for the entire heterogeneous solute population 
taken as a whole. Although not as immediately useful as for monodisperse solutions, these 
parameters can still be used to structurally characterise polydisperse samples based on 
properties other than size (Kikhney and Svergun, 2015). 
Expressed as an average of the root-mean-squared distance to the centre of density of a 
given particle, weighted by the density of the scattering length, Rg is actually one the most 
important and best-known SAXS-derived parameters, since it can be used directly 
towards determining the overall size of the sampled particles. For example, in the case of 
protein molecules featuring an identical number of amino acids, Rg will be reduced for 
compact (e.g. globular) proteins and increased for extended (e.g. unfolded) proteins. By 
knowing Rg and I(s), the Guinier approximation (s < 1/Rg) and the equation I(s) = 
I(0)exp(s2Rg2/-3) can then be used to determine the forward scattering, I(0), which will be 
directly proportional to both the concentration and molecular weight of a sampled protein 
(Kikhney and Svergun, 2015). 
Finally, the flexibility of the examined molecules (e.g. the degree of folding observed 
throughout a protein sample) can also be determined directly from analysing SAXS data 
sets and constructing a Kratky plot. Knowing that the scattering intensity of a solid 
particle will decay at a high angle (i.e. I(s) = ~1/s4), globular or folded proteins will be 
represented on Kratky plots as marked peaks followed by downward phases, whereas 
unfolded proteins with large s values will be represented as plateaus (Figure 2.4.2.3 
overleaf). Furthermore, should only the folding states of the different proteins contained 
within a polydisperse solution be important to know, then the resulting Kratky plot can 
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be normalised by assuming I(0) = 1 and multiplying s by Rg, which will in turn reveal the 
requested information at the expense of disregarding the molecular weights of the 
investigated proteins. This is also the reason why normalised Kratky curves are also 
referred to as “dimensionless” plots (Kikhney and Svergun, 2015). 
 
Figure 2.4.2.3. Normalised Kratky plot of the (sRg)
2I(s)/I(0) versus sRg parameters obtained from 
the scattering profiles of three globular (dark blue), half-unfolded (light blue) and natively 
unfolded (grey) 60 kDa proteins (adapted from Kikhney and Svergun, 2015). 
2.4.3. The virtues and limitations of SAXS 
Some of the significant advantages of performing X-ray scattering experiments include 
their straightforwardness and time-efficiency compared to running MD simulations in 
scenarios such as determining the 3D distribution of ion and water content surrounding a 
target biomolecule (Nguyen et al., 2014). In addition, SAXS experiments only require 
minimal sample volumes per measurement (e.g. 10-100 µL) and the higher the particle 
concentration, the better the scattering profiles and, consequently, the quality of the 
resulting data will be (Kikhney and Svergun, 2015). Another major advantage of SAXS 
is represented by the fact that it can be used to investigate a very wide range of specimens. 
Most of these take the form of two-phase systems (e.g. a solvent carrying a single type of 
solute), but even multiphase systems in which the electron density of one phase 
significantly outweighs those of all other sample phases can be analysed as a two-phase 
system. Such approximations are regularly used in materials science (e.g. when verifying 
the composition of metal alloys or monitoring particle growth in solution), during the 
quality control phase of industrially-manufactured items (e.g. identifying defects in the 
structure of glass and diamonds or voids in the structure of ceramics), as well as in 
chemical engineering (e.g. isolating combustible hydrocarbons from coal, crude oil and 
other fuel sources), alongside many other fields in which performing similar studies via 
in-depth techniques such as TEM would ultimately prove a great deal costlier in both time 
and funding (Pauw, 2013). 
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Additionally, through its facile complementarity with advanced computational processing 
and other high-resolution techniques such as NMR and X-ray crystallography (Pérez and 
Nishino, 2012), SAXS permits the ab initio modelling of sampled particles and the study 
of complex biomolecular dynamics without requiring any prior knowledge of the 
examined specimens beforehand (Kikhney and Svergun, 2015). SAXS measurements are 
also frequently paired with wide-angle scattering (WAXS) ones, for example in the study 
of lipid raft models comprised of phosphatidylcholine, sphingomyelin and cholesterol 
(Quinn and Wolf, 2010). 
Unfortunately, combining SAXS with other techniques can also hide its notable 
shortcomings, including the absence of an objective and undisputable means of 
determining whether the information provided by a SAXS-derived curve is accurate and 
true-to-life, even in simple scenarios such as working with background-corrected 
scattering profiles of monodisperse particle solutions. This ambiguity is felt even harder 
when studying polydisperse samples such as protein oligomer solutions (Kikhney and 
Svergun, 2015). The uncertainty surrounding the collected data stems primarily from the 
fact that typical SAXS experiments only focus on measuring the scattering intensity of a 
given sample while forgoing other parameters such as the phase of the incident X-ray 
radiation, usually resulting in the construction of scattering profiles that can match an 
entire host of potential sample configurations. In cases such as these, it is only by cross-
referencing SAXS results with those obtained using other high-resolution techniques such 
as TEM and atom probe (AP) that the information collected via X-ray scattering can be 
considered reliable enough to be incorporated into a structural study (Pauw, 2013). 
Similarly, while significant particle agglomeration would be immediately apparent during 
SAXS data analysis, a minor yet still potentially relevant amount of aggregation would 
only result in a slightly raised Rg and, by association, an inaccurately extrapolated I(0) 
value, which would nevertheless still give an incorrect impression on the morphology of 
the sampled particles (Pérez and Nishino, 2012). 
In spite of these shortcomings, SAXS has been employed with great success in studies as 
diverse as developing novel molecular rulers for providing quantitative distance 
measurements between macromolecules labelled with gold nanocrystal probes (Mathew-
Fenn et al., 2008), monitoring the deposition of positively-charged nanoparticles in a 
layer at a silica-water interface (Brenner et al., 2012) and determining the aggregation 
and sedimentation rates of silica nanoparticles in solution after interacting with globular 
proteins such as lysozyme (Bharti et al., 2011). Furthermore, SAXS was also successfully 
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used in the current project towards providing additional confirmation of correct SSBLM 
formation on the surfaces of silica nanoparticles, as will be seen further on in Chapter 4. 
2.5. Phage Display Screening 
Drug discovery has long resorted to the high-throughput screening of million-strong 
candidate molecule libraries in search of “hits” that can perform a desired therapeutic 
action with as high affinity and specificity as possible (Hoogenboom, 2002). Throughout 
recent years, however, the focus of the pharmaceutical industry has gradually shifted from 
traditional small molecule drugs, obtained via the screening of combinatorial chemistry 
libraries, to antibody-based therapeutics involving “protein-binding proteins”. These 
compounds not only exhibit higher specificities and affinities for their designated targets, 
but do so while also provoking less side effects in patients as well (Stumpp et al., 2008). 
The members of this novel drug class, which includes monoclonal antibodies (Clementi 
et al., 2012), single-chain variable fragment antibodies (scFvs) (Ahmad et al., 2012) and 
designed ankyrin repeat proteins (DARPins) (Hausammann et al., 2013) are routinely 
identified via phage display screening – a powerful technique capable of interrogating 
vast candidate libraries in order to identify nanomolar-affinity binders without the 
traditional need for animal immunisation and antisera extraction (Hanes et al., 2000). 
2.5.1. Introduction to phage display screening 
Initially developed more than 30 years ago for the selection of peptide binders (Smith, 
1985), phage display technology revolves around the expression of exogenous antibody 
fragments and other such protein-binding proteins on the extracellular surface of a 
suitable bacteriophage vector following genetic manipulation (Figure 2.5.1.1). 
 
Figure 2.5.1.1. Diagram of a typical filamentous bacteriophage displaying a binder. The DNA 
encoding the antibody fragment, in this case a variable heavy chain (red), is fused with the 
bacteriophage gene encoding the pIII coat protein (green). Once the modified pIII protein is 
expressed, the VH paratope will also be displayed on the bacteriophage surface. For the purpose 
of clarity, only the pIII and pVIII coat proteins are depicted here (adapted from Lee et al., 2007). 
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While other methods such as ribosome display have been successfully used for isolating 
numerous high-affinity binders since the concept was first introduced (Hanes and 
Plückthun, 1997), filamentous bacteriophages represent the original vehicles used in the 
display and screening of binding peptides and antibody fragments (Chasteen et al., 2006). 
The creation of diverse libraries of phages expressing “naïve” binders and their 
subsequent screening against a given antigen is in fact not entirely dissimilar to the 
immune-triggered secretion of specific antibodies in an infected host (Hanes et al., 2000). 
Phage display libraries are regularly created by inserting the coding oligonucleotides or 
gene sequences of the candidate binders into the genome of filamentous bacteriophages, 
specifically within the genes responsible for encoding either of their five different coat 
proteins – pIII, pVI, pVII, pVIII and pIX (Baek et al., 2002). The necessary genetic 
manipulation can be performed by either fusing the ligand genes onto the phage genome 
itself (i.e. using phage vectors) or by working with a plasmid harbouring only the genes 
of the chosen coat protein and then transfecting the recombinant DNA into a helper phage 
via phagemid vectors (Lee et al., 2007). Out of the five coat proteins that have been used 
for binder display thus far, pIII remains one of the most commonly employed, partly due 
to its role in bacterial infectivity (Hoogenboom, 2002). Through the phage format 
approach, all recombinant pIII proteins will be expressed from geneIII-binder fusions and 
will usually display 3-5 copies of the respective binder on their surface (i.e. “low-level” 
multivalent display). Should “high-level” multivalent display be desired, then the genes 
encoding the pVIII protein should be modified instead, since this particular coat protein 
can display more than 1,000 binder copies per unit on account of its increased surface 
area. Conversely, the phagemid format yields binder copies derived from the helper 
phage, which are then displayed monovalently (i.e. in single copies) on the surface of 
each individual phage (Lee et al., 2007). 
Just as natural antibodies undergo several cycles of somatic mutation in order to bind their 
antigens with increasingly higher affinities, so too are phage-displayed binders subjected 
to multiple rounds of selection or “panning” before ligands with near-picomolar affinities 
for their targets can be identified (Figure 2.5.1.2 overleaf). After the phages have been 
modified with the binder genes, they are infected into E. coli and cultured to express vast 
binder libraries, which are then screened against their designated immobilised antigens 
through recursive binding and washing cycles (i.e. selection rounds). Following multiple 
rounds of selection (usually 3-5), only those phages displaying the highest affinity binders 
will be eluted and amplified in E. coli for further testing (Hoogenboom, 2002). 
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Figure 2.5.1.2. Schematic representation of the phage display screening process, also known as 
the “phage display cycle”. The DNA of the candidate ligands (e.g. peptides, proteins) is batch-
cloned into the phage genome as part of one of the coat proteins (i.e. pIII, pVI, pVII, pVIII or 
pIX). Subsequent infection and virion replication in E. coli results in phage libraries numbering 
millions of candidates, which are then screened against the immobilised targets of interest through 
recursive binding and washing cycles. Identified “lead candidate” binders are then eluted, re-
infected into E. coli and amplified for further testing (adapted from Hoogenboom, 2002). 
During routine phage display screening, it is common to use libraries created using the 
phage format for the initial selection rounds since the multivalently-displayed paratopes 
will have a higher chance at binding the target antigen. Once high-affinity binders have 
been identified, the phagemid format can be employed instead so as to promote the 
enrichment of phages that monovalently-display only those binders deemed to be “lead 
candidates”. This way, investigators can more accurately characterise the affinity of a 
single binder molecule against its target of interest and not that of several molecules 
binding collectively to the same antigen (Beaber et al., 2012). 
2.5.2. Types of phages used in the display of antibody binders 
Since the first binder-coat fusion protein that started this entire field was displayed on an 
M13 bacteriophage following the insertion of EcoRI genes into the genome encoding its 
pIII coat protein (Smith, 1985), the vectors commonly associated with phage display 
screening are still represented by the E. coli bacteriophages M13, fd and f1, which 
together form the Ff filamentous phage class (Chasteen et al., 2006). Sharing a staggering 
98% sequence identity, these phages feature a single-stranded DNA conformation 
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organised inside a 7 nm-wide, 900-2,000 nm-long cylindrical structure. Thus far, they 
have been successfully used in selecting a multitude of high-affinity binders against 
targets as diverse as membrane-bound receptors, enzymes and nucleic acids (Baek et al., 
2002). 
Throughout recent years, however, T-even bacteriophages have enjoyed increasing 
popularity as alternative vehicles for binder display (Gamkrelidze and Dąbrowska, 2014). 
Classified as members of the order Caudovirales, and more specifically the Myoviridae 
family, the T-even phages T2, T4 and T6 are easily-recognisable by their lunar-lander 
shapes (Figure 2.5.2.1). Structurally, these are tailed viruses comprising of a prolate 
icosahedral head containing the ~170 kbp double-stranded DNA, followed by a 
contractible tail sheath protecting the internal DNA delivery tube and finally ending in a 
baseplate featuring six protruding tail fibers involved in bacterial cell membrane 
recognition and binding (Gamkrelidze and Dąbrowska, 2014). 
     
Figure 2.5.2.1. Transmission electron micrographs showcasing the famous NASA lunar lander 
shape of the T4 bacteriophage: A) The 168,903 bp double-stranded DNA is contained within its 
prolate icosahedral head, while the six protruding tail fibres are used to search for the membranes 
of potential bacterial hosts; B) Once the virus has bound to a bacteria, the tail sheath contracts in 
order to reveal the internal delivery tube through which the viral DNA will be released into the 
cytoplasm of the host cell (adapted from Miller et al., 2003). 
T-even bacteriophages have been studied extensively since the 1940s and were involved 
in many seminal developments, including the discovery of mRNA, of the connection 
between nucleic acids and genetic information and the fact that the genetic code is 
organised in nucleoside triplets. Of the three members of the T-even phage class, T4 has 
seen the most extensive use due to its capability of completely inhibiting the gene 
expression mechanisms of a bacterial cell, which greatly aids in the discrimination of viral 
molecular dynamics from those of its host (Miller et al., 2003). 
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Upon their attachment and infection of a host cell, bacteriophages can reproduce 
according to one of two cycles: lytic or lysogenic (Figure 2.5.2.2). Whereas through the 
lytic cycle the viral DNA ends up co-existing with the bacterial DNA as a separate 
cytoplasmic entity until the replicated viral clones escape the host cell via membrane 
lysis, through the lysogenic cycle the viral DNA becomes a part of the bacterial genome, 
integrating non-destructively into the nucleus of its host without affecting its ability to 
live and divide normally (Domingo-Calap et al., 2016). Since T4 bacteriophages fall into 
the former category and replicate hundreds of times before their host cell is ultimately 
destroyed, their exclusively lytic lifecycle constitutes an ideal phage amplification 
strategy requiring only minimal volumes of E. coli culture (Kutter et al., 1995). 
 
Figure 2.5.2.2. The two possible bacteriophage life cycles. Left: the lysogenic cycle, during 
which the viral DNA inserts into the bacterial genome and replicates alongside the bacterium 
without producing progeny. Right: the lytic cycle, during which the viral DNA subjugates the 
replication machinery of its host in order to create more virions that ultimately escape through the 
cell membrane in search of other hosts to infect (adapted from Domingo-Calap et al., 2016). 
2.5.3. Phage versus phagemid library creation 
The two pathways leading to the creation of phage libraries expressing recombinant 
binding proteins each come with their own virtues and limitations. Using the phage 
format, the genes encoding the ligands are inserted directly into the phage genome and, 
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as such, amplifying a single clone will yield viral vectors that are both genotypically and 
phenotypically identical and will all display the ligand-coat fusion proteins multivalently. 
Phage libraries are considerably less laborious to produce than phagemid libraries, which 
depend not only upon the availability of helper phage, but also upon their infection into 
bacterial cultures at specific growth stages. The amplification of phage library members 
is also straightforward and only requires the culturing of more infected bacteria, which 
represents a major advantage for high-throughput applications where large numbers of 
binders are simultaneously screened against dozens of different antigens. Furthermore, 
the multivalent nature of binder display among phage library members translates into 
multiple copies of identical paratopes being expressed on the surface of the same phage, 
ultimately leading to the recovery of more binders after a round of selection, as well as 
the potential discovery of more diverse ligands by the end of the screening phase. This 
comes into stark contrast with phagemid particles, since these only incorporate their 
recombinant proteins in as a little as 1-10% of all library members due to their monovalent 
display capabilities, which conversely also form a prerequisite for subsequent affinity 
maturation studies (Chasteen et al., 2006). 
Phagemid vectors thus represent the second pathway through which phage display 
libraries encoding recombinant binding proteins can be built, but in their case this can 
only be accomplished with the help of other phages that must provide them with 
additional proteins without which they cannot create fully-functional, binder-displaying 
clones. Given their role, these protein-donor particles are commonly referred to as “helper 
phages” and generally comprise of Ff-class filamentous bacteriophages that have been 
engineered with a specific antibiotic resistance, an additional origin of replication and a 
disabled packaging signal. Phagemid particles represent the preferential choice for 
displaying larger binding molecules such as antibody fragments and, compared to phage 
vectors, are not only easier to genetically-engineer additional properties into, but also 
enjoy a more efficient ligation-transformation process, resulting in the possibility of 
building larger binder libraries than through the use of the phage format (Chasteen et al., 
2006). 
In order to create a phagemid vector, the nucleotide sequences encoding the binding 
proteins are cloned in-frame into a plasmid containing not only the genes responsible for 
the expression of one of the phage coat proteins, but also the phage replication and 
packaging signals required for the subsequent inclusion of the phagemid into the helper 
phage particles (e.g. M13KO7 or VCSM13), whose own packaging signals have been 
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disabled to promote the expression of the ligand-coat recombinant binding proteins (Baek 
et al., 2002). Once the phagemid has been transformed into E. coli, the cells are infected 
with helper phage, which triggers the packaging of the phagemid genome together with 
the genes encoding the wild-type coat proteins of the helper phage. Upon amplification, 
the resulting virions will ultimately display the ligand-coat recombinant binding proteins 
instead of the wild-type ones – a process known as “phage rescue” (Beaber et al., 2012). 
In practice, however, it has been observed that although the disabled packaging signal of 
helper phages generally prevents them from outnumbering the phagemid particles, any 
newly-amplified phages will still heterogeneously display both the ligand-coat fusion 
proteins, as well as the wild-type proteins endogenous to the helper phage itself. While 
this could potentially reduce the number of negative avidity-related interactions occurring 
during the subsequent selection rounds, the ratio between the recombinant and wild-type 
displayed proteins is, unfortunately, regularly skewed towards the expression of the latter 
due to the proteolytic degradation occurring within the E. coli periplasmic space. This 
directly translates into a majority of the ligand-coat fusion proteins being degraded well 
before the phages can even be subjected to antigen screening. Because of this, most 
phages created using a typical phagemid vector will not display the encoded ligands at all 
and will unfortunately only serve to further hinder the already-difficult discovery of high-
affinity binders originating from a naïve phage library. The number of these “bald” 
phages can, however, be lessened by capitalising on the antibiotic resistance conferred to 
newly-amplified phages expressing the phagemid-encoded recombinant proteins. By only 
selecting those cells harbouring the same antibiotic resistance, the chances of recovering 
fully-functional phages displaying the ligand-coat proteins are significantly increased 
(Chasteen et al., 2006). A similarly beneficial outcome can also be reached if the helper 
phage themselves have been genetically-engineered beforehand to encode cleavable wild-
type coat proteins (Baek et al., 2002) or to feature rare codon clusters and ribosome 
binding site spacing alterations that promote a reduction in the overall expression levels 
of wild-type coat proteins, such as those employed by the novel XP5 helper phage class 
(Beaber et al., 2012). 
In the end, it becomes evident that libraries created using either phage or phagemid 
vectors will differ from one another in several important ways. If the effort attributed to 
the initial genetic manipulation is to be considered (i.e. the cloning and transfection of 
binder-encoding genes), then working with phagemids instead of directly modifying 
phages would represent the preferred choice, especially since libraries built via phagemid 
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vectors usually number many more binding candidates (e.g. 1010-1012). Concurrently, the 
identical genetic arrangement present within libraries created via direct phage 
manipulation would invariably be affected by the low copy number of the phage vectors 
and the poor functionality of the wild-type gene promoter. Finally, filamentous phage 
vectors also suffer from another issue in the form of a low resistance to exogenous gene 
sequence deletions, which can lead to the selective growth of only those phages that 
possess an optimal genetic make-up. This would mean that while only those recombinant 
phages featuring minimal genetic manipulation would ultimately be allowed to develop 
into functional particles, phagemid vectors – being comprised of circular DNA – would 
be affected to a much lesser extent by unpredictable DNA deletions and their encoded 
binders will have a better chance at being ultimately displayed on amplified phages 
(Chasteen et al., 2006). 
2.5.4. The virtues and limitations of phage display screening 
In diametric opposition to raising hybridoma-based antibodies inside immunised animals, 
the main advantage of phage display screening is given by its capability of expressing 
potentially millions of different proteinaceous binders and then selecting only those 
showing the most promising affinities against virtually any antigen, biological or 
otherwise, in a highly efficient manner and without ever requiring any sort of animal 
involvement throughout the entire process (Lee et al., 2007). Furthermore, as opposed to 
in vitro-exclusive display methodologies such as ribosome display, phage display can 
also be successfully performed in vivo as well, by injecting live animals with entire phage-
bound binder libraries and then identifying which candidate ligands remain bound to the 
tissue of interest (Stumpp et al., 2008). 
Other virtues of this technique are represented by its significant time- and cost-
effectiveness, both during the relatively straightforward creation of phage libraries and 
the rapid selection of high-affinity binders, as well as by its complementarity with other 
high-throughput protein interaction techniques such as yeast hybrid systems 
(Gamkrelidze and Dąbrowska, 2014). If any further improvements to phage display 
screening are to be considered, then the overall quality of the binder libraries themselves 
and the speed of their selection become the rate-limiting steps in need of additional 
optimisation before phage display screening can be implemented wholly into high-
throughput industrial scenarios (Schilling et al., 2014). 
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When considering the potential pitfalls of the technique, however, it is important to be 
aware that a synthetically-created, naïve phage library might not always include high-
affinity binders to a given antigen. This shortcoming is further compounded by the often-
poor display of ligand-coat fusion proteins (e.g. only 1-10% of phagemid library members 
might express them) or their proteolytic degradation over multiple rounds of selection, 
resulting in “bald” phages that outnumber functional clones by factors as high as 200:1 
(Beaber et al., 2012). In order to minimise these negative aspects, phage display libraries 
usually encompass between 107-1010 different members and any high-affinity binders 
identified within a selection round will be routinely amplified up to 105× so as to bolster 
the efficacy of any future panning or binding characterisation steps (Baek et al., 2002). 
Further limitations of phage display technology stem from the use of helper phage, which 
need to be continuously produced and added to growing bacterial cultures within very 
specific D600nm intervals in order to maintain a steady rate of phage production. Upon 
considering the inclusion of phage display into applications requiring the high-throughput 
screening of millions of potential binding candidates, it becomes easy to imagine the 
many delays that such a laborious rate-limiting step would cause. Fortunately, alternatives 
to helper phages have become available during the past decade in the form of novel helper 
plasmids that allow bacteria to be transformed with the phagemid and then be cultured 
overnight without the need for any D600nm measurements at all. Instead, the following day 
the replicated particles can simply be harvested by centrifuging the cell debris and 
collecting the phage-rich supernatant (Chasteen et al., 2006). 
To date, phage display technology has led to the development of several blockbuster 
antibody drugs incorporating high-affinity binders (Reichert et al., 2005). These include 
the anti-neoplastic monoclonal antibodies bevacizumab (Avastin), cetuximab (Erbitux), 
rituximab (Rituxan) and trastuzumab (Herceptin), all of which have been approved by the 
US Food and Drug Administration (FDA) for the treatment of cancer patients (Adams 
and Weiner, 2005). The following subsections, describing the major classes of binders 
selectable via phage display screening, will only further highlight the relevance of this 
technique in the fields of immunology, protein engineering and novel antibody-based 
drug development. 
2.5.5. Immunoglobulins 
To this day, natural antibodies or immunoglobulins (Igs) remain the most widely 
recognised binding proteins. Based on their distinct immunological activities and 
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distribution throughout the body, they can generally be categorised into one of five main 
antibody classes: IgG (main serum antibody involved in protection against bacteria and 
viruses), IgE (triggers histamine release following the detection of allergenic compounds 
and protects against parasitic helminth infections), IgA (prevents pathogens from 
colonising mucosal linings), IgM (involved in early bacterial and fungal infection 
response) and IgD (stimulates the production of antimicrobial and proinflammatory 
factors in basophils) (Woof and Burton, 2004; Chen et al., 2009). Other antibody classes 
not present in mammals have also been identified, including IgY – found in non-galliform 
birds such as ducks (Lundqvist et al., 2006) and IgW – discovered in cartilaginous fish 
such as sharks (Bernstein et al., 1996). Regularly secreted as antigen receptors on the 
surfaces of vertebrate plasma cells in response to intruding foreign pathogens (Borghesi 
and Milcarek, 2006), immunoglobulin molecules feature a distinctive “Y”-shaped 
structure (Figure 2.5.5.1) comprised of identical pairs of light and heavy polypeptide 
chains connected via disulfide bridges (Schilling et al., 2014). 
 
Figure 2.5.5.1. Structures of three human antibody classes: IgG, IgE and IgA. The number of red 
and orange heavy chain domains varies between the different classes, while the pair of yellow 
light chains is identical and shared between all immunoglobulins. N-linked oligosaccharides 
(blue) are also featured across the chains of IgG and IgE antibodies, while O-linked 
oligosaccharides (green) form part of the hinge region of the IgA1 molecule. The amino-acid, 
carboxy-terminal tailpiece extensions of IgA antibodies grant them the ability to assemble into 
polymeric immunoglobulin structures (adapted from Woof and Burton, 2004). 
The peptide sequences identified within each light and heavy chain region have led to the 
classification of their respective domains as either variable (V) or constant (C) (Litman 
et al., 1993). Therefore, immunoglobulin light chains each comprise of one variable 
domain (VL) and one constant domain (CL), while their heavy counterparts feature one 
variable domain (VH) and multiple constant domains (CH) (Woof and Burton, 2004). Both 
domain types can be even further subdivided into lambda (λ) and kappa (κ) light chain 
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domains and alpha (α), delta (δ), epsilon (ε), gamma (γ) and mu (μ) heavy chain domains 
(Syndercombe Court et al., 2009, p. 266). Since the pair of light chains is identical and 
conserved between all antibody classes, immunoglobulins are thus classified according 
to the type and number of their heavy chain domains, ranging from just three in human 
IgG and IgA antibodies, to four in IgE molecules, to five in duck IgY antibodies 
(Lundqvist et al., 2006) and as many as seven in carcharhine shark IgW immunoglobulins 
(Bernstein et al., 1996). A distinct hinge region was also identified within the structures 
of antibody molecules featuring only three constant domains, varying in length and 
structure between the different antibody classes (Woof and Burton, 2004) and likely 
conferring increased flexibility to their associated heavy chain domains (Syndercombe 
Court et al., 2009, p. 266). 
Immunoglobulin antigen specificities are dictated by the light and heavy variable domains 
located on the two “arms” of their “Y”-shaped molecules. Taken together, the two arms 
form the Fab (fragment-antigen binding) or hypervariable regions (Al-Lazikani et al., 
1997) displaying the antigen-binding sites at the tip of each arm (Syndercombe Court et 
al., 2009, p. 266). Conversely, the basal half of immunoglobulin molecules, comprised 
exclusively of disulfide-linked heavy chain constant domains, forms the Fc (fragment-
crystallisable) region, which facilitates their interaction with effector molecules such as 
complement in order to dictate the role of a plasma cell within the overall immune activity 
of the host organism (Woof and Burton, 2004). 
2.5.6. Monoclonal antibodies 
The strength of interaction between the different immunoglobulin classes and their 
respective antigens – termed binding “affinity” when describing the strength of individual 
antibody-antigen bonds or “avidity” when referring to the number of antigens that a 
certain immunoglobulin can bind (Syndercombe Court et al., 2009, p. 267) – is so high 
that antibody-based drugs have become widely researched and developed by the 
pharmaceutical industry. While classic antibodies or “antisera” are still collected from the 
blood of humans or animals that have developed natural immunities to specific antigens, 
so that passive immunity might then be conferred upon other patients or animals as well, 
such methods of immunisation are ultimately limited in their scope due to their reliance 
on polyclonal antibodies. Since antibodies are secreted by the entire plasma cell 
population of the particular donor that came into contact with the respective antigen, 
antisera actually comprise of an entire host of antibodies with mixed affinities and 
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specificities and, thus, the efficacy of such treatments will always be dependent upon the 
quality and amount of collected antibody serum (Rang et al., 2007, p. 772). 
Fortunately, all of these limitations became avoidable in 1975, when Georges Köhler and 
César Milstein from the Medical Research Council (MRC) Laboratory of Molecular 
Biology in Cambridge, UK, first developed a “hybridoma” cell line (Figure 2.5.6.1) by 
fusing immortalised mouse myeloma cells with spleen B lymphocytes from an 
immunised specimen secreting anti-sheep red blood cell (SRBC) antibodies (Köhler and 
Milstein, 1975). 
 
Figure 2.5.6.1. Schematic of a hybridoma cell line producing monoclonal antibodies against a 
complex antigen. A mouse is injected with foreign cell membranes and thus generates a multitude 
of different antibodies. Its antibody-rich serum is then extracted and the antibody-secreting B 
lymphocytes are immortalised via fusion to myeloma cells. Through the cloning of the resulting 
hybridomas, the selection of monoclonal antibodies against the individual antigens expressed by 
the injected immunogenic cell membranes now becomes possible (adapted from Milstein, 1999). 
The fusion process effectively transferred the immortal quality of the myeloma cell line 
to the spleen B lymphocytes, which could afterwards be perpetually cultured in vitro. By 
diluting the growth medium until a single lymphocyte could be selected, a vast number 
of monoclonal anti-SRBC antibodies could thus be derived from the same B cell and 
therefore share the same elevated specificity and affinity for their designated antigen. 
Since monoclonal antibodies displaying high affinities and specificities could then be 
raised against virtually any antigen, they were quickly introduced to clinical trials after 
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their emergence in the early 1980s. Unfortunately, by virtue of being expressed in an 
animal system, fully murine antibodies also triggered immune responses in approximately 
75% of human patients and thus had to undergo “humanisation” before they could be 
effectively used for their intended therapeutic purposes. This was achieved by modifying 
the antibody expressor genes to include cDNA encoding human Fc domains while 
preserving the mouse Fab regions responsible for antigen binding, which resulted in not 
only a much better integration into the human immune system, but also a markedly 
improved serum half-life (Rang et al., 2007, p. 773). As the pharmaceutical industry 
gradually moved towards developing fully human monoclonal antibodies, the chimeric 
human-murine molecules were improved to the point of only including murine paratopes 
on otherwise fully human Fab and Fc regions. Similarly, throughout recent years 
hybridoma cell lines have also been steadily phased out by recombinant antibody 
production in transgenic mammalian cells (Reichert et al., 2005). 
Since their humanisation, a total of 23 monoclonal antibodies have already been approved 
by the FDA for use in a clinical environment (Toporkiewicz et al., 2015). These include 
treatments for Crohn’s disease (natalizumab), psoriasis (efalizumab), asthma 
(omalizumab), rheumatoid arthritis (adalimumab) and multiple sclerosis (alemtuzumab) 
(Reichert et al., 2005). Several monoclonal antibodies have also been selected against 
cancer markers such as CD20 (rituximab) and HER2 (trastuzumab), becoming staples of 
human anti-cancer treatments. Moreover, through their capability of being coupled to 
cytotoxins, radioisotopes and other such conjugates, monoclonal antibodies have steadily 
increased their therapeutic and diagnostic versatility, leading to the development of 
commercialised immunoconjugated antibody drugs such as Mylotarg (gemtuzumab 
ozogamicin), Zevalin (ibritumomab tiuxetan) and Bexxar (131I-tositumomab). 
Considering all of the above developments, it should come as no surprise that, since their 
inception, over 150 different monoclonal antibodies have undergone clinical trials across 
the world (Toporkiewicz et al., 2015). 
2.5.7. Designed ankyrin repeat proteins 
For many years, monoclonal antibodies and the newer antibody fragments such as single-
chain variable fragments (scFvs) represented prime examples of protein binders 
displaying high affinities and specificities for their intended therapeutic targets. 
Unfortunately, their successful application in vivo has always been constrained by both 
their poor conformational stability under adverse biological conditions, as well as their 
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propensity for aggregation in solution due to their antiparallel β-sheet domain 
arrangement (Schilling et al., 2014). Luckily, more recent developments in synthetic 
antibody library design and selection have managed to improve upon these limitations 
quite significantly. 
Newer, scaffold-based binding proteins feature a modular assembly process that not only 
dramatically expands their potential applications horizon, but also imbues them with very 
desirable biophysical characteristics that confer significant advantages over traditional 
monoclonal antibodies in both in vitro and, more importantly, in vivo scenarios. These 
include low to non-existent aggregation in solution, a high potential for chemical coupling 
to functional conjugates such as fluorophores and cytotoxins, the absence of structural 
disulfide bonds (a requisite for functional E. coli cytoplasmic expression systems), high 
levels of secretion for both mono- and multimeric assemblies and the possibility of 
extending their in vivo half-lives through site-specific PEGylation or fusion to long-lived 
serum proteins (Boersma and Plückthun, 2011). With the advent of phage and ribosome 
display, in vitro production of antibody-like binders has become not only possible, but 
highly pursued throughout the entire pharmaceutical industry. These techniques enabled 
biological drug divisions to select scaffold binding proteins such as adnectins, avimers, 
anticalins and affibodies with high affinities against a variety of target antigens at a mere 
fraction of the production cost of monoclonal antibodies (Stumpp et al., 2008). 
Developed in the early ‘00s through research conducted by Prof. Andreas Plückthun’s 
group from the Biochemistry department at the University of Zurich, Switzerland 
(Molecular Partners, 2016a), designed ankyrin repeat proteins (DARPins) represent a 
novel class of binding proteins that have overcome the limitations of traditional 
monoclonal antibodies, namely expensive formulation, difficult extraction and low tissue 
penetration (Stumpp et al., 2008). Furthermore, while monoclonal antibodies can be 
either murine, primatised or, in the best of cases, chimeric or humanised (Reichert et al., 
2005), DARPins are derived from naturally-occurring ankyrin repeat proteins that are 
abundantly encoded throughout the human genome (International Human Genome 
Sequencing Consortium, 2001), contributing to a multitude of high-affinity protein-
protein interactions courtesy of their intriguing modular architecture (Schilling et al., 
2014). DARPins capitalise upon this property by being comprised of a varying number 
of protein motifs (i.e. library modules) that stack together to form the target binding 
domain (Figure 2.5.7.1 overleaf). Typical DARPin molecules regularly feature between 
4-6 motifs, but examples of single proteins consisting of up to 29 library modules have 
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also been documented in the literature (Tamaskovic et al., 2012). Their facile modularity 
grants DARPins an enormous degree of potential diversity that can lead to the creation of 
binder libraries numbering billions of different ligand combinations (Stumpp et al., 2008). 
 
Figure 2.5.7.1. Diagram of DARPin library design: A) DARPins comprise of two hydrophilic 
ends (N- and C-), capping varying numbers of internal library modules (n, shown here in grey). 
Every library module is comprised of 33 amino acids featuring 7 variable side chains (red); B) 
Examples of two DARPins – “off7” and “AR_3A” – composed of three library modules each and 
with their randomised target binding regions coloured in red and blue, respectively; C) DARPins 
off7 and AR_3A forming complexes with maltose binding protein (MBP) (PDB ID: 1SVX) and 
aminoglycoside phosphotransferase (APH) (PDB ID: 2BKK), each of them connected at their 
respective red and blue randomised target binding regions (adapted from Stumpp et al., 2008). 
From early on in their inception, DARPin libraries were constructed around a consensus 
design approach that helped define what their smallest building block – the library module 
– should contain. Originating from a desire to determine the occurrence of particular 
amino acids at specific positions based on multiple amino acid sequence alignments 
(Kajander et al., 2006), the repeat protein consensus design was applied to DARPins 
based on an initial alignment of 229 naturally-occurring ankyrin repeat proteins, each 
comprising of 33 amino acids of which 7 were variable (Stumpp et al., 2008). Upon 
further refinement, a total of 2,200 amino acid sequences were established as consensus-
approved DARPin library modules (Binz et al., 2003). The consensus design approach 
ultimately resulted in the possibility of creating highly stable and extremely versatile 
binders that could have modules added, deleted or exchanged on a case-by-case basis so 
as to better suit their intended purposes. Furthermore, their known amino acid sequences 
opened them towards even further manipulation, such as conjugation to specialised 
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functional groups (Boersma and Plückthun, 2011). These include PEG for extending 
DARPin in vivo half-lives, electrophilic moieties for binding target proteins covalently, 
cytotoxic compounds for targeted anti-cancer therapies and fluorophores, radiolabels or 
contrast agents for in vivo magnetic resonance imaging (MRI) (Moody et al., 2014). 
When generating a DARPin library, the modules are genetically engineered to feature 
hydrophilic N- and C-caps that flank the otherwise hydrophobic central binding domain, 
giving rise to potentially billions of “N×C” binders, where “×” represents the number of 
library modules employed in the creation of a specific binder. The 7 variable amino acid 
positions grant individual modules millions of different sequence variations and, as such, 
a DARPin library created using only two of these modules can reach diversities of up to 
1014 unique binders (Stumpp et al., 2008). Their consensus design enables DARPins to 
closely resemble human ankyrin repeat proteins (i.e. 67-71% sequence identity) (Stumpp 
et al., 2008), while the absence of an Fc domain renders them far less prone to trigger 
unfavourable immune responses in human patients compared to antibody fragments, 
monoclonal antibodies, aptamers, folates, lectins or transferrins (Toporkiewicz et al., 
2015). Since a single library module only weighs approximately 3.5 kDa, conventional 
DARPins featuring 4-6 modules are thus ten times smaller than classic immunoglobulin 
molecules, which greatly favours their serum solubility (>100 mg/mL), half-life (>60 
days) and tissue penetration. DARPins are also much less susceptible to both thermal and 
chemical denaturation (>100 °C or 5 M guanidine hydrochloride, respectively) and their 
stability actually increases proportionally to their number of constituent repeats. 
Furthermore, they express to a very high degree even in low expression bacterial strains 
such as XL1-blue E. coli, generating yields upwards of 200 mg of purified protein per 
litre of shake flask culture (Stumpp et al., 2008) – a result that can be improved upon even 
further through the use of specialised expression strains (e.g. the BL21 E. coli used in the 
current project) along with cell culture fermentation technologies. 
Coupled with modern in vitro selection technologies such as phage display, DARPin 
binders with low-nanomolar to picomolar affinities can be successfully selected against 
a variety of different protein targets (e.g. cytokines, proteases, kinases and membrane-
bound transporters and pumps) following a minimal number of selection rounds (Jost and 
Plückthun, 2014). Their diminutive sizes allow DARPins to be primed for vaccination 
(Wallmann et al., 2010) and to be administered in vivo through a variety of possible 
routes, including topically, orally and nasally (Stumpp et al., 2008), while also benefitting 
from a rapid clearance via the kidneys (Weidle et al., 2013). Given their high stability, 
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serum solubility and broad functionalisation capabilities, DARPin-based drugs can be 
readily formulated from either monovalent DARPins, harbouring no additional 
modifications, or from molecules that have been chemically or genetically conjugated to 
other useful moieties (Figure 2.5.7.2), enabling them to serve either as agonists, 
antagonists or inhibitors at their designated therapeutic targets (Stumpp et al., 2008). 
 
Figure 2.5.7.2. Functionalisation capabilities of therapeutic DARPins: A) Monovalent DARPin 
antagonists binding to either a ligand (green) or a membrane-bound receptor (blue). One of the 
DARPins has been PEGylated for extended serum half-life; B) Bispecific DARPin conjugate 
capable of binding two epitopes on the same target for improved efficacy; DARPins targeting cell 
surface antigens while being fused to either (C) another protein such as a cytokine, (D) a 
radioactive label for diagnostic purposes or (E) a small-molecular-weight toxin for added 
cytotoxic activity; F) Trispecific DARPin conjugate capable of binding a tumour antigen, as well 
as additional effector cells and serum proteins; G) Bispecific DARPin binding two different cell-
surface antigens in hopes of demonstrating increased tumour selectivity compared to monovalent 
binders (adapted from Stumpp et al., 2008). 
Thus far, multiple DARPin-based therapeutic compounds have shown safety and efficacy 
in preclinical models when used for diagnostic purposes (Stumpp et al., 2008), such as 
detecting coagulation factor VIII inhibitory antibodies in haemophilia A patients 
(Hausammann et al., 2013) and binding to HER2 factors in solid tumours (Zahnd et al., 
2010). Cancer immunotherapy also benefitted from the use of DARPin technology via 
the adoptive transfer of T lymphocytes expressing DARPin-based chimeric receptors for 
the recognition of solid tumour antigens (Hammill et al., 2015). 
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Anti-cancer DARPins have also been successfully conjugated to both cytotoxins for 
tumour-specific payload delivery, as well as modified serum albumin modules for 
extended half-life (Simon et al., 2013), while other binders still have been displayed on 
the capsids of adeno-associated viral vectors targeted against the tumour antigen 
HER2/neu. These DARPin-viral complexes were able to reach 75% of all tumour sites 
and extend patient survival rates beyond the capabilities of the cytostatic antibody 
Herceptin, while also demonstrating none of the associated off-target accumulation in 
unaffected tissues caused by the latter drug (Münch et al., 2015). DARPins were also 
found to prevent amyloid-β peptide aggregation and its resulting neurotoxicity in vivo, 
leading to improved cognitive abilities in murine Alzheimer models (Hanenberg et al., 
2014). Furthermore, off7 (Figure 2.5.3.1 above) was used as a starting point for 
developing a reagentless fluorescent biosensor whose fluorescence intensity increases 
proportionally to the concentration of bound MaIE maltose binding protein from E. coli 
(Brient-Litzler et al., 2010). 
Their high binding affinities not only enable DARPins to act as input domains towards 
the creation of rapid modular protein switches in the fields of novel biosensor and highly-
selective protein therapeutics development (Nicholes et al., 2016), but to also be 
formulated for intraocular administration against vascular endothelial growth factor 
(VEGF) in the treatment of diabetic macular oedema (Campochiaro et al., 2013) and wet 
age-related macular degeneration (Tamaskovic et al., 2012) (Figure 2.5.7.3).  
 
Figure 2.5.7.3. Examples of DARPin-based drugs currently undergoing clinical trials in a 
multitude of therapeutic interest areas (adapted from Molecular Partners, 2016b). 
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Lastly, DARPins binding endogenous IgE immunoglobulins in the low nanomolar range 
were found to inhibit the release of proinflammatory mediators with higher efficacy than 
the commercial anti-IgE monoclonal antibody omalizumab (Xolair), demonstrating 
significant potential towards forming the basis of future anti-allergy medications 
(Baumann et al., 2010). 
Unfortunately, while also being responsible for their very high degrees of stability, the 
rigid and concave DARPin structures can actually restrict their spectrum of potential 
therapeutic applications, especially when their modular hydrophobic regions are 
incompletely randomised (Jost and Plückthun, 2014). In an attempt at circumventing this 
limitation, a new class of “LoopDARPins” (Figure 2.5.7.4 overleaf) was recently 
engineered to include a convex paratope normally displayed within the complementarity-
determining regions (CDRs) of classic immunoglobulin variable domains. Through the 
substitution of the central DARPin β-turn with an extended, 19-amino-acid CDR-H3-like 
loop demonstrating high conformational diversity, a total of 10 additional variable amino 
acid positions became available for antigen binding without affecting the overall stability 
of the protein scaffold. Furthermore, the upper part of the introduced loop is flexible and 
can thus readily expose its randomised binding domains to previously-unreachable 
antigen epitopes. Even more interestingly, the original consensus library design was 
expanded for LoopDARPins to also cover randomised N- and C-caps, which only served 
to increase their available antigen binding surfaces even further (Schilling et al., 2014). 
LoopDARPins preserve many of the favourable characteristics that made conventional 
DARPins so exciting and actually managed to surpass them in several key areas. First of 
all, they readily express in E. coli systems, giving high yields of protein binders that can 
remain folded over several weeks at 4 °C and are much less susceptible to forming dimers 
and oligomers in solution than regular DARPins. In fact, a higher percentage of 
monomers was actually detected in LoopDARPin populations that had been subjected to 
rigorous rounds of ribosome display compared to untested library members. Finally, it 
was found that a single round of ribosome display was enough to yield LoopDARPins 
demonstrating low-nanomolar to mid-picomolar affinities towards their designated 
targets – a surprising result, given that regular DARPin libraries usually require multiple 
rounds of interrogation before binders with similar affinity levels can be identified (Jost 
and Plückthun, 2014). Despite some minor self-complementarity issues arising as an 
unfortunate consequence of the added flexibility of their extended loops, LoopDARPins 
represent an evolved scaffold protein platform that exceeds the capabilities of traditional 
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DARPins while also offering a substantial enrichment potential and an unprecedented 
selection speed against similar types of protein-based antigens (Schilling et al., 2014). 
While LoopDARPins were sadly not available for the project at hand, the binding 
capabilities of traditional DARPins against NupC were investigated as described further 
on in Chapter 5, after presenting the materials and methods in the upcoming Chapter 3. 
 
Figure 2.5.7.4. Diagram detailing the process of transforming regular DARPins into cap-
randomised LoopDARPins. Top: a conventional DARPin (PDB ID: 2XEE) harbouring three 
consensus library modules undergoes modification with an extended CDR-like loop. Middle: a 
LoopDARPin integrating the extended loop into its second library module is thereby created. 
Bottom: randomised N- and C-terminal caps (Nran and Cran, respectively, depicted in red on the 
ribbon structure and in orange on the surface structure) are added to flank the three library 
modules I (internal module), IL (loop-containing internal module) and IF (internal module 
following loop), depicted here in pink (adapted from Schilling et al., 2014). 
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CHAPTER 3 
 
Materials and Methods 
 
3.1. Reiterating the Overall Experimental Plan 
Three NupC constructs (i.e. C-terminal double Strep-tagged (II), intrinsic His6-tagged and 
untagged/wild-type NupC) were used to provide proof-of-concept for the proposed 
SSBLM phage display screening platform. Following their expression and purification 
from E. coli, their ex vivo nucleoside transport activities were measured via a transporter 
assay in order to establish whether the purified NupC constructs retained their original 
conformations and were still correctly folded. 
The formation and characterisation of model lipid SSMs on planar silica surfaces was 
then investigated via QCM-D in order to test the virtues of this particular substrate 
towards forming SSMs embedding reconstituted membrane protein targets. Planar SSM 
creation was afterwards followed by the deposition and characterisation of SSBLMs on 
the chosen 100- and 200 nm silica nanoparticle substrates. 
Finally, the presentation of the three SSBLM-embedded NupC constructs was examined 
alongside the characterisation of their orientations and epitope accessibility prior to using 
this novel platform towards the phage display screening of DARPin binders against 
NupC. 
3.2. Materials 
The BL21, C43 (DE3) and OmniMAX E. coli cell cultures and the pBPT-0217-CS2T, 
pLH13, pGJL16 and pMPSIL0079A plasmids (see Appendix), respectively encoding 
double Strep-tagged, His6-tagged and untagged NupC, as well as His6-tagged PepTSo, 
were kindly provided by Dr. Vincent Postis (The School of Biomedical Sciences, 
University of Leeds). The DARPin library, TG1 E. coli cell cultures and M13K07trp 
helper phage stock solutions were kindly provided by MedImmune Ltd. 
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Cell culture and protein expression materials included ampicillin sodium salt (Melford, 
A0104), bacteriological agar (Agar No. 1) (Oxoid, LP0011), carbenicillin disodium salt 
(Melford, C0109), Corning® non-treated culture (Petri) dishes (Sigma-Aldrich, 
CLS430589), Corning® square bioassay dishes (Sigma-Aldrich, CLS431111), glucose 
(VWR, 101174Y), HisPur™ cobalt resin (Thermo Fisher Scientific, 89965), isopropyl β-
D-thiogalactoside (IPTG) (Generon, GEN-S-02122), kanamycin monosulfate (Melford, 
K0126), Pierce™ disposable columns (5 mL) (Thermo Fisher Scientific, 29922), Slide-
A-Lyzer™ dialysis cassettes (3 mL, 10K MWCO) (Thermo Fisher Scientific, 66380), 
sodium chloride (NaCl) (Melford, S0520), Strep-Tactin® Superflow® 50% (w/v) resin 
suspension (IBA, 2-1206-002), StrepTrap HP columns (5×1 mL) (GE Healthcare Life 
Sciences, 28-9075-46), tryptone (Melford, T1332), Vivaspin® 6 and Vivaspin® 20 
centrifugal concentrators (10K MWCO) (Sartorius, VS0601 and VS2001, respectively) 
and yeast extract powder (Melford, Y1333). 
Buffer materials included 3-(N-Morpholino)propanesulfonic acid (MOPS) (Sigma-
Aldrich, M1254), bovine serum albumin (BSA) fraction V (Melford, A1302), 
cOmplete™ (EDTA-free) mini protease inhibitor cocktail tablets (Sigma-Aldrich, 
04693159001), d-Desthiobiotin (Sigma-Aldrich, D1411), ethylenediaminetetraacetic 
acid (EDTA) disodium salt (Melford, E0511), glycerol (Sigma-Aldrich, G6279), glycine 
(Melford, G0709), imidazole (Sigma-Aldrich, I202), Marvel Original dried skimmed 
milk (Tesco, 340 g), N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES) 
(Sigma-Aldrich, H3375), n-Dodecyl β-D-maltoside (DDM) (Anatrace, D310LA), 
potassium chloride (KCl) (Sigma-Aldrich, P9541), potassium phosphate dibasic 
(K2HPO4) (Sigma-Aldrich, P3786-M), potassium phosphate monobasic (KH2PO4) 
(Sigma-Aldrich, P9791), sodium dodecyl sulfate (SDS) (Sigma-Aldrich, L3771), sodium 
phosphate dibasic (Na2HPO4) (Sigma-Aldrich, S7907), sodium sulfate (Na2SO4) (Sigma-
Aldrich, 239313-M), sucrose (Melford, S0809), threo-1,4-Dimercapto-2,3-butanediol 
(DTT) (Sigma-Aldrich, 43819), tris(hydroxymethyl)aminomethane (Tris) (Melford, 
B2005), trypsin (Sigma-Aldrich, T2600000) and Tween® 20 (Sigma-Aldrich, P2287). 
Bicinchoninic acid (BCA) assay materials included BCA solution (Sigma-Aldrich, 
B9643), copper (II) sulfate pentahydrate (CuSO4·5H2O) (Sigma-Aldrich, 203165) and 
Corning® Costar® flat-bottomed 96-well plates (Sigma-Aldrich, CLS3599). 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) materials included 2-
Mercaptoethanol (Acros Organics, 125470100), acetic acid (Sigma-Aldrich, 71251), 
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acrylamide (40% (w/v) solution) (Melford, A2440), ammonium persulfate (APS) 
(Melford, A1512), bis-acrylamide (2% (w/v) solution) (Melford, A2502), bromophenol 
blue (SLS, CHE1342), Coomassie Brilliant Blue G solution (Sigma-Aldrich, B8522), 
methanol (Sigma-Aldrich, 322415), N,N,N’,N’-Tetramethylethylenediamine (TEMED) 
(Melford, T3100), PageRuler™ Plus prestained protein ladder (10-250 kDa) (Thermo 
Fisher Scientific, 26619) and PageRuler™ unstained broad range protein ladder (5-250 
kDa) (Thermo Fisher Scientific, 26630). DNA gel electrophoresis materials included 1 
kb DNA ladder (New England BioLabs, N3232S) and agarose (Sigma-Aldrich, A9414). 
Western blotting materials included 1-Step™ Ultra TMB-blotting solution (Thermo 
Fisher Scientific, 37574), precut nitrocellulose membranes (0.45 μm, 15×15 cm) (Bio-
Rad, 1620116) and precut thick blot filter paper (18×34 cm) (Bio-Rad, 1650921). Double 
Strep-tagged NupC detection employed StrepMAB-Classic mouse anti-Strep (II) primary 
antibodies (IBA, 2-1507-001) and peroxidase-conjugated AffiniPure goat anti-mouse IgG 
(H+L) secondary antibodies (Jackson ImmunoResearch Laboratories, 115-035-003). 
His6-tagged NupC detection employed HRP-conjugated mouse IgG1 anti-His antibodies 
(R&D Systems, MAB050H). Formyl peptide receptor (FPR) detection employed IgG 
0165 primary antibodies (MedImmune Ltd, proprietary) and goat anti-human IgG (Fc-
specific) peroxidase-conjugated antibodies (Sigma-Aldrich, A0170). 
Protein reconstitution materials included 1-Palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) lipids (Avanti Polar Lipids, 850457), α-[4-(1,1,3,3-
Tetramethylbutyl)phenyl]-w-hydroxy-poly(oxy-1,2-ethanediyl) (Triton X-100) (10% 
(w/v) solution) (Anatrace, APX100), Bio-Beads® SM-2 adsorbent beads (Bio-Rad, 
1523920), E. coli polar lipid extracts (67% phosphatidylethanolamine, 23.2% 
phosphatidylglycerol, 9.8% cardiolipin) (Avanti Polar Lipids, 100600), isopropanol (2-
Propanol) (Sigma-Aldrich, I9516), Mini-Extruder set with holder/heating block and two 
Hamilton Gastight #1001 (1 mL) syringes (Avanti Polar Lipids, 610000), Nuclepore™ 
polycarbonate extrusion membranes (50-, 100-, 200- and 400 nm) (GE Healthcare Life 
Sciences, 800308, 800309, 800281 and 800282, respectively) and polyester extruder 
drain discs (10 mm) (GE Healthcare Life Sciences, 230300). 
SURFE2R N1 transporter assay materials included adenosine (Sigma-Aldrich, A9251), 
guanosine (Sigma-Aldrich, G6752), N1 gold sensors (Nanion Technologies), Parafilm 
M® laboratory film (Bemis, PM999), as well as Sensor Prep A (1-octadecanethiol in 
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isopropanol (1 mM)) and Sensor Prep B (DiPhyPC in decane (7.5 mg/mL)) solutions 
(Nanion Technologies). 
QCM-D materials included silicon dioxide (SiO2)-coated Q-Sensors (Biolin Scientific). 
Fluorescence spectroscopy materials included 1,2-Dihexadecanoyl-sn-glycero-3-
phosphoethanolamine triethylammonium salt (Texas Red®) (Thermo Fisher Scientific, 
T1395MP), chloroform (Sigma-Aldrich, 288306) and methanol (Sigma-Aldrich, 
322415). 
The SSBLM substrates comprised of solid silicon dioxide (SiO2) nanospheres with 
diameters of 100- and 200 nm (10 mg/mL aqueous solutions) (nanoComposix, SISN100 
and SISN200, respectively). 
The peroxidase assay materials were included in a SensoLyte® 10-Acetyl-3,7-
dihydroxyphenoxazine (ADHP) peroxidase assay kit (fluorimetric) (AnaSpec, AS-
71111). 
Cryo-EM materials included 5 nm Ni-NTA-Nanogold® probes (0.5 µM stock solution in 
50 mM MOPS buffer, pH 7.9) (Nanoprobes, 2082) and lacey carbon film/copper mesh 
cryo-grids (Agar Scientific, AGS166). 
DNA molecular biology materials included BamHI restriction digest enzyme (New 
England BioLabs, R0136S), ChargeSwitch®-Pro plasmid miniprep kit (Thermo Fisher 
Scientific, CS30250), KOD DNA polymerase (Merck Millipore, 71085-3), NdeI 
restriction digest enzyme (New England BioLabs, R0111S), NEBuffer 3.1 (New England 
BioLabs, B7203S), nuclease-free water (Thermo Fisher Scientific, R0581), pET-16b 
expression vector (Merck Millipore, 69662-3), pET-16b forward and reverse primers 
(Eurofins, custom-made), T4 DNA ligase (New England BioLabs, M0202S), T4 DNA 
ligase reaction buffer (New England BioLabs, B0202S) and Wizard® SV gel and 
polymerase chain reaction (PCR) clean-up system (Promega, A9281). 
Enzyme-linked immunosorbent assay (ELISA) materials included 3,3′,5,5′-
Tetramethylbenzidine (TMB) liquid substrate system for ELISA (Sigma-Aldrich, 
T0440), Corning® Costar® V-bottomed 96-well plates (Sigma-Aldrich, CLS3897), 
Nunc™ MaxiSorp™ flat-bottomed 96-well plates (Thermo Fisher Scientific, 442404) 
and sulfuric acid (H2SO4) (Fisher Scientific, A300-212). 
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3.3. Buffers, Media and Solutions 
The following tables (3.3.1.1a-o) detail all of the buffers, media and solutions used for 
the experimental work described throughout the current thesis. Unless specified 
otherwise, MilliQ® water (18.2 MΩ·cm) represented the solvent for all of the recipes 
presented below. 
General buffers and solutions 
KPi buffer (pH 6.8/7.4, adjusted with NaOH) 
- 20% (w/w) KH2PO4 
- 80% (w/w) K2HPO4 
MOPS/Na2SO4 buffer (pH 7.0, adjusted with NaOH) 
- 20 mM MOPS 
- 30 mM Na2SO4 
PBS buffer (pH 7.5, adjusted with HCl) 
- 137 mM NaCl 
- 2.7 mM KCl 
- 10 mM Na2HPO4 
- 1.8 mM KH2PO4 
HEPES buffer (pH 7.4, adjusted with NaOH) 
- 30 mM HEPES 
- 25 mM NaCl 
- 100 mM KCl 
TAE buffer (pH 7.6, adjusted with HCl) 
- 40 mM Tris 
- 20 mM acetic acid 
- 1 mM EDTA 
Deep-freeze storage solution 
- 50% (w/v) glycerol 
Peroxidase reaction stop solution 
- 0.5 M H2SO4 
Table 3.3.1.1a. General buffers and solutions used for the experimental work described 
throughout the current thesis. 
Bacterial growth media 
Luria-Bertani (LB) bacterial growth medium 
- 1% (w/v) tryptone 
- 0.5% (w/v) yeast extract 
- 1% (w/v) NaCl 
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Luria-Bertani (LB) agar 
- LB bacterial growth medium 
- 1.25% (w/v) bacteriological agar 
2×TY growth medium 
- 1.6% (w/v) tryptone 
- 1% (w/v) yeast extract 
- 0.5% (w/v) NaCl 
2×TYAG growth medium 
- 2×TY growth medium 
- 100 μg/mL ampicillin 
- 2% (w/v) glucose 
2×TYAK growth medium 
- 2×TY growth medium 
- 100 μg/mL ampicillin 
- 50 μg/mL kanamycin 
Table 3.3.1.1b. The bacterial growth media used for the cell culture work described throughout 
the current thesis. 
Double Strep-tagged NupC expression and purification buffers 
Double Strep-tagged NupC Tris/EDTA buffer (pH 7.5, adjusted with HCl) 
- 20 mM Tris 
- 0.5 mM EDTA 
- 5% (w/v) glycerol 
Double Strep-tagged NupC solubilisation buffer (2×, pH 7.0, adjusted with HCl) 
- 100 mM Tris 
- 2 mM EDTA 
- 200 mM NaCl 
- 2% (w/v) DDM 
- 1 cOmplete™ (EDTA-free) mini protease inhibitor cocktail tablet per 50 mL 
Double Strep-tagged NupC wash buffer (pH 7.0, adjusted with HCl) 
- 50 mM Tris 
- 1 mM EDTA 
- 100 mM NaCl 
- 5% (w/v) glycerol 
- 0.05% (w/v) DDM 
Double Strep-tagged NupC binding dilution buffer (pH 7.0, adjusted with HCl) 
- 50 mM Tris 
- 1 mM EDTA 
- 100 mM NaCl 
- 10% (w/v) glycerol 
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Double Strep-tagged NupC elution buffer 
- Double Strep-tagged NupC wash buffer (pH 7.0) 
- 2.5 mM d-Desthiobiotin 
Table 3.3.1.1c. The buffers used for the expression and purification of double Strep-tagged NupC. 
His6-tagged NupC expression and purification buffers 
His6-tagged NupC solubilisation buffer 
- 50 mM KPi buffer (pH 7.4) 
- 150 mM NaCl 
- 5 mM imidazole 
- 10% (w/v) glycerol 
- 1% (w/v) DDM 
His6-tagged NupC wash buffer 
- 50 mM KPi buffer (pH 7.4) 
- 150 mM NaCl 
- 5 mM imidazole 
- 10% (w/v) glycerol 
- 0.05% (w/v) DDM 
His6-tagged NupC elution buffer 
- 50 mM KPi buffer (pH 6.8) 
- 150 mM NaCl 
- 300 mM imidazole 
- 10% (w/v) glycerol 
- 0.05% (w/v) DDM 
Table 3.3.1.1d. The buffers used for the expression and purification of His6-tagged NupC. 
Untagged NupC expression and membrane extraction buffers and solutions 
Untagged NupC Tris/EDTA buffer (pH 7.5, adjusted with HCl) 
- 20 mM Tris 
- 0.5 mM EDTA 
Sucrose gradient solutions 
- Untagged NupC Tris/EDTA buffer (pH 7.5) 
- 25%, 30%, 40%, 45%, 50% and 55% (w/w) sucrose, respectively 
Table 3.3.1.1e. The buffers and solutions used for the expression and inner membrane extraction 
of untagged NupC. 
BCA assay solutions 
Reagent A 
- BCA solution (commercial stock) 
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Reagent B 
- 4% (w/v) CuSO4·5H2O 
Table 3.3.1.1f. The solutions used for the BCA assays performed throughout the entire project. 
SDS-PAGE buffers and solutions 
Tris buffer (pH 6.8/8.8, adjusted with HCl) 
- 0.5 M Tris (pH 6.8) or 1.5 M Tris (pH 8.8) 
SDS-PAGE stacking gel solution (4% (v/v)) 
- 0.77 mL of stock 40% (w/v) acrylamide solution 
- 0.39 mL of stock 2% (w/v) bis-acrylamide solution 
- 0.75 mL of 0.5 M Tris buffer (pH 6.8) 
- 0.05 mL of 10% (w/v) SDS solution 
- 3.2 mL of MilliQ® water 
- 30 μL of 10% (w/v) APS solution 
- 18 μL of stock TEMED solution 
SDS-PAGE resolving gel solution (12.5% (v/v)) 
- 3.745 mL of stock 40% (w/v) acrylamide solution 
- 0.45 mL of stock 2% (w/v) bis-acrylamide solution 
- 2.81 mL of 1.5 M Tris buffer (pH 8.8) 
- 0.1 mL of 10% (w/v) SDS solution 
- 4.265 mL of MilliQ® water 
- 37 μL of 10% (w/v) APS solution 
- 24 μL of stock TEMED solution 
 SDS-PAGE loading buffer (4×, pH 7.5, adjusted with HCl) 
- 200 mM Tris 
- 400 mM DTT 
- 8% (w/v) SDS 
- 0.4% (w/v) bromophenol blue 
- 40% (w/v) glycerol 
- 20% (v/v) 2-Mercaptoethanol 
SDS-PAGE running buffer (5×, pH 7.5, adjusted with HCl) 
- 1.5% (w/v) Tris 
- 7.2% (w/v) glycine 
- 0.5% (w/v) SDS 
SDS-PAGE destaining solution 
- 7.5% (v/v) methanol 
- 5% (v/v) acetic acid 
SDS-PAGE staining solution 
- 40 mL of SDS-PAGE destaining solution 
- 2 mL of Coomassie Brilliant Blue G solution 
Table 3.3.1.1g. The buffers and solutions used for SDS-PAGE. 
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Western blotting buffers 
TBS buffer (10×, pH 7.5, adjusted with HCl) 
- 0.5 M Tris 
- 1.5 M NaCl 
TBS-T buffer 
- 1× TBS buffer (pH 7.5) 
- 0.1% (v/v) Tween® 20 
Western blotting blocking buffer 
- TBS-T buffer (pH 7.5) 
- 3% (w/v) BSA 
Table 3.3.1.1h. The buffers used for Western blotting. 
SURFE2R assay solutions 
SURFE2R activating solutions 
- PBS buffer (pH 7.5) 
- increasing concentrations of adenosine (μM range) 
SURFE2R control solutions 
- PBS buffer (pH 7.5) 
- increasing concentrations of guanosine (μM range) 
Table 3.3.1.1i. The solutions used for the purified NupC nucleoside transport SURFE2R assays. 
Phage display screening buffers 
Phage display blocking buffer 
- PBS buffer (pH 7.5) 
- 3-6% (w/v) Marvel Original dried skimmed milk 
Phage display wash buffer 
- PBS buffer (pH 7.5) 
- 0.1% (v/v) Tween® 20 
Phage display elution buffer (pH 7.5, adjusted with NaOH) 
- 0.1 M Na2HPO4 
- 1:500 (v/v) trypsin 
Table 3.3.1.1j. The buffers used for the phage display screening of DARPin binders against 
NupC. 
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DARPin DNA molecular biology reaction mixtures 
DARPin double restriction digest reaction mixture 
- 50 µL of pET-16b expression vector 
- 10 µL of NEBuffer 3.1 
- 2 µL of BamHI 
- 2 µL of NdeI 
- 36 µL of nuclease-free water 
DARPin ligation reaction mixture 
- 1:10 vector/insert molar ratio (8 µL in total) 
- 1 µL of T4 DNA ligase buffer 
- 1 µL of T4 DNA ligase 
DARPin PCR reaction mixture 
- 5 µL of KOD DNA polymerase buffer 
- 1 µL of pET-16b forward primer 
- 1 µL of pET-16b reverse primer 
- 5 µL of DARPin plasmid DNA 
- 1 µL of KOD DNA polymerase 
- 37 µL of nuclease-free water 
Table 3.3.1.1k. The reaction mixtures used for manipulating the plasmids of the lead candidate 
DARPins selected against NupC. 
Lead candidate DARPin purification buffers 
DARPin purification wash buffer 
- 2× PBS buffer (pH 7.5) 
- 30 mM imidazole 
DARPin purification elution buffer 
- 2× PBS buffer (pH 7.5) 
- 200 mM imidazole 
Table 3.3.1.1l. The buffers used for the purification of the lead candidate DARPins selected 
against NupC. 
Detergent-solubilised NupC ELISA buffers 
Detergent-solubilised NupC ELISA wash buffer 
- 2× PBS buffer (pH 7.5) 
- 0.05% (w/v) DDM 
Detergent-solubilised NupC ELISA blocking buffer 
- Detergent-solubilised NupC ELISA wash buffer 
- 3% (w/v) BSA 
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Detergent-solubilised NupC ELISA antibody wash buffer 
- 2× PBS buffer (pH 7.5) 
- 0.1% (v/v) Tween® 20 
Table 3.3.1.1m. The buffers used for the ELISAs screening the purified lead candidate DARPins 
against detergent-solubilised double Strep-tagged NupC. 
SSBLM-embedded NupC ELISA buffers 
SSBLM-embedded NupC ELISA wash buffer 
- 2× PBS buffer (pH 7.5) 
- 1% (w/v) POPC LUVs 
SSBLM-embedded NupC ELISA blocking buffer 
- SSBLM-embedded NupC ELISA wash buffer 
- 3% (w/v) BSA 
Table 3.3.1.1n. The buffers used for the ELISAs screening the purified lead candidate DARPins 
against detergent-free (i.e. SSBLM-embedded) untagged NupC. 
SSBLM-embedded FPR ELISA buffers 
SSBLM-embedded FPR ELISA wash buffer 
- HEPES buffer (pH 7.4) 
- 1% (w/v) POPC LUVs 
SSBLM-embedded FPR ELISA blocking buffer 
- SSBLM-embedded FPR ELISA wash buffer 
- 3% (w/v) Marvel Original dried skimmed milk 
Table 3.3.1.1o. The buffers used for the SSBLM-embedded mammalian FPR ELISA. 
3.4. Methods 
The following subsections describe the general experimental methods, as well as the 
expression and purification of the membrane protein targets used throughout the current 
project towards providing proof-of-concept for the SSBLM phage display screening 
platform. 
3.4.1. General methods 
The BL21, C43 (DE3) and OmniMAX E. coli cell culture stocks were made competent 
by Dr. Vincent Postis (The School of Biomedical Sciences, University of Leeds) via the 
rubidium chloride (RbCl) method developed by Hanahan (1983). The TG1 E. coli cell 
culture stocks were made competent by MedImmune technicians using the same method. 
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The “heat-shock” transformation method involved incubating 50 μL of competent cells 
with 1 μL of the chosen plasmid (i.e. 50 ng of DNA) at 4 °C for 30 minutes, then at 42 
°C for 30 seconds and finally at 4 °C for another 2 minutes. Sterile, pre-warmed LB 
medium (250 µL) lacking antibiotics was then added to the cells, followed by another 1-
hour incubation at 37 °C. 
All roller, rocking platform and magnetic mixing steps were performed on a Stuart 
Scientific SRT6 roller mixer, Grant Bio PS-3D Sunflower mini-shaker and Stuart 
Scientific magnetic stirrer SM1, respectively. 
All BCA assays were performed in triplicate in Costar® flat-bottomed 96-well plates 
using 10 μL sample volumes. A 400 μg/mL BSA solution – diluted 1:5, 1:2.5, 1:1.6 and 
1:1.25 (v/v) in deionised water to give 10 μL volumes per well – was used to build the 
standard curve. The BCA working reagent was prepared by adding Reagent A (i.e. BCA 
solution at stock concentration) to Reagent B (i.e. 4% (w/v) CuSO4·5H2O solution in 
MilliQ® water) at a 1:50 (v/v) ratio, followed by vortexing until the resulting mixture 
became light green. The working reagent was then added to each well in 200 μL volumes 
and the plate was left to incubate at 37 °C for 30 minutes, after which the absorbances 
were measured at a wavelength of 551 nm using a Thermo Scientific Multiskan™ FC 
spectrophotometer. 
All lipid extrusion steps were performed by first rehydrating desiccated lipid aliquots in 
the specified buffer at the stated concentration. The lipid suspensions were then passed 
11 times through a fully assembled Avanti Mini-Extruder fitted with a polycarbonate 
extrusion membrane of specified pore size, sandwiched between four extruder drain discs 
(i.e. two on each side of the membrane). Prior to assembly, all extrusion membranes and 
drain discs were hydrated in MilliQ® water for at least 2 minutes. Both 1 mL Hamilton 
syringes were washed first in isopropanol, then in MilliQ® water and the buffer used to 
rehydrate the lipids was passed 11 times through the full assembly before any extrusion. 
The “freeze-thaw” mixing method consisted of snap-freezing lipid solutions in liquid 
nitrogen and then allowing them to thaw while floating on MilliQ® water at room 
temperature to ensure the proper mixing of the different lipid types present in solution. 
All polyacrylamide gels (12.5% (w/w)), comprising of stacking and resolving gel 
solutions, were freshly cast prior to each round of SDS-PAGE. The resolving gel solution 
was first pipetted into the Bio-Rad gel casting assembly and left to polymerise at room 
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temperature until solid (e.g. 45 minutes) before the stacking gel solution was added on 
top. A 10-toothed plastic comb was used for moulding the gel wells. All SDS-PAGE 
samples were normalised to 5 μg of protein, made up to total volumes of 15 μL and then 
incubated with 5 μL of 4× SDS-PAGE loading buffer for 2 hours at 37 °C before being 
loaded into the wells of the solidified gels. Electrophoresis was performed in a Bio-Rad 
Mini-PROTEAN Tetra vertical electrophoresis cell filled with 1× SDS-PAGE running 
buffer under a 100 V-current applied for 2 hours through a Bio-Rad Powerpac Basic 300 
V power supply. The electrophoresed gels were then rinsed in MilliQ® water and 
incubated with the Coomassie Blue staining solution overnight at room temperature under 
gentle rocking mixing. The following day, the gels were once again rinsed in deionised 
water and left to incubate with destaining solution under similar conditions until all bands 
were clearly visible. 
Western blotting was performed by first semi-dry blotting an electrophoresed SDS-PAGE 
gel onto a nitrocellulose membrane using a MilliBlot Graphite Electroblotter II under a 
150 mA-current applied for 1 hour through a Bio-Rad Powerpac Basic 300 V power 
supply. The semi-dry blotting assembly comprised of (from bottom-to-top): two gel-sized 
blot filter paper sheets, one gel-sized nitrocellulose membrane, one electrophoresed SDS-
PAGE gel and two additional gel-sized blot filter paper sheets. The electrophoresed SDS-
PAGE gel, the gel-sized filter paper sheets and the nitrocellulose membrane were first left 
to soak in TBS buffer for at least 15 minutes prior to running any semi-dry blot. After 
each run, the blotted nitrocellulose membrane was left to incubate overnight with 20 mL 
of blocking buffer at 4 °C under gentle roller mixing, while the blotted SDS-PAGE gel 
was placed in staining solution to determine the quality of the semi-dry blotting process. 
The next day, the blotted membrane was left to incubate with 5 mL of HRP-conjugated 
antibodies diluted in blocking buffer (at the manufacturer-specified ratio) for 1 hour at 
room temperature with gentle roller mixing. The membrane was then washed four times 
with 25 mL of TBS-T buffer (for 10 minutes each time, at room temperature with gentle 
roller mixing) before being placed in a tray, covered in 1-Step™ Ultra TMB-blotting 
solution and incubated at room temperature until fully-coloured bands were readily 
visible (usually after 15 minutes of incubation). 
The cryo-EM grids were prepared using a FEI Vitrobot by first applying 3 µL of sample 
per grid, followed by the blotting of the excess solution for 2 seconds before plunging the 
grids into liquid ethane for vitrification. The grids were then studied under a FEI F20 
cryo-EM and all of the resulting images were taken with a Gatan 4K×4K CCD camera. 
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The protocols for phage display screening, as well as expressing and purifying the lead 
candidate DARPins isolated against NupC, were kindly provided by Dr. Stacey Chin 
(MedImmune Ltd). 
All DNA molecular biology reactions were performed using a Bio-Rad Dyad® DNA 
Engine PCR machine. DARPin double restriction digests were performed by incubating 
the respective reaction mixtures at 37 °C for at least 2 hours, followed by the inactivation 
of the restriction enzymes through 15-minute incubations, first at 65 °C (i.e. the NdeI 
inactivation temperature) and then at 80 °C (i.e. the BamHI inactivation temperature). 
The vector:insert ligation calculations were performed online at http://www.insilico.uni-
duesseldorf.de/Lig_Input.html, while the ligation reactions themselves were performed 
overnight at 16 °C. DNA amplification consisted of incubating the reaction mixtures first 
at 94 °C for 3 minutes, then through 32 recursive cycles of 94 °C (for 30 seconds), then 
50 °C (for another 30 seconds) and 72 °C (for 105 seconds), before finally undergoing a 
last 5-minute incubation at 72 °C, followed by overnight storage at 10 °C. 
The TAE DNA agarose gels were cast by first mixing the specified concentration of 
agarose with TAE buffer (pH 7.6), then placing the mixtures in a microwave oven and 
heating them up for 2 minutes at maximum power. The heated gel mixtures were then 
poured into either a Bio-Rad Mini-Gel or Gel caster and left to polymerise at room 
temperature until completely solid (usually after 20 minutes). All DNA gels were 
submitted to electrophoresis in a Bio-Rad Sub-Cell® GT horizontal electrophoresis cell 
powered through a Bio-Rad Powerpac Basic 300 V power supply. Current was applied at 
a constant 100 V until the dye fronts reached the bottom edge of the gels (generally after 
45-60 minutes). 
All Eppendorf tube-based SSBLM centrifugations were performed in a Thermo Scientific 
Heraeus Fresco 17 centrifuge for 1 minute at 17,000 g and 4 °C. All plate-based SSBLM 
ELISA centrifugations were performed in an Eppendorf 5810 R table-top centrifuge for 
5 minutes at 3,220 g and 4 °C. 
Finally, the protocols for expressing and purifying all of the membrane protein constructs 
used throughout the project were developed, optimised and kindly provided by Dr. 
Vincent Postis (The School of Biomedical Sciences, University of Leeds). 
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3.4.2. Double Strep-tagged NupC expression and purification 
C43 (DE3) E. coli competent cells (50 μL) harbouring the chloramphenicol-resistance 
plasmid pRARE2 (Novagen) were first transformed via the heat-shock method with 1 µL 
of the plasmid pBPT-0217-CS2T (i.e. 50 ng of DNA) encoding double Strep-tagged 
NupC. The transformed cells were then spread onto an LB-agar plate supplemented with 
carbenicillin (100 µg/mL) and incubated overnight at 37 °C. 
LB medium (100 mL) supplemented with carbenicillin (100 µg/mL) and 1% (w/v) 
glucose was inoculated the following day with a single colony from the overnight plate 
and the resulting inoculation culture was once again incubated overnight at 37 °C with 
200 rpm orbital shaking. The bacterial density was determined by measuring the D600nm 
value of the overnight culture using a Shimadzu UV-2450 spectrophotometer, after which 
the culture was used to inoculate 8×500 mL volumes of carbenicillin-supplemented (100 
µg/mL) LB medium contained in 8×2.5 L baffled flasks, so as to give starting D600nm 
values of 0.05. The new flask cultures were then incubated at 37 °C with 200 rpm orbital 
shaking and their D600nm values were monitored every hour until they reached 0.7, after 
which protein overexpression was induced via IPTG addition (0.5 mM per flask). 
Following that, the flask cultures were incubated for an additional 3 hours under similar 
conditions before the cells were harvested using a Sorvall Evolution RC centrifuge fitted 
with an SLC-6000 rotor (9,000 g spin for 20 minutes at 4 °C). The resulting cell pellets 
were resuspended in Tris/EDTA buffer supplemented with 5% (w/v) glycerol (i.e. 6 mL 
of buffer per gram of cells) and then stored overnight at -20 °C. 
The next day, the cell suspensions were thawed in a water bath set to 25 °C and one 
cOmplete™ (EDTA-free) mini protease inhibitor cocktail tablet was added per 50 mL of 
suspension so as to protect the overexpressed membrane proteins from being catabolised 
by the cytoplasmic proteases released during the following steps of the purification 
process. The cell suspensions were then pooled together and supplemented with 
Tris/EDTA buffer to give a final volume of 100 mL, before being homogenised using a 
T18 basic ULTRA-TURRAX® homogeniser and disrupted twice using a Constant 
Systems TS series continuous cell disruptor operating at 30 kpsi and 4 °C. The resulting 
cell debris was removed using a Sorvall Evolution RC centrifuge fitted with an SLA-1500 
rotor (14,000 g spin for 45 minutes at 4 °C), while the cell membranes were harvested by 
ultracentrifuging the resulting supernatant using a Beckman Coulter L-80XP 
ultracentrifuge fitted with a Ti45 rotor (100,000 g spin for 2 hours at 4 °C). The cell 
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membrane pellets were then resuspended in Tris/EDTA buffer at a concentration of 1 
g/mL, snap-frozen in liquid nitrogen and stored at -80 °C overnight. Small-volume test 
samples (i.e. <1 mL) were taken throughout the entire process so as to enable the 
measurement of membrane protein concentration at each expression and purification 
stage. 
The total protein content of the cell membrane suspension was evaluated via BCA assay 
and the determined protein concentration was used for creating the membrane 
solubilisation solution (i.e. cell membranes mixed at 2 mg of protein/mL with 1× double 
Strep-tagged NupC solubilisation buffer). This mixture was then supplemented with 1% 
(w/v) DDM and incubated for 1 hour at 4 °C with gentle magnetic mixing. The insoluble 
membrane fraction was pelleted in a Beckman Coulter L-80XP ultracentrifuge fitted with 
a Ti45 rotor (100,000 g spin for 1 hour at 4 °C), while the solubilised membranes 
contained in the supernatant were stored on ice. The Strep-Tactin® Superflow® 50% (w/v) 
resin suspension (1 mL) was then washed three times through subsequent resuspensions 
in MilliQ® water, followed by re-pelleting in an Eppendorf 5810 R table-top centrifuge 
(700 g spins for 5 minutes each at 4 °C). After the washed resin was also pre-equilibrated 
with double Strep-tagged NupC wash buffer via the same procedure, a 1:1 volume of 
binding dilution buffer was added to the solubilised membrane fraction and the resulting 
solution was mixed with the buffer-equilibrated resin. Protein-to-resin binding was then 
allowed to occur overnight at 4 °C with gentle roller mixing. 
The following day, the protein binding solution was poured through a 5 mL Pierce™ 
disposable column and the captured resin was washed dropwise under gravity with 1 
column volume (CV) of wash buffer (i.e. 1 drop every 1-2 seconds). With the column 
outlet closed, the resin was gently treated with 0.3 mL of elution buffer in order to remove 
any residual wash buffer. After this initial fraction was collected and stored separately on 
ice, the column outlet was once again closed and the resin was resuspended in 0.5 mL of 
elution buffer. The column was then incubated for 10 minutes at 4 °C with gentle roller 
mixing before the outlet was reopened and the first eluate, plus a further addition of 0.5 
mL of elution buffer, were allowed to pour through and be collected into a single 
Eppendorf tube. 
The elution steps outlined above were repeated until all of the protein had been eluted, as 
determined by measuring the A280nm values of each eluate against the elution buffer as 
blank. The “peak” fractions – containing the highest concentrations of purified double 
CHAPTER 3 – MATERIALS AND METHODS 
 
96 
Strep-tagged NupC – were then pooled together and dialysed overnight at 4 °C in a 3 mL 
Slide-A-Lyzer™ dialysis cassette (10K MWCO) against 500 mL of wash buffer, so as to 
eliminate any remaining d-Desthiobiotin. The dialysed protein solution was subsequently 
concentrated at 3,220 g and 4 °C using an Eppendorf 5810 R table-top centrifuge fitted 
with a Vivaspin® 20 centrifugal concentrator (10K MWCO) and the total amount of 
purified protein was determined via BCA assay. The concentrated double Strep-tagged 
NupC solution was then aliquoted and stored at -80 °C following snap-freezing in liquid 
nitrogen, while SDS-PAGE and western blotting were used to assess the quality of the 
purification process (see Figure 4.1.1.1 in Chapter 4). 
In the case of double Strep-tagged NupC, the semi-dry-blotted nitrocellulose membranes 
were incubated with 5 mL of StrepMAB-Classic mouse anti-Strep (II) primary antibodies 
(diluted 1/2,500 in blocking buffer) for 1 hour at 4 °C with gentle roller mixing. The 
membranes were then washed four times by incubating them with 25 mL volumes of 
TBS-T buffer for 10 minutes per wash, before being incubated with 5 mL of peroxidase-
conjugated AffiniPure goat anti-mouse IgG (H+L) secondary antibodies (diluted 
1/50,000 in TBS-T buffer) for 1 hour at 4 °C with gentle roller mixing. After four 
additional TBS-T buffer washes, the blotted membranes were incubated with 1-Step™ 
Ultra TMB-blotting solution and imaged according to the protocol detailed in subsection 
3.4.1. 
The low purification yields typical of membrane proteins prompted the need for growing 
larger bacterial cultures via bioreactor fermentation in order to express and purify double 
Strep-tagged NupC to the high levels necessary for supporting its intended applications 
throughout the project at hand. Thus, the cell membranes originating from a 30 L C43 
(DE3) E. coli fermentation culture overexpressing double Strep-tagged NupC were 
harvested and solubilised according to the protocol described above, after which the 
overexpressed protein was eluted under a step gradient (0.5 mL/min) using the same 
elution buffer in a GE Healthcare ÄKTA pure 25 fitted with a 1 mL StrepTrap™ HP 
column. 
In order to reduce the overlong column loading times, the dilution of the solubilised 
membranes using binding dilution buffer – a requirement for the protein-resin binding 
step preceding gravity-column elutions – was omitted from all ÄKTA purifications. The 
d-Desthiobiotin was, however, still dialysed from the pooled elution fractions as 
previously described. A BCA assay performed on the dialysed ÄKTA eluates revealed 
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that the purified protein yields per litre of bacterial culture were proportionate to those 
reported with the gravity-column elutions described earlier, originating from the smaller 
4 L cultures. 
3.4.3. His6-tagged NupC expression and purification 
Following the same steps outlined in subsection 3.4.2, C43 (DE3) E. coli competent cells 
were transformed via the heat-shock method with plasmid pLH13 encoding intrinsically 
His6-tagged NupC and then subsequently cultured in 4 L of LB media. 
After determining the overall concentration of overexpressed membrane proteins via 
BCA assay, the harvested cell membranes were mixed with solubilisation buffer at 5 mg 
of protein per mL. The resulting solubilisation solution was incubated for 1 hour at 4 °C 
with gentle magnetic mixing before the insoluble membrane fraction was pelleted in a 
Beckmann Coulter L-80XP ultracentrifuge fitted with a Ti45 rotor (100,000 g spin for 1 
hour at 4 °C). The solubilised membranes contained in the supernatant were stored on ice 
while the HisPur™ cobalt resin (80 µL per mg of membrane protein) was washed in 
MilliQ® water and then pre-equilibrated with His6-tagged NupC wash buffer via the 
previously-described technique. The solubilised membranes were then mixed with the 
resin and protein binding was allowed to occur overnight at 4 °C with gentle roller mixing. 
The next day, the protein binding solution was poured through a 5 mL Pierce™ disposable 
column and the captured resin was washed dropwise under gravity with 1 CV of wash 
buffer (i.e. 1 drop every 1-2 seconds), after which the His6-tagged NupC was eluted at 
room temperature using 500 μL of elution buffer per fraction. The elution steps were 
repeated until all of the protein had been eluted, as determined by measuring the A280nm 
values of each fraction against the elution buffer as blank. The peak fractions were then 
pooled and dialysed overnight at 4 °C in a 3 mL Slide-A-Lyzer™ dialysis cassette (10K 
MWCO) submerged in 500 mL of wash buffer, in order to remove any remaining 
imidazole. 
The dialysed protein solution was subsequently concentrated via centrifugation at 3,220 
g and 4 °C in an Eppendorf 5810 R table-top centrifuge fitted with a Vivaspin® 20 
centrifugal concentrator (10K MWCO). The total amount of purified protein was 
ultimately determined via BCA assay, after which the concentrated His6-tagged NupC 
solution was aliquoted and stored at -80 °C following snap-freezing in liquid nitrogen. 
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Small-volume test samples (i.e. <1 mL) were taken throughout the entire process in order 
to evaluate the expression and purification of His6-tagged NupC. 
3.4.4. Untagged NupC expression and E. coli inner membrane 
extraction 
Following the same steps outlined in subsection 3.4.2, C43 (DE3) E. coli competent cells 
were transformed via the heat-shock method with the plasmid pGJL16 encoding 
untagged/wild-type NupC and then subsequently cultured in 4 L of LB media. After the 
cell membranes were harvested via ultracentrifugation, the inner membrane (IM) fraction 
overexpressing untagged NupC was also separated from the outer membrane (OM) 
fraction through a sucrose density gradient ultracentrifugation. 
The harvested membranes were first resuspended in a 25% (w/w) sucrose solution, 
pipetted into a Ti45 ultracentrifuge tube layered with increasingly-concentrated sucrose 
gradients (30-55% (w/w)) and then ultracentrifuged at minimal acceleration with no 
braking in a Beckmann Coulter L-80XP ultracentrifuge fitted with a Ti45 rotor (100,000 
g spin for 16 hours at 4 °C). Following separation, the inner (lighter) and outer (darker) 
membrane fractions were extracted from the sucrose gradient via pipetting and then 
resuspended in minimal volumes of Tris/EDTA buffer. In order to remove the residual 
sucrose present in both of the separated membrane fractions, these were alternatingly 
pelleted via ultracentrifugation (100,000 g spins for 1 hour each at 4 °C) and then 
resuspended in similar volumes of Tris/EDTA buffer twice. The washed inner and outer 
membrane pellets were finally resuspended in minimal volumes of Tris/EDTA buffer, 
snap-frozen in liquid nitrogen and stored at -80 °C. Small-volume test samples (i.e. <1 
mL) were taken throughout the entire process in order to evaluate the expression of 
untagged NupC. 
3.4.5. His6-tagged PepTSo expression and purification 
The NupC-homologous bacterial peptide transporter PepTSo (Newstead et al., 2011) was 
deemed a suitable negative control for the SURFE2R N1 transport activity assay, as well 
as determining the specificity of any potential binding candidates to NupC. 
To this extent, a His6-tagged PepTSo construct was also expressed in C43 (DE3) E. coli 
by transforming competent cells with the plasmid pMPSIL0079A via the heat-shock 
method and then following the expression protocol outlined in subsection 3.4.2. The 
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harvested cell membranes overexpressing His6-tagged PepTSo were then mixed with a 
25% (w/w) sucrose solution prepared in Tris/EDTA buffer and added to a 30-55% (w/w) 
sucrose density gradient in order to separate the inner and outer membrane fractions 
through the same procedure described for untagged NupC. 
3.4.6. Measuring nucleoside transport activity via the SURFE2R N1 
Desiccated POPC aliquots (5 mg) were rehydrated with 1 mL of PBS buffer each and 
subsequently extruded through a 200 nm polycarbonate filter using the Avanti Mini-
Extruder to create 5 mg/mL LUV suspensions. These were then titrated at room 
temperature with 1 µL volumes of Triton X-100 at stock concentration (i.e. 10% (w/v) in 
ultrapure water) until Rsat was reached. At this point, an additional 5 µL of Triton X-100 
were added to ensure that the LUVs had been optimally destabilised. Purified double 
Strep-tagged or His6-tagged NupC were then added to the destabilised LUVs to give 
protein/lipid ratios of 1% (w/w). The resulting proteoliposomes were vortexed for 60 
seconds using a Heidolph Reax Top test tube shaker, then left to incubate at room 
temperature for 15 minutes with gentle roller mixing. Bio-Beads® SM-2 were then added 
to a concentration of 50 mg/mL and the proteoliposomes were left to incubate for another 
30 minutes under similar conditions in order to remove the Triton X-100 from solution. 
Following that, the Bio-Beads were left to sediment and the proteoliposomes were 
transferred into a new Eppendorf tube along with 50 mg of fresh Bio-Beads®. After an 
additional 60-minute incubation at 4 °C with gentle roller mixing, the proteoliposomes 
were once again transferred into a new Eppendorf tube containing 50 mg of fresh Bio-
Beads® and then incubated overnight under identical conditions. The next day, the Bio-
Beads® were removed and the proteoliposomes were harvested using a Beckmann 
ultracentrifuge fitted with a Ti45 rotor (100,000 g spin for 1 hour at 4 °C). The 
proteoliposomes were finally resuspended in PBS buffer to give concentrations of 5 
mg/mL POPC and 50 μg/mL NupC (assuming a 100% recovery rate) and then re-extruded 
through a 200 nm polycarbonate filter to ensure their homogeneity. 
In order to construct the hybrid alkanethiol/phospholipid biomimetic SSMs required for 
proteoliposomal adsorption, the stock N1 gold sensors were first incubated with 50 μL of 
Sensor Prep A (i.e. 1-octadecanethiol in isopropanol (1 mM)) for 15 minutes at room 
temperature while covered by a Petri dish, so as to ensure that the self-assembled thiol 
monolayer already present on their surface (as supplied by Nanion Technologies) was of 
sufficiently-high quality at the start of the SURFE2R N1 transport activity measurements. 
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The Sensor Prep A solution was removed by tapping on the up-ended sensors, after which 
their surfaces were rinsed thoroughly with MilliQ® water, then dried under a nitrogen 
stream. Any remaining solvents were allowed to evaporate from the uncovered sensors 
during an additional 15-minute incubation at room temperature. Sensor Prep B was then 
added in 3 μL volumes on top of the thiol layers while avoiding direct contact between 
the pipette tip and the thiolated gold surfaces. Immediately after, the sensors were filled 
with 50 μL of PBS buffer supplemented with 0.2 mM DTT and incubated at 4 °C covered 
in Parafilm M® to avoid desiccation. 
Following that, the sensors were drained as previously described and immediately re-
filled with 100 μL of PBS buffer. The proteoliposomes (1% (w/w) protein/lipid ratio) 
were then pipetted into the sensor wells in 5 μL volumes without disturbing the SSMs. 
So as to ensure their complete adsorption and the correct formation of the vesicle-SSM 
capacitively-coupled systems, the loaded sensors were subjected to centrifugation in an 
Eppendorf 5810 R table-top centrifuge (2,500 g spins for 30 minutes at 4 °C). After 
another 15-minute incubation at 4 °C, the sensors were finally ready to be used with the 
SURFE2R N1 workstation. 
3.4.7. Traditional plate-based phage display screening 
For performing a traditional plate-based phage display screening round against detergent-
solubilised NupC, 100 µL of a purified His6-tagged NupC solution (10 µg/mL) were 
added to the well of a Nunc™ MaxiSorp™ flat-bottomed 96-well plate and left to adsorb 
overnight at 4 °C. The following day, a TG1 E. coli cell culture was set up by using one 
colony from a TG1 E. coli stock Petri dish to inoculate 20 mL of 2×TY growth medium, 
which was then left to incubate at 37 °C with 200 rpm orbital shaking until it reached log-
phase (i.e. D600nm = 0.5-1.0). The MaxiSorp™ well containing the adsorbed His6-tagged 
NupC was washed three times with 300 µL volumes of PBS buffer, then incubated with 
300 µL of blocking buffer for 1 hour at room temperature with gentle rocking mixing so 
as to block any potential non-specific binding sites. Concomitantly, a 50 µL DARPin 
library aliquot was also blocked with a 1:1 volume of blocking buffer under similar 
conditions. Following the blocking incubations, the NupC-containing well was once 
again washed three times with 300 µL volumes of PBS buffer, after which the blocked 
DARPin library solution (100 µL) was added to the well. The plate was then left to 
incubate for another hour at room temperature before being washed five times with 300 
µL of wash buffer, as well as five times with 300 µL of regular PBS buffer. 
CHAPTER 3 – MATERIALS AND METHODS 
 
101 
A 100 µL volume of elution buffer was then added to the well and left to incubate at 37 
°C for 30 minutes with 600 rpm orbital shaking. Following that, the eluted DARPins were 
extracted from the well and infected into 900 µL of log-phase TG1 E. coli cell culture. 
This was then left to incubate at 37 °C for 1 hour with 200 rpm orbital shaking before 
being diluted 1:10, 1:100 and 1:1,000 (v/v) using 2×TY growth medium and plated onto 
separate 2×TYAG agar Petri dishes. All of the leftover cells were pelleted via 
centrifugation, resuspended in 3 mL of 2×TY growth medium and spread onto a 2×TYAG 
bioassay dish. After an overnight incubation at 30 °C, the colonies on the diluted Petri 
dish cultures were counted in order to determine the phage input titre, serving as an 
indication of the degree of overnight amplification and the number of phages that will be 
carried forward into the next round of selection. The bioassay dish was then scraped clean 
using 10 mL of 2×TY growth medium supplemented with 50% (w/v) glycerol. The 
scraped cells were used to create a 2 mL backup for storage at -80 °C, while the remaining 
8 mL of infected TG1 E. coli were stored at -20 °C in preparation for phage rescue. 
The following day, the phage rescue procedure involved inoculating 25 mL of 2×TYAG 
growth medium with infected TG1 E. coli to give a starting D600nm value of 0.1. This 
phage rescue culture was then incubated at 37 °C with 280 rpm orbital shaking until it 
reached log-phase, after which it was superinfected with 2.5 μL of M13K07trp helper 
phage stock solution. Following that, the culture was left to incubate for one additional 
hour at 37 °C with 150 rpm orbital shaking before the cells were harvested via 
centrifugation (3,220 g spin for 10 minutes at 4 °C). While the supernatant was ultimately 
discarded, the cell pellet was resuspended in 0.5 mL of 2×TYAK growth medium and 
used to further inoculate 25 mL of the same media. Phage production was then left to 
occur overnight at 25 °C with 280 rpm orbital shaking. The next day, 1 mL of the 
overnight culture was pelleted at maximum speed in a table-top centrifuge and the 
resulting supernatant – containing the replicated phages – was transferred into a new 
Eppendorf tube and stored on ice in preparation for the next round of selection. 
At the end of a second round of selection (performed by repeating the same steps outlined 
above), the colonies from the 1:10, 1:100 and 1:1,000-diluted Petri dish cultures were 
counted to give the phage output titre (i.e. an indication of the total phage selection output 
for the tested screening format). Individual colonies were then transferred onto a Costar® 
flat-bottomed 96-well plate containing 120 µL of 2×TYAG growth medium per well and 
left to incubate overnight at 37 °C with 150 rpm orbital shaking. The next day, 40 µL 
samples were taken from each well and transferred onto a new Costar® flat-bottomed 96-
CHAPTER 3 – MATERIALS AND METHODS 
 
102 
well plate that was later sent for binder sequencing and diversity assessment, while the 
remaining well contents were each supplemented with 40 µL of 50% (w/v) glycerol so as 
to create another backup for storage at -80 °C. 
3.4.8. Plasmid DNA extraction 
In order to extract the plasmid DNA encoding each of the phage-bound DARPin binders 
selected against NupC, 5 mL of 2×TY growth medium supplemented with carbenicillin 
(100 µg/mL) were inoculated with thawed TG1 E. coli glycerol backups harbouring the 
respective phages. The 5 mL cultures were then left to incubate overnight at 37 °C with 
200 rpm orbital shaking. The following day, the cells were pelleted in a table-top 
centrifuge (3,220 g spin for 15 minutes at room temperature) and then resuspended in 250 
µL of resuspension buffer (provided in the ChargeSwitch®-Pro miniprep kit). After that, 
250 µL of provided lysis buffer were added on top and left to incubate for 4 minutes at 
room temperature before 250 µL of provided precipitation buffer were added to the lysed 
cells. The resulting white precipitates were pelleted in a table-top centrifuge (17,000 g 
spin for 1 minute at room temperature), while the supernatants were transferred to the 
provided spin columns and re-centrifuged under similar conditions. The flowthroughs 
were then discarded and 750 µL of provided wash buffer 1 were added to the spin 
columns, followed by re-centrifugation. The flowthroughs were once again discarded and 
the centrifugation was repeated using 250 µL of provided wash buffer 2. After the last 
flowthroughs were discarded, the individual plasmids were eluted via centrifugation 
under similar conditions using 100 µL of provided elution buffer. In order to maximise 
the DNA yield, each eluate was transferred back into their original spin column and re-
centrifuged one final time under similar conditions before being stored at -20 °C. 
Having described all of the materials and general methods used throughout the 
experiments presented in the current thesis, the following chapter will begin showcasing 
the concept development work that led to the creation of the SSBLM platform embedding 
reconstituted purified NupC. 
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CHAPTER 4 
 
SSBLM Formation and Characterisation 
 
4.1. Target Protein Expression and Purification 
Since the current chapter will focus on the step-by-step formation and characterisation of 
the SSBLM screening platform, the following subsections will present the quality-control 
results ensuring that the target proteins expressed and purified to a high-enough degree. 
4.1.1. Double Strep-tagged NupC expression and purification 
After using the protocol described in subsection 3.4.2, SDS-PAGE and Western blotting 
were used to assess the quality of purified double Strep-tagged NupC (Figure 4.1.1.1). 
 
Figure 4.1.1.1. Coomassie Blue-stained polyacrylamide gel (top) and corresponding Western blot 
(bottom) stained to detect the Strep-tags of key samples taken during the expression and 
purification of double Strep-tagged NupC. The lanes represent, from left to right: I. Protein ladder; 
II. Pre-IPTG induction cell culture sample; III. Cell membrane pellet; IV. Soluble membrane 
fraction; V. Insoluble membrane fraction; VI. Overnight protein binding solution; VII. Elution 
fraction 1; VIII. Elution fractions 2, 3 and 4 (pooled); IX. Elution fraction 5; X. Protein ladder. 
The two red rectangles highlight the bands representative of purified double Strep-tagged NupC. 
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Ultimately, the purification of double Strep-tagged NupC was clearly successful, 
amounting to yields of approximately 0.5 mg of pure protein per 4 L of C43 (DE3) E. coli 
cell culture. Apart from the expected NupC monomer band at approximately 35 kDa, both 
SDS-PAGE and Western blotting also revealed the presence of NupC oligomers which 
co-eluted during the final stages of the purification process (Hao et al., 2016). 
4.1.2. His6-tagged NupC expression and purification 
SDS-PAGE and Western blotting revealed that His6-tagged NupC also expressed and 
purified successfully (Figure 4.1.2.1), amounting to average yields of 3 mg of pure protein 
per 4 L of C43 (DE3) E. coli cell culture. Oligomeric His6-tagged NupC states (clearly 
visible on the Western blot) were also detected. 
 
Figure 4.1.2.1. Coomassie Blue-stained polyacrylamide gel (top) and corresponding Western blot 
(bottom) stained to detect the His6-tags of key samples taken during the expression and 
purification of His6-tagged NupC. The lanes represent, from left to right: I. Protein ladder; II. 
Insoluble membrane fraction; III. Soluble membrane fraction; IV. Elution fraction 1; V. Elution 
fraction 2; VI. Elution fraction 3; VII. Elution fractions 2, 3 and 4 (pooled); VIII. Elution fraction 
5; IX. Vivaspin® concentrator filtrate; X. Protein ladder. The two red rectangles highlight the 
bands representative of purified His6-tagged NupC. 
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4.1.3. Untagged NupC expression and E. coli inner membrane 
extraction 
Subjecting these key samples to SDS-PAGE revealed the presence of untagged NupC at 
each step of the protein expression and membrane harvesting processes (Figure 4.1.3.1). 
A BCA assay also indicated that the total protein content of the separated IM fraction 
amounted to 48 mg per 4 L of C43 (DE3) E. coli cell culture. The differences between 
the inner and outer membrane fractions with respect to their different protein contents 
were also highlighted via SDS-PAGE, confirming that – apart from some minor band 
overlap – the sucrose density separation was overall successful. 
 
Figure 4.1.3.1. Coomassie Blue-stained polyacrylamide gel of key samples taken during the 
expression of untagged NupC. The lanes represent, from left to right: I. Protein ladder; II. 
Disrupted cells; III. Cell debris supernatant; IV. Cell debris pellet; V. Cytoplasmic protein 
fraction; VI. Cell membrane pellet; VII. Separated IM fraction; VIII. Separated OM fraction; IX. 
Control IM fraction; X. Protein ladder. The red rectangle highlights the bands representative of 
untagged NupC. 
4.1.4. His6-tagged PepTSo expression and purification 
The NupC-homologous bacterial peptide transporter PepTSo (Newstead et al., 2011) was 
deemed a suitable negative control for the SURFE2R N1 transport activity assay, as well 
as any future assays determining the specificity of isolated binding candidates to NupC. 
Key samples taken throughout the expression of a His6-tagged PepTSo construct were 
loaded onto polyacrylamide gels and subjected to both SDS-PAGE and Western blotting 
(Figure 4.1.4.1 overleaf). Instead of purifying the protein via high-affinity 
chromatography, a sucrose density gradient was once again used towards separating the 
inner and outer bacterial membrane fractions, ultimately resulting in a total IM protein 
yield of 34 mg per 4 L of C43 (DE3) E. coli cell culture, as revealed by a BCA assay. 
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Figure 4.1.4.1. Coomassie Blue-stained polyacrylamide gel (top) and corresponding Western blot 
(bottom) stained to detect the His6-tags of key samples taken during the expression and 
purification of His6-tagged PepTSo. The lanes represent, from left to right: I. Protein ladder; II. 
Pre-IPTG induction cell culture sample; III. Cell debris supernatant; IV. Cell debris pellet; V. 
Cytoplasmic protein fraction; VI. Cell membrane pellet; VII. Separated IM fraction; VIII. 
Separated OM fraction; IX. Control IM fraction; X. Protein ladder. The red rectangles highlight 
the bands representative of His6-tagged PepTSo. 
4.2. Assaying the Transport Activity of Purified NupC 
So as to determine whether the nucleoside transport activities of the three NupC 
constructs were preserved following their purification or IM extraction, several samples 
were prepared for use with the SURFE2R N1 workstation. Double Strep-tagged and His6-
tagged NupC/POPC LUVs (200 nm, 1% (w/w) protein/lipid ratios) were formed 
according to the protocol outlined by Geertsma et al. (2008), reproduced in subsection 
3.4.6. At first, the SURFE2R did not detect any signals representative of nucleoside 
transport from either proteoliposome sample (data not shown here), suggesting that these 
two constructs might not be active when reconstituted into lipid vesicles post-purification. 
Furthermore, 200 nm untagged NupC-embedding LUVs extruded directly from E. coli 
IMs overexpressing this particular construct also failed to produce signals indicative of 
nucleoside transport (Figure 4.2.1.1 overleaf). 
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Figure 4.2.1.1. SURFE2R N1 trace of the measured nucleoside transport activity of untagged 
NupC embedded in native IM LUVs (200 nm in diameter). The addition of the activating solution 
(i.e. PBS buffer containing 5 µM adenosine at t = 0 s) did not trigger any transient currents 
indicative of nucleoside transport into the sensor-bound LUVs (black arrow). 
In order to determine whether the lack of transport activity was an unintended 
consequence of NupC overexpression, the IMs were mixed 1:50 (w/w) with E. coli polar 
lipid extracts (PLEs) dissolved in PBS buffer (5 mg/mL), then tip-sonicated 100× using 
a Hielscher UP50H (0.5 cycles, 20% amplitude) before using the same SURFE2R 
protocol. With these untagged NupC-embedding IM/PLE LUVs, transient currents 
suggestive of bidirectional adenosine transport became readily apparent (Figure 4.2.1.2). 
 
Figure 4.2.1.2. SURFE2R N1 trace of the measured nucleoside transport activity of untagged 
NupC embedded in 200 nm IM/PLE LUVs. The addition of the activating solution (i.e. PBS 
buffer containing 5 µM adenosine at t = 0 s) triggered a transient inward current (black arrow) 
indicative of nucleoside transport into the sensor-bound LUVs. The reintroduction of the control 
solution (i.e. regular PBS buffer at t = 2 s) caused the substrate to be transported back out of the 
adsorbed LUVs and thus generate a transient outward current (i.e. the depression at t = 2.25 s). 
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The amplitudes of the measured transient currents were expectedly found to be directly 
proportional to the substrate concentrations of the activating solutions, which helped 
generate a Michaelis-Menten-like activity profile with a Km of 3.9 µM (Figure 4.2.1.3). 
 
Figure 4.2.1.3. Michaelis-Menten curve of transient inward current peak amplitudes generated 
by increasing substrate concentrations using IM/PLE LUVs embedding untagged NupC. The 
following values have been calculated using this curve: Vmax = 0.54 nA, Km = 3.9 μM. 
The above results confirmed that untagged NupC was still functional while overexpressed 
in E. coli IM fractions. Further measurements were performed during a summer internship 
by an undergraduate student – Katrina Moisley – using the double Strep- and His6-tagged 
NupC constructs presented in the same IM/PLE LUV format. Although no transport 
activity was ever detected from double Strep-tagged NupC presented in either format, 
IM-bound His6-tagged NupC did ultimately show signs of nucleoside transport, albeit at 
much lower levels compared to untagged NupC (data not shown here). While this was 
not investigated any further, the most likely culprit behind these unfavourable results was 
probably the His6-tag itself (Mohanty and Wiener, 2004), whose insertion into one of the 
extramembranous loops could have disrupted the conformation of the central pore and 
thus hampered the transport capabilities of this particular NupC construct. 
4.3. Planar SSM Formation and Characterisation 
Following the purification or IM extraction of the above membrane protein constructs, 
the focus of the project shifted towards characterising and optimising the formation of 
lipid SSMs on planar silica substrates towards the goal of ultimately embedding the 
purified membrane protein targets in a native-like antibody screening platform. 
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4.3.1. Monitoring planar SSM formation via QCM-D 
Initial attempts at forming planar SSMs on SiO2 sensor chips involved running 200 nm 
POPC LUVs diluted to 0.5 mg/mL in MOPS buffer through a Q-Sense E4 QCM-D set to 
a constant temperature of 22 °C and a pump flow rate of 100 µL/min. These attempts 
were met with consistent success and one such example is depicted in Figure 4.3.1.1 
below. After the addition of the POPC LUV solution to the SiO2 QCM-D sensor (A), the 
measured frequency dropped rapidly while dissipation increased proportionately due to 
the adsorption of increasing numbers of vesicles to the sensor surface (Richter et al., 
2006). After the critical concentration of adsorbed LUVs had been reached (B), the 
vesicles began to fuse together and burst, increasing frequency as buffer was released 
from the ruptured LUVs. These then reassembled into a continuous lipid bilayer on the 
sensor surface (C) and, once the surplus vesicles were washed off with MilliQ® water (D) 
and plain MOPS buffer was reintroduced to the system (E), the resulting stable SSM was 
characterised by a frequency shift of -25 Hz, mirrored by a dissipation value of 
approximately 0.1×10-6 (Cho et al., 2010). 
 
Figure 4.3.1.1. Planar lipid SSM formation kinetics given by frequency (blue, left Y-axis) and 
dissipation (red, right Y-axis) as monitored via QCM-D using POPC LUVs suspended in MOPS 
buffer at a concentration of 0.5 mg/mL: (A) The POPC LUV solution is introduced; (B) Critical 
LUV coverage is reached and lipid bilayer formation begins; (C) Intact LUVs are washed off with 
MilliQ® water; (D) Plain MOPS buffer is re-introduced; (E) Stable SSM formation is reached. 
The data was presented at the 7th, 9th and 11th resonance overtones of the SiO2 QCM-D sensor. 
Due to providing a better representation of the native membrane environment of NupC, 
200 nm LUVs were also extruded from E. coli PLEs towards replicating the favourable 
POPC SSM formation results on identical SiO2 sensors. Unfortunately, this proved 
significantly more difficult, in no small part due to the considerable electrostatic repulsion 
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occurring between the negatively-charged E. coli phospholipid head groups and the 
similarly-charged SiO2 substrate, which impeded the adsorption of the LUVs to the sensor 
surface. In order to circumvent this issue, a divalent cation solution (i.e. 10 mM CaCl2) 
was mixed with the LUV suspension so as to promote vesicle-substrate interactions and, 
consequently, facilitate SSM formation (McMillan et al., 2013). Further attempts also 
included running the E. coli PLE LUVs through the QCM-D at higher temperatures that 
were closer to the ideal E. coli proliferation conditions (i.e. 37 °C). 
While applying the above-mentioned protocol iterations did ultimately result in E. coli 
PLE SSMs forming on the SiO2 sensors, their formation kinetics were unfortunately 
extremely slow, as stable SSMs were only formed after more than 2 hours of running 
time. This contrasted sharply with POPC SSM formation, during which LUVs readily 
formed lipid bilayers on the SiO2 surface not only without the need for any supplementary 
chemical intervention, but also within a significantly shorter time frame as well (i.e. less 
than 40 minutes of running time). The much quicker bilayer formation kinetics reported 
with POPC LUVs ultimately rendered them as the better choice for fast and reliable SSM 
formation over their E. coli PLE counterparts. 
4.3.2. Planar SSM formation using NupC-embedding proteoliposomes 
In order to form POPC SSMs featuring embedded NupC, the purified double Strep-tagged 
and His6-tagged constructs were reconstituted into 400 nm POPC LUVs (1% (w/w) 
protein/lipid ratios) diluted in KPi buffer (5 mg/mL) following the protocol described in 
subsection 3.4.6. Unfortunately, the first attempts at forming SSMs using either 
proteoliposomes on identical SiO2 sensors proved unsuccessful. While the measurements 
did indicate LUV adhesion to the sensor surfaces (data not shown here), SSM formation 
could not be achieved even after the forced osmotic lysis brought on by the MilliQ® water 
wash. Proteoliposomes extruded through polycarbonate filters with smaller pore sizes 
(i.e. 200-, 100- and 50 nm) were also tested, but without any success. Fortunately, limiting 
the Triton X-100 titrations to the bare minimum required to reach Rsat during the NupC 
reconstitution phase ultimately resolved SSM formation using both the double Strep- and 
His6-tagged NupC/POPC proteoliposomes (Figures 4.3.2.1b and 4.3.2.1c overleaf). Not 
only that, but their different dissipation values reported to that of the POPC negative 
control SSM (Figure 4.3.2.1a overleaf) also confirmed the presence of embedded protein. 
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Figure 4.3.2.1a. SSM formation kinetics given by frequency (blue, left Y-axis) and dissipation 
(red, right Y-axis) as monitored via QCM-D using protein-free, 50 nm negative control POPC 
SUVs: (A) The POPC SUV solution is introduced; (B) Critical SUV coverage is reached and lipid 
bilayer formation begins; (C) Intact SUVs are washed off with MilliQ® water; (D) Plain KPi 
buffer is re-introduced; (E) Stable SSM formation is reached. The final dissipation value of 
approximately 0 suggested that the SSM formed a rigid structure on the sensor surface. The data 
was presented at the 7th, 9th and 11th resonance overtones of the SiO2 sensor. 
 
Figure 4.3.2.1b. SSM formation kinetics given by frequency (blue, left Y-axis) and dissipation 
(red, right Y-axis) as monitored via QCM-D using 50 nm double Strep-tagged NupC/POPC SUVs 
(1% (w/w) protein/lipid ratio): (A) The NupC/POPC SUV solution is introduced; (B) Critical 
SUV coverage is reached and lipid bilayer formation begins; (C) Intact SUVs are washed off with 
MilliQ® water; (D) Plain KPi buffer is re-introduced; (E) Stable SSM formation is reached. The 
final dissipation value of approximately 0.6×10-6 suggested that the formed SSM also embedded 
double Strep-tagged NupC. The data was presented at the 7th, 9th and 11th resonance overtones of 
the SiO2 sensor. 
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Figure 4.3.2.1c. SSM formation kinetics given by frequency (blue, left Y-axis) and dissipation 
(red, right Y-axis) as monitored via QCM-D using 50 nm His6-tagged NupC/POPC SUVs (1% 
(w/w) protein/lipid ratio): (A) The NupC/POPC SUV solution is introduced; (B) Critical SUV 
coverage is reached and lipid bilayer formation begins; (C) Intact SUVs are washed off with 
MilliQ® water; (D) Plain KPi buffer is re-introduced; (E) Stable SSM formation is reached. The 
final dissipation value of approximately 0.6×10-6 suggested that the formed SSM also embedded 
His6-tagged NupC. The data was presented at the 7
th, 9th and 11th resonance overtones of the SiO2 
sensor. 
While SSM formation using native membrane vesicles is complicated not only by the 
presence of non-bilayer-forming lipids, but also that of a myriad of other naturally-
occurring membrane constituents (Elie-Caille et al., 2005), positive results have 
nevertheless been reported with proteoliposomes formed after mixing harvested native 
membranes with bilayer-forming model lipids such as phosphatidylcholine (Dodd et al., 
2008). 
In order to test this with NupC, E. coli IMs overexpressing the untagged construct were 
mixed with 50 nm POPC SUVs at a 1:50 (w/w) ratio via the freeze-thaw method and were 
fortunately also found to form bilayers on SiO2 QCM-D sensors (Figure 4.3.2.1d 
overleaf). This result was particularly encouraging towards the future formation of SSMs 
embedding other classes of potential membrane protein targets while still being expressed 
in their original native membrane environments, without any need to spend additional 
time and effort on purifying and subsequently reconstituting them into model lipid 
vesicles. 
CHAPTER 4 – SSBLM FORMATION AND CHARACTERISATION 
 
113 
 
Figure 4.3.2.1d. SSM formation kinetics given by frequency (blue, left Y-axis) and dissipation 
(red, right Y-axis) as monitored via QCM-D using 50 nm E. coli IM/POPC SUVs overexpressing 
untagged NupC: (A) The IM/POPC SUV solution is introduced; (B) Critical SUV coverage is 
reached and lipid bilayer formation begins; (C) Intact SUVs are washed off with MilliQ® water; 
(D) Plain KPi buffer is re-introduced; (E) Stable SSM formation is reached. The final dissipation 
value of approximately 1.5×10-6 suggested that the formed SSM also embedded untagged NupC. 
The data was presented at the 7th, 9th and 11th resonance overtones of the SiO2 sensor. 
4.4. SSBLM Formation and Characterisation 
Since the positive QCM-D results presented above were found to be reproducible, the 
focus of the project shifted towards replicating SSM formation – first lipid-only, then 
protein-embedding – on the surfaces of spherical silica nanoparticles. 
4.4.1. Confirmation of substrate saturation via fluorescence 
spectroscopy 
SSBLM formation was initially attempted on 100- and 200 nm silica nanoparticles using 
fluorescently-labelled POPC LUVs, so as to enable the detection of the newly-formed 
SSBLMs via spectrofluorometry. The fluorescent labelling of POPC was achieved by 
first dissolving Texas Red® (TR)-modified lipids in a 1:1 (v/v) mixture of chloroform and 
methanol (0.5 mg/mL). A 100 µL volume of the resulting TR solution was then added to 
a desiccated 5 mg POPC aliquot, followed by a vigorous 60-second vortexing to ensure 
the proper mixing of the different lipid types. The solvent mixture was removed at room 
temperature by placing the vial first under a nitrogen stream for 60 seconds, then under 
vacuum for 2 hours. The desiccated TR/POPC lipids (1% (w/w) ratio) were then finally 
rehydrated using 1 mL of PBS buffer and extruded through a 200 nm polycarbonate filter. 
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In order to determine the LUV/nanoparticle (w/w) ratios that would saturate the chosen 
substrates (i.e. achieve 100% lipid bilayer coverage), fluorescent SSBLMs were formed 
on 100- and 200 nm silica nanoparticles by mixing 25 μL of each nanoparticle stock 
solution (i.e. 10 mg/mL in deionised water) with increasing amounts of TR/POPC LUVs, 
ranging from 0-100% (w/w) LUVs/nanoparticles for the 100 nm nanoparticles and 0-50% 
(w/w) LUVs/nanoparticles for the 200 nm nanoparticles. The resulting mixtures were 
then each made up to 100 µL using MilliQ® water and subjected to 60 seconds of vigorous 
vortexing, causing the LUVs and nanoparticles to collide with one another. Ultimately, 
this lead to the former collapsing and re-forming into SSBLMs enveloping the latter. 
The SSBLM samples were then left to incubate for 1 hour at room temperature with gentle 
roller mixing before the particles were pelleted in a Thermo Scientific Heraeus Fresco 17 
centrifuge (13,000 g spin for 30 seconds at 4 °C). The supernatants were transferred into 
separate Eppendorf tubes and stored at 4 °C, while the SSBLM pellets were washed in 
similar volumes of MilliQ® water during a 30-minute incubation at 4 °C with gentle roller 
mixing before being re-pelleted and resuspended in 100 μL of PBS buffer each. The 
particle samples were then diluted 20× further in a Hellma Quartz SUPRASIL precision 
cuvette using MilliQ® water, after which a Perkin Elmer LS 55 spectrofluorometer was 
used to measure their emissions at 615 nm with excitation set to 595 nm (Figure 4.4.1.1). 
  
Figure 4.4.1.1. The fluorescence emissions resulting from 100 nm (left) and 200 nm (right) silica 
nanoparticles coated with SSBLMs formed using TR-labelled POPC liposomes (red), as well as 
from their respective supernatants (blue) after pelleting the particles. The saturation thresholds at 
which 100% SSBLM coverage was achieved were 30- and 15% (w/w) for the 100- and 200 nm 
silica nanoparticles, respectively. The error bars represent the standard error of the mean, n = 2. 
In the case of the 100 nm silica nanoparticles, the minimal LUV/nanoparticle ratio that 
appeared to saturate the substrate was 30% (w/w). Increasing the LUV concentration 
beyond this point resulted in the surplus fluorescent material remaining in the sample 
supernatants and thus leading to a mirrored increase in emission that ultimately saturated 
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the spectrofluorometer at the top-end of the spectrum. A similar result was observed for 
the 200 nm silica nanoparticles, where substrate saturation occurred beyond an 
LUV/nanoparticle ratio of 15% (w/w). 
Having determined the saturation thresholds for both particle sizes, all subsequent 
SSBLM experiments were performed at LUV/nanoparticle ratios of at least 50- and 25% 
(w/w) for the 100- and 200 nm particles, respectively, in order to ensure the saturation of 
the silica substrate. This provided not only maximal antigen coverage, but also minimised 
the chances of any potential non-specific interactions occurring between the experimental 
solutions and areas of silica left bare as consequence of incomplete SSBLM formation. 
4.4.2. Characterisation of SSBLM formation via SAXS 
While fluorescence spectroscopy did indicate that the POPC lipid material was attaching 
to the silica substrate to the point of saturation, it could not also be used to discriminate 
the correct formation of actual SSBLMs around the nanoparticles from the mere adhesion 
of intact lipid vesicles to the available silica surface. It is for this reason then that SAXS 
– a technique capable of deriving structural information from nanosized objects 
suspended in solution – was subsequently used for the detection and characterisation of 
silica-bound SSBLMs. All of the SAXS measurements described in this section were 
taken at room temperature by Dr. Amin Sadeghpour from the School of Food Science and 
Nutrition at the University of Leeds. 
Prior to starting the SAXS measurements, the optimal beam exposure time was 
determined after vigorously vortexing both the SSBLM and negative control (i.e. bare 
silica nanoparticle) samples for 60 seconds and then measuring the time needed for both 
particle types to sediment at room temperature under normal gravity. It was thus revealed 
that the minimal time required for the complete sedimentation of both samples was in 
excess of 2-3 hours, thereby ensuring that the SAXS measurements could be performed 
using longer beam exposure times in order to improve the resolution of the individual 
scattering profiles. 
Having determined the above, POPC SSBLMs were formed on 100 nm silica 
nanoparticles at a 60% (w/w) LUV/nanoparticle ratio according to the protocol described 
in subsection 4.4.1, after which the washed SSBLM pellets were resuspended in PBS 
buffer at particle concentrations of 30 mg/mL. These were then measured together with 
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their bare stock counterparts at room temperature and a significant difference was noted 
between the two scattering profiles (Figure 4.4.2.1). 
  
Figure 4.4.2.1. Left: the scattering profiles obtained from stock 100 nm silica nanoparticles (red), 
as well as POPC SSBLMs before and after washing away the excess LUV material (green and 
blue, respectively). Right: the same data after deconvoluting the scattering curves with the beam 
profile in order to increase curve resolution (courtesy of Dr. Amin Sadeghpour, The School of 
Food Science and Nutrition, University of Leeds). 
The data analysis for the SAXS measurements comparing the 100 nm POPC-coated 
nanoparticles to the negative control ones offered confirmation of correct SSBLM 
formation. By fitting the data from the stock nanoparticles and including a Gaussian size 
distribution, a radius (R) with a value of 47.8 ± 3.5 nm was determined, which proved 
consistent with manufacturer nanoComposix's specifications for the stock 100 nm silica 
nanoparticles used throughout the project (Figure 4.4.2.2). 
 
Figure 4.4.2.2. The scattering profiles obtained from 100 nm bare silica nanoparticles (blue) and 
POPC SSBLM samples (red), alongside their corresponding fit functions (A) and electron density 
profiles presented according to the fitting parameters deduced from the raw data (B) (courtesy of 
Dr. Amin Sadeghpour, The School of Food Science and Nutrition, University of Leeds). 
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The data from the POPC-coated samples was then fitted with the fixed silica nanoparticle 
radius according to a strip model. All electron densities of the modelled SSBLM layers 
were set to their literature values and the radial dimensions of the lipid bilayer were kept 
free. While this resulted in a correct fit, the lipid bilayer thickness – specifically the 
phosphate-to-phosphate distance – appeared higher than normal (i.e. 4.6 nm, compared 
to 3.9 nm at room temperature (Kučerka et al., 2011)). 
Unfortunately, the very high nanoparticle concentrations required for obtaining high-
resolution scattering profiles (i.e. 30 mg/mL) were prohibitive towards taking SAXS 
measurements of SSBLMs embedding either of the three NupC constructs due to the sheer 
amount of purified membrane protein required to create such highly-concentrated 
samples. This ultimately prevented the use of SAXS as a means of confirming the 
presence of SSBLM-embedded NupC and thus alternative methods had to be used to this 
end instead. 
4.5. Formation and Characterisation of SSBLMs Embedding 
NupC 
After demonstrating the successful formation of SSBLMs on the silica nanoparticle 
substrates, the presence of the embedded protein was confirmed using a suite of 
techniques described throughout the following subsections. 
4.5.1. Confirmation of SSBLM-embedded NupC via Western blotting 
Western blotting represented one of the more straightforward methods explored for 
confirming the presence of SSBLM-embedded (His6-tagged) NupC. After multiple 
protocol iterations, a protein/lipid reconstitution ratio of 2.4% (w/w) was used to create 
200 nm NupC/POPC proteoliposomes from which 100 μL SSBLM samples were formed 
at LUV/nanoparticle ratios of 20- and 50% (w/w) for the 100 nm nanoparticles and 10- 
and 25% (w/w) for their 200 nm counterparts. The supernatant solutions resulting from 
pelleting the SSBLMs – containing all of the excess proteoliposomal material – were also 
included on the Western blot. 
Upon imaging the blotted membrane following its incubation with 5 mL of HRP-
conjugated mouse IgG1 anti-His antibodies diluted 1:5,000 (v/v) in PBS buffer, several 
bands were revealed at a molecular weight consistent with that of purified His6-tagged 
NupC, which was used as a positive control in lane X (Figure 4.5.1.1 overleaf). The 
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appearance of the bands confirmed that Western blotting represents a viable means of 
detecting SSBLM-embedded NupC. Furthermore, the direct relationship between the 
LUV/nanoparticle ratios and the intensity of the bands encouraged the predominant use 
of the 100 nm nanoparticles in all subsequent experiments, in order to maximise the 
available surface area for antigen presentation on the SSBLM particles. 
 
Figure 4.5.1.1. Western blot of 100- and 200 nm POPC SSBLMs embedding His6-tagged NupC. 
The lanes represent, from left to right: I. Protein ladder (not visible as chemiluminescence); II. 
100 nm, 20% (w/w) SSBLMs; III. 100 nm, 20% (w/w) SSBLM supernatant; IV. 100 nm, 50% 
(w/w) SSBLMs; V. 100 nm, 50% (w/w) SSBLM supernatant; VI. 200 nm, 10% (w/w) SSBLMs; 
VII. 200 nm, 10% (w/w) SSBLM supernatant; VIII. 200 nm, 25% (w/w) SSBLMs; IX. 200 nm, 
25% (w/w) SSBLM supernatant; X. Purified His6-tagged NupC positive control. The red 
rectangle highlights the bands representative of His6-tagged NupC. 
It was certainly interesting to note, however, that the supernatant-containing lanes (i.e. 
III, V, VII and IX) did not produce any bands on the Western blot at all, especially given 
that their respective SSBLM samples had been created using an excess of proteoliposomal 
material (as determined in subsection 4.4.1). While this occurrence was not investigated 
any further, the absence of any supernatant bands suggested that the entire membrane 
protein content of the excess proteoliposomes had instead been completely adsorbed onto 
the nanoparticle substrates, resulting in SSBLMs embedding a higher NupC content than 
anticipated. This, in turn, would imply that using LUV/nanoparticle ratios exceeding the 
established saturation thresholds during SSBLM formation could ultimately prove 
beneficial towards maximising the total antigen presented by a given particle population. 
4.5.2. Confirmation of SSBLM-embedded NupC via peroxidase assay 
The second method of detecting NupC presented in the SSBLM format focused on 
determining the accessibility of the embedded protein towards antibody binding. This 
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involved the use of a peroxidase assay to detect the presence of HRP-conjugated anti-His 
antibodies bound to SSBLM-embedded His6-tagged NupC. 
To this extent, a 1% (w/w) reconstitution of purified His6-tagged NupC into detergent-
destabilised 200 nm POPC LUVs yielded proteoliposomes that were subsequently used 
towards forming 100- and 200 nm SSBLM samples at 50- and 25% (w/w) 
LUV/nanoparticle ratios, respectively. POPC-only LUVs of similar sizes were also used 
to create protein-free SSBLMs for negative control purposes. The washed SSBLM 
particles were then incubated with 1:1 volumes of HRP-conjugated mouse IgG1 anti-His 
antibodies (diluted 1:5,000 (v/v) in PBS buffer) for 1 hour at room temperature under 
gentle roller mixing before the SSBLMs were pelleted via centrifugation (13,000 g spin 
for 30 seconds at 4 °C) and the supernatant solutions were removed alongside any 
unbound antibodies. The particles were then washed twice via two 10-minute incubations 
at room temperature with gentle roller mixing in 1:1 volumes of PBS buffer supplemented 
with 2.5% (w/v) POPC LUVs – so as to patch-up any potential areas of exposed silica 
substrate – followed by re-centrifugation. 
The SSBLMs were finally resuspended in 50 μL of PBS buffer, transferred to a Costar® 
flat-bottomed 96-well plate in 1, 2, 4, 8, 16, 20, 30, 40 and 50 µL volumes and 
supplemented with ADHP working reagent solution (50 µL/well, prepared according to 
the protocol supplied by AnaSpec). The developing fluorescence emission was then 
measured at 590 nm using a Perkin Elmer Victor X3 Multilabel fluorescent plate reader 
throughout a total reagent incubation time of 30 minutes (Figure 4.5.2.1 overleaf). 
Measuring the fluorescence at regular intervals revealed an almost linear increase in 
detected emission that was directly proportional to the SSBLM sample volumes. The 
surprisingly high background signal emitted by the protein-free negative controls was 
attributed to the non-specific binding of HRP-conjugated anti-His antibodies to either 
patches of exposed silica following incomplete substrate coverage or to the SSBLM lipid 
component itself, likely coupled with an insufficiently-thorough wash of any remaining 
unbound antibodies prior to the ADHP reagent incubation and fluorescence measurement 
phases. 
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Figure 4.5.2.1. The fluorescence emissions resulting from 100 nm (left) and 200 nm (right) silica 
nanoparticles coated with SSBLMs formed using protein-free POPC LUVs (blue) and 
proteoliposomes embedding His6-tagged NupC (red) after 30 minutes of incubation with the 
ADHP working reagent. The error bars represent the standard error of the mean, n = 2. 
Several protocol optimisations were tested towards reducing non-specific antibody 
binding in hopes of eliminating the significant background fluorescence emission. Thus, 
new 100- and 200 nm SSBLM samples were respectively formed at 50- and 25% (w/w) 
LUV/nanoparticle ratios using 200 nm His6-tagged NupC/POPC proteoliposomes created 
at 2.4% (w/w) protein/lipid ratios. POPC-only SSBLMs were once again formed at 
similar ratios to serve as protein-free negative controls. Following the MilliQ® water 
wash, the SSBLM solutions were divided into 50 µL volumes, pelleted via centrifugation 
(13,000 g spin for 30 seconds at 4 °C) and resuspended in increasing volumes (i.e. 1, 2, 
4, 8, 12, 16, 20, 30, 40 and 50 µL) of HRP-conjugated mouse IgG1 anti-His antibodies 
diluted 1:5,000 (v/v) in PBS buffer. In an attempt at blocking any available non-specific 
binding sites, each SSBLM solution was then further supplemented with 1 mg/mL BSA 
and 1% (w/v) POPC LUVs before being made up to a final volume of 50 µL using 
MilliQ® water, followed by vigorous vortexing for 60 seconds. 
The SSBLM solutions were left to incubate with their respective anti-His antibody 
solutions for 1 hour at room temperature with gentle roller mixing before the particles 
were washed twice in 1:1 volumes of the above-mentioned blocking buffer via two 10-
minute incubations under similar conditions, followed by pelleting and resuspension in 
the same buffer. The washed SSBLM particles where once again vortexed vigorously for 
60 seconds before being transferred onto a Costar® flat-bottomed 96-well plate and mixed 
with 50 µL of ADHP working reagent to give final volumes of 100 µL per well. The 
fluorescence emission of the SSBLM samples was then measured using the same 
fluorescent plate reader setup as before (Figure 4.5.2.2 overleaf). 
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Figure 4.5.2.2. The fluorescence emissions resulting from 100 nm (left) and 200 nm (right) silica 
nanoparticles coated with SSBLMs formed using protein-free POPC LUVs (blue) and 
proteoliposomes embedding His6-tagged NupC (red) after 30 minutes of incubation with the 
ADHP working reagent. The samples were formed according to the optimised SSBLM peroxidase 
assay protocol. The error bars represent the standard error of the mean, n = 2. 
The results depicted above in Figure 4.5.2.2 not only confirmed the presence of SSBLM-
embedded His6-tagged NupC, but also the elimination of the abnormally high background 
fluorescence. The addition of BSA and protein-free POPC LUVs to the PBS buffer used 
during the antibody binding and washing steps proved greatly beneficial towards keeping 
the negative control emission close to baseline levels. This was likely due to the extra 
POPC lipids repairing potential defects within the formed SSBLMs and thus covering up 
any patches of exposed silica, while the BSA served to block any remaining non-specific 
binding sites (as in the case of Western blotting), thereby maximising the correct binding 
of the HRP-conjugated antibodies to the SSBLM-embedded His6-tagged NupC. The 
iterative changes that led to the development of the optimised peroxidase assay protocol 
are reflected by the workflow presented in Table 4.5.2.3 below. 
Final SSBLM-embedded NupC peroxidase assay detection protocol 
SSBLM sample creation 
- 50% (w/w) 100 nm NupC/POPC and POPC-only SSBLMs (2.5 mg particles/1 mL sample) 
- 25% (w/w) 200 nm NupC/POPC and POPC-only SSBLMs (2.5 mg particles/1 mL sample) 
↓ 60-second vortexing ↓ 
MilliQ® water wash 
- 1 mL of MilliQ® water per sample 
- one wash during a 10-minute incubation at room temperature with gentle roller mixing 
↓ 60-second vortexing ↓ 
SSBLM sample division 
- use half of the total sample volumes (i.e. 500 µL) 
- divide these further into a total of 40×50 µL smaller working samples 
↓ 60-second vortexing ↓ 
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Anti-His antibody incubation 
- 1:5,000 (v/v) in PBS buffer supplemented with 1 mg/mL BSA and 1% (w/v) POPC LUVs 
- 1, 2, 4, 8, 12, 16, 20, 30, 40 and 50 µL of antibody solution added per sample 
↓ 60-second vortexing ↓ 
Antibody wash 
- PBS buffer supplemented with 1 mg/mL BSA and 1% (w/v) POPC LUVs 
- two washes during 10-minute incubations at room temperature with gentle roller mixing 
↓ 60-second vortexing ↓ 
Plating 
- 50 µL of sample transferred per well of a Costar® flat-bottomed 96-well plate 
- 50 µL of ADHP working reagent added per well to give 100 µL final sample volumes 
↓ 30-second shaking ↓ 
Results 
- NupC-embedding SSBLM emission significantly higher than that of POPC-only SSBLMs 
- Fluorescence emission of protein-free negative controls reduced to expected baseline levels 
Table 4.5.2.3. Workflow illustrating the optimised protocol for the peroxidase assay detection of 
SSBLM-embedded His6-tagged NupC. 
The optimised peroxidase assay protocol detailed above was also used to test whether 
SSBLMs formed using IM/POPC LUVs overexpressing His6-tagged NupC represented a 
viable method for performing antibody binding studies against protein targets embedded 
in their original biological membranes, since this approach could prove particularly useful 
towards the future assaying of membrane proteins that are difficult to purify and/or 
reconstitute into lipid vesicles. To this end, 200 nm POPC LUVs (diluted to 5 mg/mL in 
PBS buffer) were mixed via the freeze-thaw method with E. coli IMs overexpressing 
His6-tagged NupC at increasing IM/POPC (w/w) ratios (i.e. total IM protein content 
versus model lipid weight). Additional POPC LUVs were also mixed at identical w/w 
ratios with E. coli IMs overexpressing untagged NupC to serve as negative controls. 
The resulting IM/POPC solutions were re-extruded through another 200 nm 
polycarbonate filter to ensure LUV size homogeneity, then mixed with 100- and 200 nm 
silica nanoparticles to respectively form 100 µL SSBLM samples at 50- and 25% (w/w) 
LUV/nanoparticle ratios. Following the MilliQ® water wash, the SSBLMs were 
resuspended in 1:1 volumes of HRP-conjugated mouse IgG1 anti-His antibodies diluted 
1:5,000 (v/v) in PBS buffer supplemented with 1 mg/mL BSA and 1% (w/v) POPC 
LUVs, then incubated for 1 hour at room temperature with gentle roller mixing. After 
that, the SSBLMs were washed twice in the above blocking buffer to remove any unbound 
antibodies, then resuspended in the same buffer, transferred onto a Costar® flat-bottomed 
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96-well plate (50 µL of sample per well) and supplemented with 50 µL of ADHP working 
reagent. The fluorescence emission was finally measured using a BMG LABTECH 
FLUOstar OPTIMA spectrofluorometer at a wavelength of 590 nm. The assay yielded 
reproducible results that consistently saturated the spectrofluorometer beyond the 20-
minute reagent incubation mark (Figure 4.5.2.4). 
  
Figure 4.5.2.4. The fluorescence emissions resulting from 100 nm (left) and 200 nm (right) silica 
nanoparticles coated with SSBLMs formed using IM/POPC LUVs embedding untagged (blue) 
and His6-tagged NupC (red) after 20 minutes of incubation with the ADHP working reagent. The 
samples were formed according to the optimised SSBLM peroxidase assay protocol. The error 
bars represent the standard error of the mean, n = 3. 
Based on the results presented above in Figure 4.5.2.4, it was decided that all future mixed 
membrane LUVs be formed at the highest (i.e. 40% (w/w)) protein/lipid ratio. This 
specific ratio was also employed by Dodd et al. (2008), who successfully formed and 
characterised mixed membrane SSMs on planar silica surfaces and ultimately reported 
that this distribution of native membrane to model lipids allowed for an optimal balance 
between facile bilayer formation and embedded membrane protein coverage. 
4.5.3. Confirmation of SSBLM-embedded NupC via cryo-EM 
While the previous subsections confirmed that NupC could indeed be successfully 
embedded into the SSBLM format, the spectrofluorometric detection methods presented 
above still could not differentiate between protein-rich SSBLMs correctly enveloping the 
nanoparticles and intact proteoliposomes merely attaching to the silica substrate without 
actually forming a bilayer. The high-resolution imaging of NupC-embedding SSBLM 
samples was thus attempted via cryo-EM towards demonstrating correct bilayer 
formation with embedded protein around the chosen silica nanoparticles. 
Fresh SSBLM samples were thus formed by mixing 200 nm His6-tagged NupC/POPC 
proteoliposomes (2% (w/w) protein/lipid ratio) with 200 nm silica nanoparticles at a 25% 
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(w/w) LUV/nanoparticle ratio. POPC-only SSBLMs were also formed at the same w/w 
ratio to serve as protein-free negative controls. After the SSBLMs were washed in 
MilliQ® water, the particles were resuspended in 1:1 volumes of PBS buffer 
supplemented with 1 mg/mL BSA and 1% (w/v) POPC LUVs and incubated for 1 hour 
at room temperature with gentle roller mixing. 
The SSBLMs were then pelleted via centrifugation (13,000 g spin for 30 seconds at 4 °C) 
and resuspended in identical volumes of a 5 nm Ni-NTA-Nanogold® probe solution 
prepared in the above blocking buffer at a 2:1 probe/protein molar ratio. Following 
another 30-minute incubation at room temperature with gentle roller mixing, the SSBLMs 
were washed twice – first in blocking buffer and then in regular PBS buffer – for 10 
minutes per wash under similar conditions. The washed SSBLM solutions were then 
diluted 10× in PBS buffer and applied to the cryo-EM grids as described in subsection 
3.4.1 before finally being imaged at a magnification of 35,000× using a FEI Tecnai F20 
TEM fitted with a Gatan 4K×4K CCD camera (Figure 4.5.3.1). 
  
Figure 4.5.3.1. Left: 200 nm silica nanoparticles coated with POPC SSBLMs embedding His6-
tagged NupC, imaged at a 35,000× magnification using a FEI Tecnai F20 TEM fitted with a Gatan 
4K×4K CCD camera. The particles had been pre-incubated with Ni-NTA-Nanogold® probes at a 
2:1 probe/protein molar ratio in order to reveal the presence of SSBLM-embedded His6-tagged 
NupC, as evidenced by the black dots representative of the 5 nm probe-conjugated gold 
molecules. The red circles highlight unfused NupC/POPC LUVs. Right: 200 nm silica 
nanoparticles coated with POPC-only SSBLMs for negative control purposes (courtesy of Dr. 
Stephen Muench, The School of Biomedical Sciences, University of Leeds). 
The cryo-EM images presented above in Figure 4.5.3.1 revealed not only poor Ni-NTA 
probe coverage (possibly as a consequence of unequal blotting and/or poor vitrification 
of the cryo-grids by the FEI Vitrobot), but also unfused LUV remnants, prompting the 
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need for more stringent washing and a higher probe/protein molar ratio in subsequent 
attempts. While very few probes were visible in this first instance, they were nevertheless 
found in close proximity to (i.e. less than 5-10 nm) or even on top of the imaged 
nanoparticles, suggesting that the SSBLMs were indeed present, even though the discrete 
structure of their lipid components could not be resolved using the TEM setup available 
at our disposal. 
The imaging was therefore repeated using new 200 nm SSBLM samples pre-incubated 
with Ni-NTA probes at a higher 10:1 probe/protein molar ratio. Concurrently, the 
blocking and PBS buffer washing steps were each supplemented with 1-minute rounds of 
vigorous vortexing before and after each pelleting and resuspension. While the resulting 
images suffered from less-than-ideal vitreous ice quality, the abundance of Ni-NTA 
probes dotting the surface of the NupC-embedding nanoparticles – but not that of the 
POPC-only negative controls – nevertheless confirmed the presence of SSBLM-
embedded His6-tagged NupC, even though the lipid membrane components revealed by 
Mornet et al. (2005) or Trépout et al. (2007) still remained unresolved (Figure 4.5.3.2). 
  
Figure 4.5.3.2. Left: 200 nm silica nanoparticles coated with POPC SSBLMs embedding His6-
tagged NupC, imaged at a 30,000× magnification using a FEI Tecnai F20 TEM fitted with a Gatan 
4K×4K CCD camera. The multitude of gold-conjugated Ni-NTA probes (black dots) detected 
either on the surface or in the immediate vicinity of the imaged nanoparticles confirmed the 
presence of SSBLM-embedded His6-tagged NupC. Right: 200 nm silica nanoparticles coated with 
POPC-only SSBLMs for negative control purposes showing no signs of Ni-NTA probe binding 
(courtesy of Dr. Stephen Muench, The School of Biomedical Sciences, University of Leeds). 
Having established not only the successful formation of SSBLMs embedding the different 
NupC constructs on the 100- and 200 nm silica nanoparticles, but also the accessibility of 
the target protein towards high-affinity antibody binding, the platform was deemed 
suitable for the phage display screening of DARPin binders against NupC presented in 
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this novel format. For a recapitulative look at the overall platform development plan, a 
summary of the experimental findings presented in the current chapter can be found in 
Figure 4.5.3.3 below. 
SSBLM FORMATION AND CHARACTERISATION CONCLUSIONS 
NupC construct expression and purification 
✓ Overexpressed double Strep-tagged, His6-tagged and untagged NupC in E. coli 
✓ Purified or isolated each NupC construct according to the described protocols 
↓ 
Purified NupC transport activity measurement 
✓ SURFE2R assays confirmed that IM-bound untagged NupC retained its transport activity 
✓ IM-bound His6-tagged NupC also demonstrated some activity, albeit at much lower levels 
↓ 
Planar SSM formation and characterisation 
✓ Successfully formed POPC SSMs on planar silica substrates as reported via QCM-D 
✓ Achieved successful planar SSM formation embedding each of the three NupC constructs 
↓ 
SSBLM formation and characterisation 
✓ Established the saturation thresholds resulting in full coverage of the chosen nanoparticles 
✓ Confirmed the correct formation of SSBLMs around the silica nanoparticles via SAXS 
↓ 
Embedding NupC into the SSBLM platform 
✓ Successfully formed SSBLMs on the chosen nanoparticles using reconstituted NupC LUVs 
✓ Confirmed the presence and accessibility of SSBLM-embedded NupC via antibody binding 
Figure 4.5.3.3. Workflow summarising the experimental findings presented in the current chapter 
regarding the development of our proposed SSBLM phage display screening platform. 
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CHAPTER 5 
 
SSBLM-Based Phage Display Screening 
 
5.1. Introduction to SSBLM-Based Screening against NupC 
Following the successful characterisation of the SSBLM platform embedding the 
different NupC constructs, this novel target presentation format was used towards the 
selection of DARPin binders against His6-tagged NupC. While phage display screening 
generally requires between 3-5 panning rounds before high-affinity binders can be 
isolated against a given antigen (Hoogenboom, 2002), for the purposes of this project 
only two rounds of selection were performed against His6-tagged NupC across each of 
the different screening formats detailed in the following subsections. In short, these 
included traditional “solid” selections performed against detergent-solubilised His6-
tagged NupC adsorbed onto regular 96-well plates, as well as “soluble” selections 
performed against the SSBLM-embedded protein suspended in small-volume liquid 
samples. For providing even better comparisons between the traditional and SSBLM-
based screening approaches, the solid selections were performed both with and without 
extra detergent added to the screening buffers (so as to determine the extent of epitope 
occlusion caused by the detergent micelles), while the soluble selections were carried out 
both with and without a prior deselection step performed on protein-free, POPC-only 
SSBLMs (so as to eliminate any non-specific binders from the final selection output). 
After completing all of the selection rounds across each of the different screening formats 
described above, the amino acid sequences encoding the DARPins forming the final 
selection output were aligned and examined in order to identify those candidates which 
showed the highest potential binding affinity for His6-tagged NupC. Following that, the 
top 20 most promising DARPins (i.e. the lead candidates) were purified and subjected to 
further binding validation assays against the two other constructs (i.e. double Strep-
tagged and untagged NupC), in order to isolate any binders that might have actually 
targeted the His6-tag of the NupC construct used during screening and not its natural 
epitopes that would normally also be accessible in vivo. To this end, the 20 lead candidate 
DARPins were re-screened against detergent-solubilised double Strep-tagged NupC 
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presented in the traditional plate-bound format, as well as untagged NupC embedded 
within SSBLMs formed using mixed membrane IM/POPC LUVs. 
5.2. The Different DARPin Screening Formats Tested against 
NupC 
DARPin binders were selected against His6-tagged NupC presented in a variety of 
different formats so as to better allow for comparisons to be drawn between the traditional 
method of performing phage display screening against detergent-solubilised membrane 
protein targets and the novel detergent-free SSBLM platform. The individual formats will 
be described in further detail throughout the subsections below. 
5.2.1. Traditional plate-based screening against detergent-solubilised 
NupC 
Before trialling the novel SSBLM-based screening method, a traditional selection against 
detergent-solubilised His6-tagged NupC adsorbed onto a classic 96-well plate support was 
performed according to the protocol detailed in subsection 3.4.7 for comparison purposes. 
Following the completion of the two selection rounds, the sequencing results revealed a 
DARPin diversity of 67% after panning the library against His6-tagged NupC presented 
in this format. Two new rounds of selection were then performed against the plate-bound 
detergent-solubilised protein following the same protocol while also supplementing all of 
the screening solutions and buffers with 0.05% (w/w) DDM. A summary of the traditional 
selections performed against detergent-solubilised His6-tagged NupC and their respective 
outcomes can be found in Table 5.2.1.1 below. 
Antigen presentation 
format 
Deselected 
against 
Phage 
input titre 
Phage 
output titre 
DARPin 
diversity 
Detergent-solubilised His6-
tagged NupC 
No 
deselection 
1.8×1012 
cfu/mL 
3.4×105 
cfu/mL 
67% 
Detergent-solubilised His6-
tagged NupC with additional 
0.05% (w/w) DDM present 
No 
deselection 
4.5×1012 
cfu/mL 
6.5×106 
cfu/mL 
93% 
Table 5.2.1.1. Details and outcomes of the traditional plate-based DARPin selections performed 
against detergent-solubilised His6-tagged NupC. 
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5.2.2. Novel SSBLM-based screening against detergent-free NupC 
In order to provide proof-of-concept for this novel phage display screening platform, 1 
mL SSBLM samples were respectively formed on both 100- and 200 nm silica 
nanoparticles at 60- and 30% (w/w) saturation ratios, embedding His6-tagged NupC at a 
4% (w/w) protein/lipid ratio. Protein-free SSBLMs were also created at identical 
saturation ratios from POPC-only LUVs for use during the deselection phases. 
Two rounds of soluble DARPin selection were then performed against the SSBLM-
embedded His6-tagged NupC suspensions held in 1.5 mL Eppendorf tubes, each round 
using only 500 μL (i.e. half) of each SSBLM solution. To begin with, both the protein-
free and NupC-embedding SSBLMs were first pelleted via centrifugation (3,220 g spin 
for 1 minute at 4 °C) and had their supernatants replaced with 1:1 volumes of blocking 
buffer. The SSBLMs were then left to incubate for 1 hour at room temperature with gentle 
roller mixing, alongside the DARPin library solutions undergoing the same procedure 
(i.e. two 50 μL DARPin library aliquots mixed with 450 μL of blocking buffer each). 
Deselection was then performed by pelleting the protein-free SSBLMs via centrifugation 
(3,220 g spin for 1 minute at 4 °C) and then replacing their supernatants with the 500 μL 
blocked DARPin library aliquots, followed by another hour of incubation under the above 
conditions. After that, both the protein-free and NupC-embedding SSBLMs were re-
pelleted, the supernatants of the latter samples were discarded and the supernatants of the 
former ones – containing the deselected DARPin libraries – were added to the NupC-
embedding SSBLM pellets. The resuspended protein-rich SSBLMs were then left to 
incubate for another hour under the previously-stated conditions to allow for the 
deselected DARPins to bind to the SSBLM-embedded His6-tagged NupC. 
Following this incubation, the NupC-embedding SSBLMs were pelleted via 
centrifugation, their supernatants were discarded and the particles were washed five times 
in regular PBS buffer via 5-minute incubations at room temperature with gentle roller 
mixing. The bound phages were then eluted by resuspending the SSBLMs in elution 
buffer and leaving them to incubate for 30 minutes at 37 °C with gentle roller mixing. 
The eluted phages were amplified by adding each of the particle supernatants to 4.5 mL 
of TG1 E. coli cultured to log-phase in 2×TY growth medium and incubating the resulting 
mixtures for 1 hour at 37 °C with 150 rpm orbital shaking. Finally, the phage-infected 
TG1 cell cultures were serially-diluted in 2×TY growth medium from 1:10 to 1:1,000 
(v/v) and 100 μL volumes of each dilution were spread onto 2×TYAG agar Petri dishes. 
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The remaining TG1 cells were then harvested via centrifugation (3,220 g spin for 1 minute 
at 4 °C), resuspended in 1 mL of 2×TY growth medium per pellet and spread onto separate 
2×TYAG bioassay dishes. An identical volume of a non-infected, log-phase TG1 cell 
culture was also spread onto its own 2×TYAG Petri dish to serve as a negative control. 
All of the Petri and bioassay dishes were then left to incubate overnight at 30 °C. 
The following day, the TG1 cells harbouring the eluted phages were scraped off the 
bioassay dishes using 10 mL 2×TY growth medium volumes supplemented with 50% 
(w/v) glycerol and used to create 2 mL -80 °C backups. The remainder of the scraped 
bacteria were then transferred into 25 mL volumes of 2×TYAG growth medium to give 
starting D600nm values of 0.1. These cultures were incubated at 37 °C with 150 rpm orbital 
shaking until log-phase was reached, at which point they were each superinfected with 
2.5 μL of M13K07trp helper phage stock and left to incubate for an additional hour under 
similar conditions. Following that, the cells were harvested via centrifugation (3,220 g 
spin for 10 minutes at 4 °C), their supernatants were discarded and the pellets were each 
resuspended in 0.5 mL of 2×TYAK growth medium. These cell suspensions were then 
used to further inoculate 25 mL volumes of 2×TYAK growth medium, after which the 
phage rescue was allowed to take place overnight at 25 °C with 280 rpm orbital shaking. 
Finally, 1 mL volumes were taken from each overnight culture and the harboured cells 
were pelleted at maximum speed in a table-top centrifuge. The supernatants – containing 
the amplified phages – were then used during the second round of selection performed 
against the remaining 500 µL volumes of each initial SSBLM solution. Once the second 
round of selection was also completed, colonies were picked from the serially-diluted 
Petri dish cultures, transferred to Costar® flat-bottomed 96-well plates containing 120 μL 
of 2×TYAG growth medium per well and incubated overnight at 37 °C with 150 rpm 
orbital shaking. The next day, 40 µL samples were taken from each well and transferred 
onto new Costar® flat-bottomed 96-well plates that were later sent for binder sequencing 
and diversity assessment, while the remaining well contents were each supplemented with 
40 µL of 50% (w/v) glycerol so as to create further backups for storage at -80 °C. 
Two rounds of DARPin selection were also performed against SSBLM-embedded His6-
tagged NupC without a prior deselection done on protein-free particles, so as to evaluate 
the usefulness of this step towards isolating high-affinity binders against membrane 
protein targets presented in the SSBLM format. The final sequencing results revealed 
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DARPin diversities in the range of 91-95% across all of the selections performed against 
SSBLM-embedded His6-tagged NupC (Table 5.2.2.1). 
Antigen presentation 
format 
Deselected 
against 
Phage 
input titre 
Phage 
output titre 
DARPin 
diversity 
SSBLM-embedded 
His6-tagged NupC 
(with deselection) 
100 
nm 
POPC-only 
SSBLMs 
4.9×1012 
cfu/mL 
4.7×104 
cfu/mL 
93% 
200 
nm 
POPC-only 
SSBLMs 
4.6×1013 
cfu/mL 
5.2×105 
cfu/mL 
91% 
SSBLM-embedded 
His6-tagged NupC 
(without 
deselection) 
100 
nm 
No 
deselection 
5.9×1012 
cfu/mL 
5.1×105 
cfu/mL 
93% 
200 
nm 
No 
deselection 
6.4×1012 
cfu/mL 
1.1×105 
cfu/mL 
95% 
Table 5.2.2.1. Details and outcomes of the novel SSBLM-based DARPin selections performed 
against detergent-free His6-tagged NupC. 
5.3. Identifying the Lead Candidate DARPin Binders 
Following the completion of the DARPin selections across all of the above screening 
formats, the lead candidate binders were isolated for further validation in order to confirm 
their genuine affinity for NupC. 
5.3.1. Aligning the amino acid sequences of the total selection output 
Upon aligning the amino acid sequences of the 707 unique DARPin binders selected 
against His6-tagged NupC (Figure 5.3.1.1 overleaf), it was discovered that a number of 
these repeated between 3-20× not only throughout the total selection output, but also 
across the different screening formats as well. Therefore, the isolated candidates encoded 
by these recurring sequences were believed to have the highest chances of representing 
genuine NupC binders. 
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Figure 5.3.1.1. The DARPin amino acid sequences featuring the highest number of repeats 
throughout the total selection output (shown here in brackets), as aligned using Clustal Omega. 
The highlighted areas represent conserved regions shared by every consensus-built DARPin, 
while the variable regions unique to each binder have been left white for enhanced readability.  
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After examining the amino acid sequences presented above in Figure 5.3.1.1, it became 
clear that a majority of the most promising DARPins featured tryptophans heavily, which 
could have translated into a potential affinity for the lipid bilayer components of the 
SSBLMs in addition to that against the embedded His6-tagged NupC. Positively-charged 
amino acids such as asparagine were also prominently displayed, which likely facilitated 
binding to the negative regions of the protein or protein-membrane interfaces, as well as 
being indicative of a strong affinity for any negatively-charged patches of exposed silica. 
Therefore, in order to highlight the structural relationships identified between each chosen 
candidate, a phylogenetic tree was also constructed as shown in Figure 5.3.1.2 below. 
 
Figure 5.3.1.2. The phylogenetic tree resulting from aligning the most recurring DARPin amino 
acid sequences using Clustal Omega. The clones marked with a red “X” were chosen as the lead 
candidate binders selected against His6-tagged NupC across all of the different screening formats. 
Out of the 36 DARPins presented above in Figure 5.3.1.2, a “shortlist” of the 20 clones 
showing the highest number of repeats throughout the total alignment (each marked with 
a red “X”) were ultimately designated as the lead candidate binders and taken forward for 
purification and affinity re-assessment against the other available NupC constructs. 
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5.4. Purifying the Lead Candidate DARPin Binders 
The steps involved in purifying each of the chosen lead candidates – from binder plasmid 
isolation to high-affinity chromatography – will be presented throughout the following 
subsections. 
5.4.1. Isolating the plasmid DNA encoding the lead candidate DARPins 
The plasmids encoding the 20 lead candidate DARPins were purified using a 
ChargeSwitch®-Pro plasmid miniprep kit according to the protocol supplied by the 
manufacturer, reproduced in subsection 3.4.8. 
The purified DARPin plasmids contained a pC6 expression vector that Dr. Vincent 
Agboh (The School of Biomedical Sciences, University of Leeds) discovered to be 
unsuitable for the purification of the selected binders due to a malfunctioning amber stop 
codon leading to the expression of the entire ligand-coat fusion protein instead. Therefore, 
each of the isolated DARPin plasmids had to be subcloned into a new pET-16b expression 
vector in order to bypass this issue. To this end, a double restriction digest was performed 
on commercially-sourced pET-16b for a minimum of 2 hours at 37 °C before the product 
was run on a 1% (w/v) TAE agarose gel and the relevant band – containing the digested 
vector – was cut from the gel and cleaned using a Wizard® SV gel and PCR clean-up 
system, then stored at -20 °C. After that, PCRs were performed on the DARPin DNA and 
the amplified plasmids were run on 2% (w/v) TAE agarose gels. The bands containing 
the PCR products were then extracted, cleaned up using the same Wizard® system and 
subjected to an overnight double restriction digest so as to remove the DARPin DNA 
fragments from the pC6 vector. The resulting digests were run on and subsequently cut 
out of 1% (w/v) TAE agarose gels, applied to the Wizard® clean-up system and then 
ligated with the digested pET-16b overnight at a 1:10 vector/insert molar ratio. The 
ligation products were transformed into competent OmniMAX E. coli (i.e. 5 µL of 
ligation product per 20 µL of cell culture) which were finally spread onto 2×TY agar Petri 
dishes supplemented with carbenicillin (100 µg/mL) and left to incubate overnight at 
37 °C. 
A double restriction digest control was used to confirm the presence of the DARPin 
fragments before an expression trial was attempted. Figure 5.4.1.1 overleaf showcases 
the DNA fragments encoding seven of the lead candidate DARPins, confirming that they 
had been successfully ligated with pET-16b. The other thirteen lead candidate plasmids 
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showed similar bands on identical 1% (w/v) TAE agarose gels (not shown here). For extra 
validation, all DARPin plasmids were sent to Source Bioscience for sequencing and the 
results confirmed that all of the DNA fragments encoding the 20 lead candidates were 
present within their respective plasmids after their subcloning into the pET-16b vector. 
 
Figure 5.4.1.1. TAE agarose gel of 7 lead candidate DNA fragments subcloned into a pET-16b 
expression vector. The lanes represent, from left to right: I. 1 kb DNA ladder; II. A11 100 nm 
REDUX2; III. C04 200 nm REDUX1; IV. G02 SS-DESEL 100 nm; V. A07 SSBLM 100 nm; VI. 
H04 100 nm REDUX2; VII. C07 SSBLM 200 nm; VIII. E11 SSBLM 200 nm. The red rectangle 
highlights the bands representative of the DARPin-encoding DNA fragments. 
5.4.2. Small-scale expression trial of the lead candidate DARPins 
A small-scale trial was used to verify the expression levels of the chosen lead candidate 
DARPins before tackling their full-scale purification. To this end, all 20 DNA fragments 
subcloned into a pET-16b expression vector were transformed into competent BL21 E. 
coli (i.e. 1 µL of pET-16b/DARPin plasmid per 10 µL of cell culture), after which they 
were spread onto 2×TY agar Petri dishes supplemented with carbenicillin (100 µg/mL) 
and left to incubate overnight at 37 °C. 
The following day, 1 mL volumes of 2×TY growth medium supplemented with 
carbenicillin (100 µg/mL) were inoculated with one colony from each plate and the 
resulting cultures were left to incubate overnight at 37 °C with 280 rpm orbital shaking. 
The next day, other 5 mL volumes of 2×TY growth medium supplemented with 
carbenicillin (100 µg/mL) were inoculated with 250 µL from the overnight cultures and 
incubated for 2 hours at 37 °C with 280 rpm orbital shaking. After that, the cultures were 
separated into 2.5 mL volumes, 0.5 mM IPTG was added to half of these and then all of 
the cultures were left to incubate for an additional 4 hours under the same conditions. 
Following protein overexpression, 1 mL volumes were taken from each culture and the 
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cells were harvested via centrifugation (17,000 g spin for 10 minutes at 4 °C). The 
supernatants were discarded and the cell pellets were each resuspended in 1 mL of 2× 
PBS buffer before being diluted 1:10 (v/v) using the same buffer. SDS-PAGE loading 
buffer (4×) was then added in 2.5 µL volumes per 10 µL of diluted cell suspension, after 
which all of the samples were left to incubate at 95 °C for 10 minutes. Finally, given that 
all of the DARPin fragments also encoded His6-tags for purification purposes, both SDS-
PAGE and Western blotting were performed in order to verify the outcome of the small-
scale expression trial using a purified E3-5 DARPin supplied by MedImmune as a 
positive control (Figure 5.4.2.1). 
 
Figure 5.4.2.1. Coomassie Blue-stained polyacrylamide gel (top) and corresponding Western blot 
(bottom) stained to detect the His6-tags of the DARPin samples resulting from the small-scale 
expression trial. The lanes represent, from left to right: I. Protein ladder; II. H01-; III. H01+; IV. 
C01-; V. C01+; VI. H11-; VII. H11+; VIII. A08-; IX. A08+; X. E3-5. The “+” lanes contain 
samples that had been incubated with 0.5 mM IPTG, whereas the “-” lanes contain samples that 
had been kept uninduced. 
Judging from the results depicted above in Figure 5.4.2.1, it became clear that the isolated 
DARPins were not readily visible on Western blots incubated with our commercially-
sourced anti-His antibodies. Nevertheless, all 20 constructs did ultimately express 
according to the purified DARPin concentrations revealed via BCA assay and despite the 
fact that all of the lead candidates showed slightly different migration patterns on 
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otherwise identical SDS-PAGE gels. IPTG induction also did not appear to significantly 
influence DARPin expression, although this finding was not explored any further. 
5.4.3. Full-scale expression and purification of the lead candidate 
DARPins 
Following the successful small-scale expression trial, the 20 lead candidate DARPins 
were expressed and purified in larger volumes according to a MedImmune protocol 
optimised by Dr. Vincent Agboh (The School of Biomedical Sciences, University of 
Leeds), reproduced here for clarity. Firstly, competent BL21 E. coli were transformed 
with each lead candidate plasmid (i.e. 1 µL of pET-16b/DARPin DNA per 10 µL of cell 
culture), then spread onto 2×TY agar Petri dishes supplemented with carbenicillin (100 
µg/mL) and subjected to an overnight incubation at 37 °C. The next day, a single colony 
from each plate was used to create inoculation cultures comprising of 30 mL volumes of 
carbenicillin-supplemented 2×TY growth medium. These cultures were also left to 
incubate overnight at 37 °C with 280 rpm orbital shaking, after which they were 
subsequently used to inoculate even larger 500 mL volumes of carbenicillin-
supplemented 2×TY growth medium with starting D600nm values of 0.1. The 500 mL 
cultures were then incubated for 2 hours at 37 °C with 280 rpm orbital shaking before 0.5 
mM IPTG was added to each flask and DARPin overexpression was allowed to occur 
over an extra 4 hours of incubation under similar conditions. A 1 mL volume of 2×TY 
growth medium without any antibiotics was also inoculated with 50 µL of stock BL21 
competent cells as a negative control. 
The cells of the IPTG-induced cultures were harvested via centrifugation in a JLA-10.500 
rotor (9,000 g spin for 30 minutes at 4 °C), the supernatants were discarded and the cell 
pellets were stored at -20 °C overnight. After being thawed the next day, each pellet was 
resuspended in 25 mL of 2× PBS buffer and disrupted twice through a Constant Systems 
TS series cell disruptor operating at 30 kpsi and 4 °C. The resulting cell debris was 
pelleted via ultracentrifugation in a Ti50.2 rotor (100,000 g spin for 1 hour at 4 °C) and a 
BCA assay was used to determine the total protein content of the supernatants harbouring 
the expressed lead candidate DARPins. Owing to their His6-tagged N-terminals, each 
supernatant solution was further mixed with 1 mL of HisPur™ cobalt resin (first washed 
in 10 mL volumes of MilliQ® water, then pre-equilibrated with 2× PBS buffer) and left 
to incubate overnight at 4 °C with gentle roller mixing in the presence of 10 mM 
CHAPTER 5 – SSBLM-BASED PHAGE DISPLAY SCREENING 
 
138 
imidazole, so as to prevent other cytoplasmic proteins from adhering non-specifically to 
the added resin. 
The following day, the mixtures were loaded into 5 mL Pierce™ disposable columns and 
allowed to flow through twice, in order to maximise the retention of all of the material 
from the overnight incubation. The resin was then washed dropwise with 10 CVs of wash 
buffer before 600 µL of elution buffer were added and allowed to flow through so as to 
remove any residual wash buffer. After that, the column ends were sealed and 400 µL of 
elution buffer were added, then left to incubate with the resin for 10 minutes at 4 °C with 
gentle roller mixing. These 400 µL volumes were afterwards collected separately and the 
remaining DARPins were eluted in 10×1 mL subsequent fractions. Based on their A280nm 
values, the first four “peak” fractions were pooled together and dialysed extensively in 
2× PBS buffer so as to remove any residual imidazole. Quality control was then 
performed on the purified DARPins via SDS-PAGE and Western blotting, as shown 
below in Figure 5.4.3.1 for the H01 100 nm REDUX1 clone. Although each of the lead 
candidates ultimately showed different levels of expression, in the end all appeared to 
have purified to a high degree, resulting in average yields of 1 mg of pure protein per 100 
mL of cell culture. 
 
Figure 5.4.3.1. Coomassie Blue-stained polyacrylamide gel (top) and corresponding Western blot 
(bottom) stained to detect the His6-tags of the H01 100 nm REDUX1 DARPin purification 
samples. The lanes represent, from left to right: I. Protein ladder; II. Pre-IPTG induction cell 
culture sample; III. Column flowthrough; IV. Column wash; V. Fraction 0; VI. Fraction 1; VII. 
Fraction 2; VIII. Fraction 3; IX. Fraction 4; X. E3-5 positive control. The red rectangle highlights 
the bands representative of the H01 100 nm REDUX1 DARPin clone. 
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5.5. Characterising the Purified Lead Candidate Binders 
Following their purification, all of the 20 lead candidate DARPins were re-screened 
against the other available NupC constructs presented in both detergent-solubilised (i.e. 
plate-based), as well as detergent-free (i.e. SSBLM-embedded) formats in order to assess 
their binding affinities against native NupC epitopes. 
5.5.1. Re-screening against detergent-solubilised double Strep-tagged 
NupC 
In an attempt at uncovering any potential His6-tag binders isolated throughout the 
numerous DARPin selection phases, the 20 lead candidates were re-screened against 
detergent-solubilised double Strep-tagged NupC using an ELISA protocol optimised with 
the help of Dr. Vincent Agboh (The School of Biomedical Sciences, University of Leeds), 
reproduced here below. 
Purified double Strep-tagged NupC was first diluted in wash buffer to a concentration of 
1 mg/mL, then added to the wells of Nunc™ MaxiSorp™ flat-bottomed 96-well plates in 
50 µL volumes so as to bind 5 µg of protein per well. Identically-diluted His6-tagged 
NupC was also added to a few empty wells as a positive control. The plates were then 
covered with adhesive plastic lids and NupC was left to adsorb overnight at 4 °C. The 
next day, the coating solutions were removed and the plates were washed three times with 
200 μL of wash buffer per well. The wells were then each filled with 200 μL of blocking 
buffer and the plates were once again covered and left to incubate for 1 hour at 4 °C. After 
three more washes with 200 μL of wash buffer per well, a serial dilution of the purified 
lead candidate binders – ranging from 10 µM to 1 pM – was prepared in the same buffer. 
Three of the blocked wells seeded with double Strep-tagged NupC were then filled with 
50 µL volumes of wash buffer to serve as negative controls, while the serially-diluted 
DARPin solutions were added to the remaining test wells in identical volumes. In order 
to provide additional negative controls, the assayed binders were likewise added at 10 
µM, 1 µM and 100 nM concentrations to protein-free wells that had also undergone 
blocking, after which the plates were covered once more and left to incubate for 1 hour 
at 4 °C. 
After the plates were washed with three additional volumes of 200 μL of wash buffer per 
well, HRP-conjugated mouse IgG1 anti-His antibodies (diluted 1:5,000 (v/v) in blocking 
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buffer) were added to each well in 50 µL volumes. The covered plates were then left to 
incubate for 1 more hour at 4 °C before the wells were washed three times with 200 μL 
of antibody wash buffer each. Finally, pre-warmed TMB liquid substrate system for 
ELISA was added in 50 µL volumes per well and the covered plates were left to incubate 
at room temperature with gentle rocking mixing. After 30 minutes of colour development, 
the conjugated HRP was inactivated by dispensing similar volumes of 0.5 M H2SO4 into 
each well. Their respective absorbance values were then measured at a wavelength of 450 
nm using a Thermo Scientific Multiskan™ FC spectrophotometer, revealing that a 
majority of DARPins showed signs of weak (i.e. micromolar) binding to double Strep-
tagged NupC. The top five candidates with the highest affinities for this detergent-
solubilised construct were presented in Figure 5.5.1.1 below. 
 
Figure 5.5.1.1. The absorbances resulting from the DARPins with the highest affinities for 
detergent-solubilised double Strep-tagged NupC: G02 SS-DESEL 100 nm, C04 200 nm 
REDUX1, A07 SSBLM 100 nm, F03 200 nm REDUX1 and E11 SSBLM 200 nm. The averaged 
His6-tagged NupC positive controls and double Strep-tagged NupC negative controls are 
presented as green and red lines, respectively. The error bars represent the standard error of the 
mean, n = 3. 
5.5.2. Re-screening against detergent-free untagged NupC 
Having assayed all of the purified DARPins against detergent-solubilised double Strep-
tagged NupC, the lead candidates were also re-screened against untagged NupC presented 
in the SSBLM format so as to obtain further validation over the above binding results. 
The protocols for creating the requisite samples and then running the SSBLM-based 
ELISAs will be reproduced below for consistency. 
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In order to create the SSBLM particles embedding untagged NupC, 5 mg POPC aliquots 
were first rehydrated with 1 mL of PBS buffer each, then subjected to a 60-second round 
of vigorous vortexing. E. coli IMs overexpressing untagged NupC, as well as His6-tagged 
PepTSo (acting as the positive control), were also diluted to 5 mg/mL of total protein 
content using PBS buffer before being vortexed with the POPC solutions to create 40% 
(w/w) IM/POPC mixtures via the freeze-thaw method. The NupC/POPC and 
PepTSo/POPC suspensions were then subjected to an additional 2 minutes of vigorous 
vortexing alongside the leftover POPC solution before being extruded through separate 
polycarbonate filters to yield 400 nm LUVs. Following that, the resulting IM/POPC and 
protein-free vesicles were mixed with 100 nm silica nanoparticles (10 mg/mL in 
deionised water) to produce SSBLMs at 50% (w/w) LUV/nanoparticle ratios. The particle 
solutions were then vigorously vortexed for another 2 minutes before being left to 
incubate overnight at 4 °C with gentle roller mixing. The next day, the SSBLMs were 
once again subjected to 2 minutes of vigorous vortexing before being harvested via 
centrifugation (17,000 g spin for 1 minute at 4 °C) and washed in 1:1 volumes of MilliQ® 
water through a 30-minute incubation at 4 °C with gentle roller mixing. Finally, the 
washed particles were once again vortexed vigorously for 120 seconds, re-pelleted via 
centrifugation and resuspended in similar volumes of blocking buffer. 
The SSBLM-based DARPin ELISAs consisted of adding the sample solutions to the wells 
of Costar® V-bottomed 96-well plates in 50 µL volumes, then supplementing these with 
an additional 150 µL of blocking buffer per well and leaving the covered plates to 
incubate for 1 hour at 4 °C with gentle rocking mixing. The SSBLMs were then pelleted 
via centrifugation (3,220 g spin for 5 minutes at 4 °C) and washed twice via resuspension 
in 200 µL of wash buffer per well followed by 5-minute centrifugations under similar 
conditions. The washed SSBLMs were then re-pelleted via centrifugation and 
resuspended in 50 µL of serially-diluted DARPins per well (i.e. 10 µM to 1 pM). 
Following a 1-hour incubation at 4 °C with gentle rocking mixing, the SSBLMs were 
washed twice as previously described and resuspended in 50 µL volumes of HRP-
conjugated mouse IgG1 anti-His antibodies (diluted 1:5,000 (v/v) in blocking buffer) per 
well. After an additional 1-hour incubation at 4 °C with gentle rocking mixing, the 
SSBLMs were once again washed twice in wash buffer and resuspended in 50 µL of plain 
PBS buffer before being transferred onto Costar® flat-bottomed 96-well plates. Pre-
warmed TMB liquid substrate system for ELISA was then added to the wells in 50 µL 
volumes and the plates were left to incubate at room temperature with gentle rocking 
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mixing. Following sufficient colour development (i.e. after approximately 15 minutes of 
incubation), 50 µL volumes of 0.5 M H2SO4 were added to each well to stop the reaction. 
The absorbance values were ultimately measured at a wavelength of 450 nm using the 
same Thermo Scientific Multiskan™ FC spectrophotometer, yet the new results appeared 
polarising: a number of clones that previously demonstrated micromolar affinity for 
detergent-solubilised double Strep-tagged NupC did not appear to bind to the untagged 
construct at all (e.g. C04 200 nm REDUX1), while other candidates that showed no 
affinity for double Strep-tagged NupC now appeared to bind SSBLM-embedded 
untagged NupC within the same micromolar range observed previously (Figure 5.5.2.1). 
 
Figure 5.5.2.1. The absorbances resulting from the DARPins with the highest affinities for 
detergent-free (i.e. SSBLM-embedded) untagged NupC: E10 SSBLM 200 nm, D02 SSBLM 100 
nm, A07 SSBLM 100 nm, C04 200 nm REDUX1 and A08 100 nm REDUX3. The averaged His6-
tagged PepTSo positive controls and untagged NupC negative controls are presented as green and 
red lines, respectively. The error bars represent the standard error of the mean, n = 3. 
The results presented above in Figure 5.5.2.1 appear to indicate that several NupC 
epitopes that had been previously occluded by detergent micelles during the first ELISAs 
performed against detergent-solubilised NupC became readily accessible when the 
protein was embedded within the SSBLM format. On the other hand, the possibility of 
the lipid bilayer component shielding yet another epitope subset could also explain why 
the clones showing affinity for detergent-solubilised NupC were no longer able to bind 
the SSBLM-embedded protein. This would likewise explain why the affinities of a 
number of promising DARPins identified via the previous ELISAs were reduced when 
the same clones were re-screened against the embedded untagged NupC. 
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5.6. Evaluating the Outcome of the DARPin Selections 
The results of the DARPin phage display screening performed against NupC and their 
significance towards the future development of the SSBLM antigen presentation format 
will be examined throughout the following subsections. 
5.6.1. The phage display screening of antibodies against membrane 
proteins 
The DARPin selections presented earlier in the chapter ultimately yielded a number of 
weak, micromolar-affinity binders against NupC mainly due to the fact that the time spent 
at MedImmune only allowed for two rounds of panning for each of the different screening 
formats. Unfortunately, a binding validation assay could also not be developed in time 
for re-screening the total selection output of 707 unique DARPins against NupC in a high-
throughput manner before the most promising binders had to undergo expression and 
purification. With that being said, even though phage display screening typically requires 
between 3-5 rounds of selection before high-affinity binders can be identified 
(Hoogenboom, 2002), it is important to remember that the aim of the project was never 
to discover strong ligands against NupC. Rather, the focus was on developing the SSBLM 
platform and comparing it to the traditional antigen presentation methods with special 
regard given to the issues caused by the presence of detergents during antibody screening. 
This goal was clearly supported by the results presented throughout the current chapter, 
with the data from Tables 5.2.1.1 and 5.2.2.1 being especially interesting. Significant 
differences in clone diversity were registered between the traditional plate-based 
selections performed against detergent-solubilised His6-tagged NupC with and without 
extra detergent present in the screening buffers (i.e. 67% versus 93% binder diversity, 
respectively). Given that higher diversity numbers generally reflect selection outputs 
featuring lower-affinity binders, it would appear that the addition of even more detergent 
to successive panning rounds is clearly detrimental towards antibody binding, likely due 
to the detergent occlusion of target epitopes. The subsequent selections performed against 
the same NupC construct embedded within the SSBLM format showed similarly-high 
diversities (i.e. >90% for both particle sizes), but in this case they came as a consequence 
of the greatly increased surface area dedicated to antigen binding offered by the nanosized 
substrates compared to the wells of traditional assay plates. Moreover, the insignificant 
differences arising from the inclusion or omission of the deselection step performed 
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against protein-free particles questioned its usefulness towards future selections and could 
potentially vouch for its complete removal so as to reduce the time cost of the already-
lengthy screening rounds. Finally, it is important to note that none of the binders identified 
through the ELISA performed against detergent-solubilised double Strep-tagged NupC 
were found to be repeated throughout the total selection output or across the different 
screening formats. This would, in turn, suggest that even though the DARPins selected 
against detergent-solubilised NupC without DDM supplementation enjoyed the lowest 
clone diversity and, consequently, the highest potential binding affinities for their 
intended target, these particular binders likely favoured an epitope that is normally 
occluded by the lipid bilayer component of the SSBLM particles and – most probably – 
living cell membranes as well. This finding sheds considerable light on the importance of 
using a close-to-native antigen presentation method for screening antibodies against 
membrane protein targets, so as to ultimately maximise the chances of isolating 
candidates that actually target epitopes normally accessible in vivo. 
Additionally, the facile adaptability and versatility of the SSBLM platform allows for the 
complete coverage of not just nanoparticles, but also micrometre-sized beads in 
continuous lipid bilayers mimicking the spherical architecture of living cells (Schadauer 
et al., 2015). This model can be even further improved upon through the use of surface 
treatments that can direct the orientation of reconstituted membrane proteins (Trépout et 
al., 2007) and allow targets to retain their natural mobility throughout the supporting 
bilayers (Richards et al., 2016). Furthermore, using mesoporous particles as substrates for 
SSBLM formation could create artificial cytoskeletons whose aqueous interspaces would 
connect with the cytoplasmic sides of the embedded membrane proteins and thus allow 
these constructs to also be successfully used in functional assays as advanced substitutes 
for the proteoliposomes routinely used up until now (Nordlund et al., 2009). Coupled with 
straightforward protocols, as well as easy manipulation with only minimal training, the 
results presented throughout the past chapters show great promise for continuing the 
research on SSBLMs and testing them on a wider variety of membrane protein targets. 
5.6.2. Testing the SSBLM format on new membrane protein targets 
In order to further validate SSBLMs as versatile antigen-immobilisation platforms for the 
screening of binder candidates against membrane protein targets originating from more 
advanced expression systems, MedImmune provided us with mammalian cell pellets 
overexpressing a formyl peptide receptor (FPR) that they had already raised a high-
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affinity antibody against. SSBLMs were therefore created using mixtures of POPC and 
FPR-expressing mammalian cell membranes, then subjected to another ELISA performed 
according to the protocol detailed in subsection 5.5.2, reproduced below for clarity. 
To begin with, the supplied FPR-expressing and uninduced (i.e. negative control) 
mammalian cell pellets were resuspended in 2 mL of HEPES buffer each and disrupted 
by passing the mixtures 11 times through an isobiotec cell homogeniser. The resulting 
cell debris and organelles were pelleted via centrifugation (6,000 g spin for 10 minutes at 
4 °C) and the cell membranes were harvested by ultracentrifuging the supernatants 
(100,000 g spin for 2 hours at 4 °C). The membrane pellets were then each resuspended 
in 500 μL of HEPES buffer and a BCA assay was used to determine their overall protein 
concentrations before they were snap-frozen in liquid nitrogen and stored at -80 °C 
overnight. The two different membrane suspensions were diluted the next day to 5 mg/mL 
of total protein content using HEPES buffer, then mixed at a 40% (w/w) ratio via the 
freeze-thaw method with a similarly-concentrated POPC solution prepared in the same 
buffer. The resulting mixtures were subsequently extruded into 400 nm LUVs and used 
towards the formation of 100 nm SSBLMs at a 50% (w/w) LUV/nanoparticle ratio. 
The SSBLM-based FPR ELISAs then followed the same steps outlined in subsection 
5.5.2 up until the antibody incubation, at which point the blocked nanoparticle pellets 
were each resuspended in 100 µL of anti-FPR IgG 0165 primary antibodies (diluted to 1 
μg/mL in HEPES buffer) and left to incubate for 1 hour at 4 °C with gentle rocking 
mixing. Afterwards, the particles were once again washed twice in wash buffer, followed 
by pelleting via centrifugation and resuspension in 100 µL of goat anti-human IgG (Fc-
specific) peroxidase-conjugated antibodies diluted 1:2,000, 1:6,000, 1:12,000, 1:24,000 
and 1:48,000 (v/v) in blocking buffer. Following an additional 1-hour incubation at 4 °C 
with gentle rocking mixing, the SSBLMs were washed twice once more, re-pelleted via 
centrifugation and finally resuspended in 50 µL of plain HEPES buffer per well before 
being transferred onto a Costar® flat-bottomed 96-well plate. 
Pre-warmed TMB liquid substrate system for ELISA was then added to each well in 50 
µL volumes and the SSBLMs were left to incubate at room temperature with gentle 
rocking mixing until sufficient colour development had occurred (i.e. after approximately 
15 minutes). Following that, 50 µL volumes of 0.5 M H2SO4 were added per well to stop 
the reaction and the absorbances were ultimately measured at a wavelength of 450 nm 
using a Thermo Scientific Multiskan™ FC spectrophotometer (Figure 5.6.2.1 overleaf). 
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Figure 5.6.2.1. The absorbances resulting from an ELISA testing the epitope accessibility of 
membrane-bound mammalian FPR embedded into the SSBLM format. Uninduced membrane and 
POPC-only particles (red and green, respectively) were used as negative controls, alongside the 
averaged absorbances of empty wells (purple). Only the data points for the 1:12,000, 1:24,000 
and 1:48,000 (v/v) secondary antibody dilution factors were presented here, in order to keep 
background absorbance levels to a minimum and also avoid reaching the saturation limit of the 
employed spectrophotometer. The error bars represent the standard error of the mean, n = 3. 
The results presented in Figure 5.6.2.1 confirmed that the embedded mammalian FPR 
was accessible towards high-affinity antibody binding and that the SSBLM format was 
suitable for screening candidate libraries against not just prokaryotic membrane proteins 
such as NupC, but also eukaryotic ones as well. By also taking into account that a density 
gradient was not used to separate the lysosomal membranes from the plasma membranes 
prior to creating the FPR/POPC particles, it is very likely then that the results presented 
above can be improved upon even further with additional protocol optimisation. To 
conclude, a more detailed discussion regarding the applicability of the SSBLM platform 
towards membrane protein research in general will be presented throughout the final 
Chapter 6. 
Until then, a summative perspective on the SSBLM-based phage display screening of 
DARPin binders against NupC, alongside the other experimental findings presented in 
the current chapter, can be found in Figure 5.6.2.2 overleaf.  
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SSBLM-BASED PHAGE DISPLAY SCREENING CONCLUSIONS 
Testing the SSBLM platform for phage display screening 
✓ Screened MedImmune’s DARPin library against His6-tagged NupC across different formats 
✓ Only performed two rounds of selection per screening format for comparison purposes 
↓ 
Identifying and purifying the “lead candidate” binders 
✓ Aligned the total selection output via Clustal Omega and discovered repeating sequences 
✓ Isolated the plasmids, then purified the lead candidates with the highest number of repeats 
↓ 
Determining the success of the SSBLM platform 
✓ Re-screened the purified lead candidates against the other available NupC constructs 
✓ Tested the SSBLMs with FPR and confirmed their applicability to other protein targets 
Figure 5.6.2.2. Workflow summarising the experimental findings presented in the current chapter 
regarding the SSBLM-based phage display screening of DARPin binders against NupC. 
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CHAPTER 6 
 
Discussion and Conclusions 
 
6.1. Discussion 
The impact screening supports have on selecting antibody binders against reconstituted 
membrane protein targets, as well as the virtues and limitations of the novel SSBLM 
format, will be evaluated throughout the following subsections. 
6.1.1. Presenting targets for screening in a close-to-native format 
Model membranes represent valuable tools for the study of membrane proteins in vitro, 
but their successful application is closely linked to the characteristics of not only the 
protein targets themselves, but also to those of the assay at hand. Depending on the type 
of membrane protein being studied, certain models such as lipid bilayers formed on Ni-
NTA-treated surfaces could facilitate target relipidation in a preferred orientation, while 
other membrane models such as proteoliposomes would not. Conversely, the latter model 
could allow a membrane protein such as an integral transporter to preserve its function 
post-purification, while the former SSM model would not. This is especially noteworthy 
considering that the solvent-filled gap formed between the solid support and the deposited 
lipid bilayer might not even permit the correct integration of certain membrane protein 
targets whose extramembranous domains extend further than a few nanometres (Richards 
et al., 2016). Nevertheless, even following successful SSM integration, coming into 
contact with the underlying substrate would undoubtedly affect protein fluidity within the 
model membrane and, in turn, lead to an unequal target distribution throughout the 
antigen presentation area. 
In order to circumvent the issues caused by target immobility, as well as the need for 
finding an optimal detergent for membrane destabilisation ahead of protein reconstitution 
(Seddon et al., 2004), several alternatives to the traditional method of SSM formation via 
proteoliposome deposition have already been trialled. These included the self-insertion 
of membrane protein targets into an already-formed SSM (Diaz et al., 2008) or the 
sonication of native cell membranes together with PEGylated synthetic lipids, followed 
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by the deposition of the resulting mixed vesicles onto a solid substrate to form a polymer-
supported lipid bilayer (Pace et al., 2015). Unfortunately, neither of these methods is 
without its own drawbacks, since the former has only been tested for a specific class of 
membrane proteins (i.e. annexins), while the sonication step required by the latter would 
invariably disturb the orientation of the embedded protein targets (Richards et al., 2016). 
Beyond its long-term denaturating effect and the potential occlusion of target epitopes, 
the detergent solubilisation of membrane proteins comes with several other issues not 
pertaining directly to antibody screening. Firstly, detergent monomers seldom arrange 
into neatly-packaged micelles and it is therefore possible that their inability to solubilise 
certain membrane protein classes arises from the defects inherent to monomer packing, 
which can ultimately lead to protein aggregation and inactivation following purification 
(Garavito and Ferguson-Miller, 2001). Furthermore, the complete delipidation of 
membrane proteins – long pursued by X-ray crystallographers and NMR experts striving 
to obtain high-purity samples – has also been linked to increased chances of protein 
denaturation and, consequently, loss-of-function post-purification (le Maire et al., 2000). 
It is because of these undesirable side effects that a new “purer is not always better” 
paradigm has emerged in modern Structural Biology, paving the way for the purification 
of protein-lipid complexes rather than just the membrane protein targets by themselves 
(Garavito and Ferguson-Miller, 2001). Several approaches have already been made 
available to this end through the use of apolipoprotein nanodiscs (Hagn et al., 2013) and 
styrene-maleic acid copolymer lipid particles (SMALPs) (Lee et al., 2016), both of which 
can extract protein targets from their native membrane environments along with a 
proximal portion of their associated lipid bilayer components as well. Hopefully, these 
emergent technologies will help bolster the number of membrane protein structures 
available to date – unfortunately representing less than 1% of all submissions to the 
Protein Data Bank (PDB) (Mancia and Love, 2010) – and thus refine our understanding 
of membrane proteins and the treatment of their related disorders at the same time. 
6.1.2. Current limitations of the SSBLM screening format 
While highly versatile and clearly adaptable to membrane protein targets originating from 
both prokaryotic and eukaryotic expression systems, rapid SSBLM sedimentation under 
normal gravity (i.e. <10 minutes) was nevertheless observed for both particle sizes below 
vesicle/nanoparticle ratios of 20% (w/w) for the 100 nm nanoparticles and 10% (w/w) for 
their 200 nm counterparts. However, upon increasing the vesicle concentrations above 
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said ratios, both samples remained suspended in solution over much longer periods of 
time (i.e. >3 hours). The rapid sedimentation was therefore likely caused by the 
incomplete SSBLM formation observed below the two experimentally-determined 
saturation ratios, since non-functionalised nanoparticles tend to aggregate in high ionic 
strength buffers (Moore et al., 2015), such as the PBS buffer used for resuspending the 
particles following the MilliQ® water washing step. However, once the SSBLMs are 
completely enveloping the silica nanoparticles, their aggregation is prevented due to the 
altered surface chemistries of the particles promoting dispersion in solution. 
Our attempts at reproducing the results obtained by Mornet et al. (2005) and Trépout et 
al. (2007) towards resolving the lipid component of the SSBLMs via cryo-EM have, 
unfortunately, not been met with the same level of success. Luckily, the SAXS 
measurements detailed in subsection 4.4.2 did provide similarly-strong evidence of 
correct SSBLM formation around the nanoparticle substrates. Moreover, even though the 
cryo-EM images presented in subsection 4.5.3 did not reveal the lipid bilayers 
surrounding the depicted 200 nm nanoparticles, the positioning of the gold-labelled Ni-
NTA probes – either on top of or within lipid-bilayer proximity to the silica substrate – 
strongly suggested that the SSBLMs were indeed present, but simply remained 
unresolved using the TEM setup we had at our disposal at the time. It should also be noted 
that Mornet et al. (2005) used vesicles of a different lipid composition to our own, in 
addition to the fact that we aimed to match the quality of their results using 
proteoliposomes embedding reconstituted membrane proteins, whose mere presence 
undoubtedly impacts SSBLM formation in ways that are not yet fully understood at the 
moment (Granéli et al., 2003). 
6.2. Future Directions 
Throughout recent years, the study of membrane protein targets embedded in detergent-
free, close-to-native formats such as SSBLMs, SMALPs and nanodiscs has become more 
and more commonplace, fostering a deeper understanding of the complex proteolipid 
interactions affecting their conformations and functions in relation to the lipid bilayer 
component of native cell membranes. These novel research platforms will undoubtedly 
pave the way for new exciting contributions in the near future as well. Considering their 
performance during the phage display screening of DARPin binders against His6-tagged 
NupC, it has become clear that SSBLMs represent a valuable new means of assaying 
antibody binding to membrane proteins embedded in a close-to-native format that not 
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only mimics the biological environment from which the screening targets originated, but 
also elegantly circumvents the undesirable consequences of traditional detergent-based 
selection methods. 
With that being said, the SSBLM format would certainly benefit from faster washing 
steps that do not rely on centrifugation for the removal of particles from solution. Rather, 
the use of iron oxide-core, silica-shell nanoparticles for the formation of future SSBLM 
samples would undoubtedly save considerable time due to the increased pelleting speed 
afforded by a high-power magnetic separator compared to a table-top centrifuge. 
Ultimately, even more advanced levels of automation would very likely be possible in an 
industrial setting, allowing the true value of the SSBLM platform to be fully appreciated. 
It was certainly unfortunate that the available project time did not allow for an 
examination of the potential effects the lead candidate DARPins might have had on the 
ex vivo nucleoside transport activity of purified NupC. Nevertheless, the SURFE2R 
measurements did reveal that said activity was mainly dependent on the level of NupC 
expression relative to that of other E. coli IM proteins and not necessarily on the 
concentration of NupC-embedding vesicles loaded onto a prepared N1 sensor. This 
observation helped reinforce the idea that an unambiguous comparison between the post-
purification transport activities demonstrated by the three NupC constructs used 
throughout the project would be quite difficult to perform, especially given that 
membrane protein expression levels can vary substantially between different purification 
runs. 
In the end, should high-affinity antibody binders be selected via phage display screening 
against future SSBLM-embedded targets, then the optimal number of selection rounds 
must be rigorously observed (i.e. 3-5 instead of just 2). Furthermore, a high-throughput 
method of detecting phage-bound antibody binding to the embedded membrane proteins 
must also be developed in order to ensure that only those candidates displaying the highest 
affinities towards their intended targets are carried forward though the laborious and time-
consuming full-scale expression and purification processes. 
6.3. Conclusions 
With greatly varied applications and still-untapped potential, model membranes have 
already contributed substantially to our understanding of native membrane biophysics 
and biochemistry and have helped researchers translate theoretical knowledge into real-
CHAPTER 6 – DISCUSSION AND CONCLUSIONS 
 
152 
life technological applications in fields as diverse as micro- and nanoarray sensor 
development (Wittenberg et al., 2011), novel functional materials (Collins et al., 2016), 
advanced drug delivery methods (Lockhart et al., 2016) and even nanoscale encapsulation 
for the preservation of foodstuffs and drugs (Ghorbanzade et al., 2016). 
Research into membrane biology is especially relevant at present given that a majority of 
the pharmaceuticals available today target membrane proteins exclusively (Hopkins and 
Groom, 2002). While these drugs regularly take the form of antibodies or antibody 
mimetics, the screening procedures employed in their discovery require the fragile 
membrane protein targets to be detergent-solubilised for post-purification stability prior 
to their immobilisation onto a screening support. Unfortunately, the presence of detergent 
micelles during antibody selection can prevent the isolation of high-affinity binders 
through the occlusion of key epitopes on the target protein surface. 
Therefore, the main objective of the project at hand revolved around adapting SSM 
technology featuring reconstituted membrane protein targets into a novel research 
platform that could bring several improvements to the traditional process of phage display 
screening while simultaneously circumventing the issues caused by detergent 
solubilisation. As the results presented throughout the current thesis have already 
demonstrated, SSBLMs embedding reconstituted membrane proteins represent an 
enhanced format for presenting antigens to binding candidates that could potentially act 
as therapeutics by modulating the function of their bound targets. 
SSBLMs combine the desirable properties of both nanomaterials and model membranes, 
representing objects of great scientific and even commercial interest, especially for the 
drug discovery industry. They constitute a versatile, native-like format for the embedding 
of phenotypically-diverse membrane proteins while significantly reducing or outright 
eliminating the screening issues associated with target denaturation, antigen availability 
or epitope accessibility. SSBLMs also facilitate research and development opportunities 
such as the creation of nanovectors capable of delivering therapeutic payloads to drug 
targets (Mornet et al., 2005). Furthermore, there is already convincing evidence to support 
applying the SSBLM formation strategies presented thus far to nanoparticles coated with 
shells of a different composition, such as superparamagnetic ferrite nanoparticles (Mornet 
et al., 2002) or fluorescent quantum dots (Rochard et al., 2002), so as to expand the 
physical properties of the platform in any way that might prove useful towards 
manipulating biomolecules of varying sizes and functions. 
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The future development of this novel format specifically for use in phage display 
screening would also undoubtedly benefit the selection of novel antibody-based 
therapeutics for a number of reasons. By embedding membrane protein targets into 
SSBLMs, a resilient support for the high-throughput screening of vast candidate libraries 
can be constructed in a time-efficient manner with minimal effort and no specialist 
training. Coupled with the substantially increased surface area and feasibility offered by 
nanoscopic redispersible substrates, this technology shows promise towards becoming a 
genuine boon for the screening of novel protein-binding therapeutics such as the 
DARPins selected against NupC during the current project. Moreover, the fact that fully-
functional SSBLMs can be also created from vesicles extruded from native cell 
membranes mixed with model lipids supports their use towards performing binding 
validation assays in a semi-in vivo fashion as well. 
In conclusion, the nanoscale SSBLM model represents a highly promising platform for 
the selection of antibody binders against a multitude of potential membrane protein 
targets and, as such, it rightfully deserves to be further explored and refined in the near 
future. 
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APPENDIX 
 
Figure A1. Map of the pBPT-0217-CS2T plasmid encoding double Strep-tagged NupC (courtesy 
of Dr. Vincent Postis, The School of Biomedical Sciences, University of Leeds). 
 
Figure A2. Map of the pLH13 plasmid encoding His6-tagged NupC (courtesy of Dr. Vincent 
Postis, The School of Biomedical Sciences, University of Leeds). 
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Figure A3. Map of the pGJL16 plasmid encoding untagged/wild-type NupC (courtesy of Dr. 
Vincent Postis, The School of Biomedical Sciences, University of Leeds). 
 
Figure A4. Map of the pMPSIL0079A plasmid encoding His6-tagged PepTSo (courtesy of Dr. 
Vincent Postis, The School of Biomedical Sciences, University of Leeds). 
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